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ABSTRACT 
 
Psoriasis vulgaris is a chronic, hyper-proliferative skin condition which affects the patient’s 
quality of life. The treatment strategy involves long term use of drugs that maintain the 
condition, however; playing a pivotal negative role in patient compliance. A constructive 
development in the design of treatment addressing the disease should focus on the 
challenges faced by current designs. Hence, cellular internalization and trans-barrier 
transport of nanoparticles can be manipulated on the basis of the physicochemical and 
mechanical characteristics of nanoparticles to enhance the treatment options of the condition 
by reducing dosing and increasing the healing due to intracellular drug delivery. Dictating 
these characteristics allows for the control of the rate and extent of cellular uptake, as well 
as delivering the drug-loaded nanosystem intra-cellularly which is imperative for drugs that 
require a specific cellular level to exert their effects, as is with psoriasis. Additionally, 
physicochemical characteristics of the nanoparticles should be optimal for the nanosystem to 
bypass the natural restricting phenomena of the body and act therapeutically at the targeted 
site.  
 
Neo-geometric copper nanoparticles (CuNPs) in the biomedical application ascertained skin 
permeation and retention of the CuNPs as a drug delivery system. The approach to the use 
of the nanocrystal exploited the shape properties as a function of enhanced cellular uptake 
and the copper in the inflamed psoriatic environment acted as a cytotoxic agent against 
hyper-proliferating keratinocytes. A Self-Oscillating Polymeric Network (SOPN) served as a 
vehicle for the topical delivery of the geometric CuNPs in addition to its oscillating 
phenomenon to promote the permeation of the active nanoparticles across the rate limiting 
barrier of the skin, the stratum corneum. This twofold system adequately targets the key 
limitations in addressing psoriasis. 
 
A statistical experimental design comprising a full factorial model for the optimization of the 
geometric CuNPs and Box-Behnken design applied on the SOPN served as a refining factor 
to achieve stable, homogenous, geometric nanoparticles using a one-pot method for the 
systematic optimization of the geometric CuNPs. The optimization of the SOPN involved 
amplitude and duration of the oscillations, permeation kinetics and cytotoxicity. After 
optimization of the nano-shapes and oscillations of the SOPN, extensive ex vivo cellular 
internalization studies were conducted to elucidate the effect of geometric CuNPs on uptake 
rates; in addition to the vital toxicity assays to further understand the cellular effect of 
geometric CuNPs as a drug delivery system. Complementing the geometry analysis; 
volume, surface area, orientation to the cell membrane and colloidal stability were also 
addressed. The SOPN was also investigated ex vivo for its biocompatibility to determine the 
LD50 and permeation kinetics. 
 
The in vivo study probed the nanosystem embedded in the innovative SOPN to stimulate the 
permeation of the CuNPs across the stratum corneum of the induced psoriasiform-plaque in 
a BALB/c mouse model. The results confirmed an optimized CuNPs-loaded SOPN topical 
system with promising plaque thickness reduction when compared with a commercial gold 
standard in the treatment of the skin condition. This novel system can be safely used with 
less frequent, lower dosing and no odour, therefore promoting patient compliance. 
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CHAPTER 1 
INTRODUCTION AND RATIONALE OF THE STUDY 
 
1.1. Background to the Study 
 
Dermal psoriasis is a chronic, inflammatory condition which is characterized by plaques on 
the flexor surfaces of the body (Kilfoyle et al., 2012). In the pathophysiology of the disease, 
cytokine production is up-regulated resulting in the hyper-proliferation of keratinocytes and 
T-cell pathogenesis found in the basal layer of the epidermis (Tzu et al., 2006). The psoriasis 
plaque is the result of the accompanying inflammatory process (Tzu et al., 2006). The 
disease affects the patients’ quality of life socially and psychologically and improved therapy 
would substantially reduce discomfort and the augment patients’ quality of life (Raddadi et 
al., 2011). Current therapeutic interventions include topical corticosteroids, vitamin D 
analogues, tacrolimus, salicylic acid, coal tar and combination therapy (Raddidi et al., 2011).  
Studies show that these drugs have been successively incorporated into topical 
nanosystems such as biodegradable nanoparticles, tyrosine-derived nanospheres (Kilfoyle 
et al., 2012), lipid nanocarriers (Agrawal et al., 2012), activated nanogels (Singka et al., 
2010) and drug-loaded mesoporous nanoparticles (Vadia and Rajput, 2012) which focus on 
keratolytic processes. However, these interventions do not allow for the delivery of active 
agents intracellularly or the enhanced permeation of anti-psoriatic dugs through the stratum 
corneum and thick psoriatic plaque by a direct mechanism. Epidermal hyperplasia as the key 
component in this immune response and maintenance of the psoriatic plaque (Griffiths and 
Barker, 2007) and the highly implicated stratum corneum significantly affects permeability of 
foreign substances (Elias and Menon, 1990). In the treatment of psoriasis, surpassing these 
barriers may significantly enhance the treatment prognosis. 
 
Studies to specifically determine the effect of nanoparticle shape on cellular internalization 
are limited (Gould, 2006) yet necessary in order to enhance biomedical technology and 
inform toxicity studies. The various pathways for cellular internalization of nanoparticles 
includes 1) clathrin-mediated endocytosis in which membrane invagination occurs due to the 
clathrin protein, 2) clathrin-independent endocytosis, 3) caveolae-mediated endocytosis 
where caveolin proteins induce plasma invaginations, 4) dynamin-dependent endocytosis 
causes vesicle scission at the plasma membrane, and 5) clathrin- and caveolae-independent 
pathways (Musyanovych et al., 2011). Nanoparticles for enhanced internalization may use 
the same mechanism and mimic the structural parameters of natural peptides such as 
proteins or hormones which internalize readily. Factors affecting cellular internalization 
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include the nanoparticle size, shape, surface charge, chemical composition, surface 
morphology, functionality and stability (Gratton et al., 2008). For example, dermal psoriasis 
of which there is no cure would have an increased prognosis factor if therapeutic 
interventions targeted intracellular components in its treatment strategy. 
 
Therefore, this study focuses on improved cell uptake via a smart nanosytem of neo-
geometric copper nanoparticles (CuNPs) embedded in a vehicle to promote the delivery of 
the copper as a model drug. The field of nanomedicine is characterized in drug delivery in 
terms of nanoparticle shape, size, type, chemical composition and use (Li et al., 2008). The 
scope for further research into this ever-advancing concept has immense potential to 
progress medical care by decreasing side-effect profiles due to specific and targeted drug 
release, improving bioavailability and bypassing first-pass metabolism of drugs (Nomura et 
al., 2009). Nanoparticle shape can impact the cellular internalization process and may 
enhance the performance of nano-polymer drug carriers (Kuntsche et al., 2010). Gratton and 
co-workers (2008) undertook a study which proved that cylindrical nanoparticles enhanced 
the internalization of HeLa cells. However, this internalization was dependent on the 
appropriate orientation of the nanoparticles to the targeted cells. In this study, the shape 
effect of internalization will be ascertained and when coupled with the cytotoxic potential of 
the copper, this novel drug delivery system may prove to be at the forefront of psoriatic 
treatment innovations. 
 
In the synthesis of the Self-Oscillating Polymeric Network (SOPN) vehicle, utilising the 
Belousov-Zhabotinsky (BZ) reaction provides a dynamic system of redox oscillations which 
can be applied to transdermal drug delivery (Yoshida and Ueki, 2014). This phenomenon 
promotes periodic, mechanical, macroscopic waves when applied to gels and polymers, in 
acidic solution with required substrates. The automatic mechanical oscillation of the polymer 
gel will be induced by the covalently coupled BZ reaction encouraged by ionic charge 
oscillations of the required substrates. Also known as tunnelling, the quantum mechanical 
occurrence allows for a particle to penetrate and cross a barrier that it typically cannot 
without external control. Providing the additional energy supplied by the macroscopic waves 
of the BZ reaction, the anti-psoriatic drug will be stimulated to cross the skin barrier into the 
hyper-keratinized layer. The chemical process produces mechanical and physical change 
within the system resulting in biomedical and therapeutic benefits.  
 
The inflamed environment of the psoriasis, after application of the gel system, serves as the 
external stimuli controlling the activation of the reaction to create the periodic oscillations, 
hence the use of a stimuli-sensitive polymer activator. Thus, the rhythmic and spatial 
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patterns produced by the reaction stimulate the movement of the nanoparticles and 
enhances penetration through the psoriatic skin. Applying this concept to drug delivery and 
overcoming the limitation of drug transport through the stratum corneum, especially the 
thickened psoriatic plaque, will serve as an innovative strategy in the treatment of various 
dermal syndromes. Increasing drug content to penetrate this layer will significantly reduce 
therapeutic time and dosing periods. 
 
1.2. Rationale and Motivation for this Study 
 
According to the World Health Organization (WHO) (2013), studies in developed countries 
have an estimated psoriasis prevalence of 4.6% and 90% of these cases is plaque psoriasis 
(Al Raddadi et al., 2011). Psoriasis is incurable and due to the nature of the skin disorder, is 
a challenge to treat. Making use of a nanosystem with enhanced intracellular delivery and a 
delivery vehicle to stimulate penetration of anti-psoriatic drug through the stratum corneum 
allows for increased drug permeation, reduced duration of treatment and a decreased drug 
concentration required for application. Delivering drug at the intended dermal target site 
provides a direct means to treat dermal conditions allowing for the avoidance of hepatic 
metabolism and systemic side effects (Alexander et al., 2012).  
 
When considering psoriasis, first-line therapy consists of topical agents (Al Raddadi et al., 
2011); hence, maximising the efficacy of topical treatment should be a priority focus in 
psoriasis research. Topically applied CuNPs between 15-100nm have been evaluated to 
penetrate skin pores and induce necrosis in the epidermal layer where cellular vitality is 
significantly affected (Cohen et al., 2013). Copper has an anti-proliferative and cytotoxic 
effect by inducing apoptosis and has been reported to improve anti-cancer therapy (Jose et 
al., 2011), properties which make it suitable for use as an agent to therapeutically target 
psoriasis and will therefore be used as a model drug compound in this study. Most drugs 
used in the treatment strategy for psoriasis are cytotoxic (Tzu et al., 2006). By designing 
shape-specific CuNPs for enhanced cellular internalization, the cytotoxicity to surrounding 
tissue is reduced and targeted for the cells associated with the pathophysiology of the 
disease. Copper will be used as the drug model as it confers apoptotic properties and the 
shape of the metal nanoparticles, using varying surfactant concentrations, can be 
manipulated to conduct this study (Figure 1.1). 
 
In the course of the BZ reaction of the SOPN vehicle, the transition metal catalyst 
periodically changes between the reduced state and the oxidised state creating the 
macroscopic vibrations. The reaction will be activated upon application of the CuNPs-loaded 
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SOPN to the psoriatic plaque in response to the change in pH provided by the mediators of 
psoriasis by varying the reaction substrates, altering its lower critical solution temperature 
values and employing the use of a thermo-responsive polymer with sensititivity to 
hydrophobic changes initiated by the BZ reaction. The inflammation-responsive SOPN will 
promote periodic, mechanical, macroscopic waves when applied to gels and polymers with 
required substrates in an area of inflammation which corresponds with low pH. The response 
will allow for the resulting BZ reaction to produce mechanical oscillating waves and stimulate 
the delivery of the CuNPs to permeate the stratum corneum barrier of the skin. Automatic 
mechanical oscillations of the polymer-gel will be induced by the covalently coupled BZ 
reaction encouraged by ionic charge oscillations of the required substrates. Providing the 
additional energy supplied by the macroscopic waves of the BZ reaction, the CuNPs will be 
stimulated to penetrate the skin barrier, hair follicles and skin pores (Figure 1.2). Once the 
CuNPs bypass the stratum corneum, the shape-specific CuNPs for enhanced cellular 
internalization into keratinocytes will confer its directed cytotoxicity and minimize effects on 
surrounding tissue by targeting for the cells associated with the pathophysiology of the 
disease. The importance of shape-specificity plays its role in the cellular uptake kinetics and 
cytotoxic potential of psoriasis drugs; and maintaining the integrity of the surrounding healthy 
tissue.  
 
 
                                          
 
Figure 1.1: Preliminary surfactant –coated copper nanoparticles of different shapes (ie. 
round, spherical, rod-like, elongated rod, cylindrical, filiform) to determine enhanced 
intracellular delivery to keratinocytes. 
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Figure 1.2: Schematic representation illustrates: a) the formulated neo-geometrical 
nanoparticles for enhanced cellular internalization suspended in the Self-Oscillating 
Polymeric Network; b) topical application of CuNPs dispersed within the inflammation-
responsive SOPN system; c) low pH activation of the BZ reaction results in a chemical 
reaction producing mechanical oscillations; d) oscillations promote enhanced penetration of 
CuNPs through thickened psoriatic plaque. 
 
1.3. Possible Therapeutic Applications of the Study 
 
• Local treatment of skin disorders (e.g. squamous cell carcinoma, bacterial/fungal 
infections, atopic dermatitis) by directly applying gel to targeted area. 
• Drugs that induce systemic side effects (e.g. tretinoin, NSAIDs) will bypass hepatic 
metabolism if delivered via the transdermal route and will not affect other 
physiological processes. 
• Skin disorders with hyper-keratosed characteristics and for application to body parts 
with thickened skin. 
a b 
c d 
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• Drug-free SOPN can be applied to any dermal condition with the inclusion of 
appropriate drug. 
• Dermal infection sites – copper has shown to confer antibacterial properties, utilising 
this phenomena and targeted delivery to the target site will result in enhanced drug 
delivery and shorter duration of therapy. 
 
1.4. Novelty of the Study 
 
• Shape-specific nanoparticles offer enhanced cell targeting from the intracellular 
component. 
• Selective accumulation of the CuNPs in the epidermis should eliminate adverse side 
effects associated with systemic exposure. 
• This formulation will control the over-proliferation of keratinocytes, dose-control the 
delivery of the CuNPs, and ease skin irritation caused by psoriasis. 
• It will be incorporated into a self-oscillating gel formulation that allows enhanced skin 
contact, this also ensures that the CuNPs limited to area of application and ease of 
application. 
• Use of the BZ reaction and its resulting mechanical oscillations in its application for 
topical therapy. 
• Use of the acidic environment provided by the psoriasis to control the activation of 
the BZ reaction.  
• Suspension of neo-geometrical CuNPs in the stimuli-responsive SOPN to enhance 
the permeability of the CuNPs through the skin barrier. 
 
1.5. Aim and Objectives of this Study 
 
The aim of this study was to synthesize CuNPs of various geometries to ascertain the effect 
of shape on cellular internalization. Upon completion of this aim and its relevant objectives, 
formulation advances were made to develop, enhance and evaluate a stimuli-responsive 
self-oscillating polymeric dermal delivery system that has the capability to activate 
mechanical oscillations by means of a chemical reaction after responding to the low pH 
generated by the psoriatic skin. The synthesized CuNPs is suspended in the SOPN gel 
which also serves as the delivery vehicle. The ultimate goal of the system was to synthesise 
a smart, dermal device to mechanically enhance the delivery of drugs through the skin 
barrier whereby the advantageous properties of both systems may be combined.  
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This study focused on designing a system with the following design criteria: 
• For the purpose of topical administration, the BZ reaction formed part of polymer-gel 
complex for ease of administration and familiarity to the patient in a conventional 
physical form. 
• The system consists of a polymeric gel system that is composed of a stimuli-
responsive polymer such as N-isopropylacrylamide to ensure activation of the BZ 
reaction upon exposure to the skin affected and reaction substrates to precede the 
reaction, creating mechanical oscillations.  
• Suspended within this polymeric gel network is the synthesized neo-geometric 
CuNPs for enhanced cellular internalization to promote optimal therapeutic 
responses.   
• Activation of the SOPN will occur only upon exposure to the site of application 
enstipulating stimuli-responsive behaviour ensuring the maintenance of the reaction 
until after topical application of the SOPN.  
 
The afore-mentioned objectives were met as determined through the completion of Design 
of Experiments statistical approach. 
 
The following objectives were also undertaken to ensure pragmatic fulfilment of the study: 
 
1.5.1. Neo-geometric copper nanoparticles 
a. The selection of appropriate materials and polymers to complement the synthesis of 
various copper nano-particulates using an adapted microemulsion, reverse micelle 
and thermal reduction method. 
b. Physicochemical and physicomechanical characterization of nano-shaped 
particulates will include size analysis, zeta potential tests and Transmission Electron 
Microscopy (TEM) for the shape identification of the nanoparticles, crystallinity and 
elemental composition by High Resolution Transmission Electron Microscope (HR-
TEM) analysis, X-ray diffraction (XRD), Selected Area Electron Diffraction (SAED), 
Energy Dispersive Spectra (EDS),  degradation of copper and stabilising coat by 
Thermo-Gravimetric Analysis (TGA) and molecular transitions by Fourier-Transform 
Infrared (FTIR). 
c. Ex vivo studies will investigate the cytotoxic potential and intracellular delivery of 
nanoparticles by incubating keratinocytes and cervical cancer cells with CuNPs. 
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1.5.2. Self-oscillating polymeric network 
a. The selection of appropriate materials, polymers and methods to complement the 
synthesis of the inflammation-sensitive self-oscillating polymer-gel for neo-geometric 
CuNPs. 
b. Synthesis of the thermo-responsive SOPN polymer-gel blend and incorporation of 
CuNPs will be conducted. 
c. Physicochemical characterization of oscillating polymer-gel blend will include 
Ultraviolet-Visible (UV) Spectroscopy, FTIR, and Differential Scanning Calorimetry 
(DSC). 
d. Ex vivo permeation studies will be carried out on excised mice skin to ascertain 
transport of the CuNPs from the SOPN through the stratum corneum. 
e. Ex vivo cytotoxicity studies will determine the biocompatibility of the system. 
f. The clinical potential of the system will be determined by conducting in vivo research 
upon a suitable animal model whereby the response of the SOPN will be tested on 
exposure to psoriatic skin upon completion of in vitro studies. Plaque thickness 
reduction and histological evaluation will be included in in vivo analyses. 
 
1.6. Overview of the Thesis 
 
Chapter 1 of this thesis provides an introduction and background to this study and highlights 
the rationale, aim, objectives and potential benefits of this study. 
 
Chapter 2 is a critical review of nano-characteristics affecting cellular internalization and 
transbarrier transport. Drug delivery systems using these techniques have also been 
addressed in addition to the current nanobiotechnology advances in application of the 
various biological barriers of the body. 
 
Chapter 3 of the thesis describes the preliminary synthesis parameters in the growth of neo-
geometric CuNPs. Analysis of the effect of dual surfactants creating a cationic complex 
evaluates the shape formation during synthesis of the nanocrystals. Physicochemical 
properties are also investigated for further analysis into the geometric nanocrystals. 
 
Chapter 4 highlights the investigation of synthesizing homogenous, stable geometric CuNPs 
through institution of a statistical experimental Full Factorial Design. The design, 
development and optimization are detailed. Using the key optimized geometric CuNPs, 
cellular uptake and toxicity studies on two cells lines are extensively investigated. 
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Chapter 5 focuses on the synthesis of a SOPN system and is optimized through a Box-
Behnken template for formulary analysis whereby 15 formulations are obtained. The 
optimized formulations are further characterized to elucidate its physicochemical and 
physicomechanical properties. The in vivo performances of the CuNPs and SOPN as 
independent and combined systems are investigated in the induced-psoriasis Bagg Albino 
(inbred research mouse strain) (BALB/c) mouse model in the determination of healing of the 
psoriasiform plaque. 
 
Chapter 6 concludes this thesis, discussing the limitations and recommendations for future 
use of the system. 
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CHAPTER 2 
A REVIEW OF PARAMETERS AND CHARACTERISTICS GOVERNING CELLULAR 
INTERNALIZATION AND TRANSBARRIER TRAFFICKING OF NANOSTRUCTURES 
 
2.1. Introduction 
 
The emergence of nanomedicine provides a strategic, therapeutic tool which aims to 
increase drug targeting to site-specific areas within the body. Nanoparticle research has 
identified the crossing of mucosal barriers and cellular uptake to support nanoparticle 
utilization, as well as nanoparticle surface properties that affect these phenomena (Alonso, 
2004). In the design of nanoparticles for biological use, significant factors to overcome 
limitations associated with insufficient drug delivery to targeted sites are inclusive of 
nanoparticle size, surface charge, nanoparticle shape, chemical composition and stability 
(Gratton et al., 2008a; Parveen et al., 2012). Manipulating these pertinent nanoparticle 
characteristics may facilitate various applications and enhanced cellular and transbarrier 
internalization of nanoparticles into the target sites. These sites innately have a biological 
barrier to prevent the entry of foreign objects, thus resulting in decreased drug 
concentrations at the intended site. Ideally, nanomedicine should circumvent the biological 
barriers and enhance drug targeting and nanoparticle uptake (Brzoska et al., 2004). 
 
Figure 2.1 illustrates different transport mechanisms across and into the biological 
membrane for the internalization of nanoparticles and key terms related to nanoparticle 
internalization and transbarrier are provided in Table 2.1. According to Kumari and co-
workers (2010a), nanoparticle internalization occurs mainly through intracellular, paracellular 
and transcellular pathways. However, endocytosis pathways are poorly understood 
regardless of their clinical significance and continued research (Parveen et al., 2012). 
Continued research in this paradigm, coupled with nanoparticulate internalization and 
characterization will provide immense insight into an ideal pharmaceutical formulation 
design.  
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Figure 2.1: The transport mechanisms of a typical biological barrier: a) cellular 
internalization of nanoparticle into cell via endocytosis; b) transcellular transport of 
nanoparticles through cell; c) paracellular transport of nanoparticle between cells through the 
tight junction; d) receptor-mediated transcytosis. 
 
Current studies on nanomedicine are encouraged in order to structure a framework that 
enables efficient, safer drug delivery and to eliminate many of the disadvantages posed by 
conventionally delivered drugs. Studies to specifically determine the effect of nanoparticle 
internalization are limited yet necessary in order to enhance biomedical technology and 
inform toxicity studies. Elucidating the parameters of nanoparticles that enable them to target 
cells in response to disease-specific signals could significantly improve therapeutic care of 
complex diseases. The current review therefore discusses nanoparticle properties and 
characteristics such as size, shape, charge, shape, hydrophobicity and ligand attachments 
that influence its uptake into target cells and through biological barriers. Intracellular 
pathways and current mechanisms employed to augment nanoparticle uptake and 
biological-barrier transport are also discussed in detail. 
 
Table 2.1: Key terms  
Term Definition 
Cellular internalization 
 
Process by which biological and foreign matter is taken up by cells. 
Endocytosis 
 
Energy or enzyme-dependent mechanism of cellular internalization. 
Transbarrier 
 
Refers to transport of nano- and micro-substances through cells from 
extracellular fluid through the apical and basolateral membrane. 
Opsonization 
 
Biological phenomenon whereby opsonin molecules adsorb onto the 
surface of foreign particles to enhance Reticulo Endothelial System 
(RES) recognition and phagocytosis. 
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PRINT particles 
 
Particles fabricated using a lithographic technique of Particle Replication 
in Non-wetting Templates (PRINT) to produce monodisperse, shape-
controlled particles. 
 
2.2. Transport Mechanisms of Nanocarriers 
 
2.2.1. Intracellular endocytic delivery pathways 
Various receptor-mediated pathways exist for cellular internalization of biological substances 
such as hormones and enzymes that require internalization to exert an effect at a cellular 
level (Figure 2.2). By adopting these mechanisms, drugs and nanoparticles can be delivered 
to the necessary cell type. Cellular uptake mechanisms need to be understood in order to 
enhance internalization and identify nanoparticle characteristics that promote specific 
mechanisms (Alonso, 2004). The mechanisms of different endocytic pathways as illustrated 
in Figure 2.1a are thoroughly described in the subsequent discussions. 
 
 
Figure 2.2: Mechanisms of endocytosis sub-divided into categories of cell-uptake. 
 
2.2.1.1. Pinocytosis 
Included in the pinocytosis classification are clathrin-mediated endocytosis, caveolae-
mediated endocytosis and macropinocytosis. Clathrin-mediated endocytosis involves 
clathrin-coated vesicle formation in the presence of adaptor and accessory proteins. 
Endocytic event cascade is activated by the signalling of the nanoparticle on the cell surface 
(Xiang et al., 2012), which aligns surface proteins to prompt clathrin recruitment from the 
cytosol to begin clathrin-coating on the inner membrane of the cell. An adaptor protein, 
Epsin, is involved in the initial stages of membrane curvature and pit formation and 
accessory proteins such as dynamin (GTPase) affect vesicle formation from shallow to deep 
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invagination by inducing deformation of the membrane (Mousavi et al., 2004). With the aid of 
dynamin, a clathrin-coated vesicle with a size of 100-150nm is formed due to polymerization 
of the coat complex and the nanoparticle -containing clathrin-coated vesicle then internally 
detaches from the donor membrane (Xiang et al., 2012). Once within the cell, clathrin and 
adaptor proteins uncoat to allow fusing of the vesicle within the cell to release the 
endocytosed nanoparticles (Figure 2.3). 
 
 
Figure 2.3: Mechanism of clathrin-mediated endocytosis of nanoparticles.  
 
Caveolae-mediated endocytosis is a pathway dependent on membrane cholesterol, dynamin 
and cell receptor mediation (Xu et al., 2013). Caveolae are formed by a cluster of caveolin 
proteins (caveolin-1, -2, -3) that bind directly to membrane cholesterol (Kumari et al., 2010b), 
as shown in Figure 2.4. Complex signalling is driven by the cell-membrane bound 
nanoparticles to be endocytosed which induces actin re-organization and dynamin 
recruitment from the cytosol (Pelkmans et al., 2002) to stimulate membrane invagination and 
further on, vesicle budding. The uncoated invagination initially assumes a flask shape with a 
body diameter of 60-80nm and a neck diameter of 10-15nm (Wang et al., 2009). Similar to 
clathrin-mediated endocytosis, dynamin regulates vesicle budding of the caveolae to 
internalize cell membrane segments that contain the cargo and the caveolae membrane 
fuses into the acceptor compartment to release its contents.  
 
2.2.1.2 Macropinocytosis 
Macropinocytosis is a clathrin-, caveolin and dynamin independent process, which involves 
uptake of a larger volume of the membrane, also allowing for larger sized particles of sizes 
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>1 µm to be internalized (Sahay et al., 2010). The pathway proceeds by forming protrusions 
due to actin polymerization from the cell membrane which then encapsulates the substance 
to be internalized and once again fuses back with the cell membrane (Kumari et al., 2010b). 
The process is initiated by activation of tyrosine kinases which signals a cascade of changes 
in the actin cytoskeleton and the formation of membrane protrusions. The random 
macropinocytic extensions enclose the material in the extracellular environment for cellular 
uptake (Figure 2.4), and collapses to fuse with the cell membrane generating an internalized 
macrosome vesicle of an average of ~10µm (Kerr et al., 2009; Sahay et al., 2010). The 
uncoated membrane of the macrosome either acidifies and shrinks or fuses with the 
lysosomal compartment consequently releasing the nanoparticles or contents into the 
intracellular compartment (Hillaireau and Couvreur, 2009). 
 
2.2.1.3. Phagocytosis 
Similar to macropinocytosis, phagocytosis is also a clathrin-, caveolin- and dynamin-
independent process and is proficient in internalizing larger particles inclusive of drug 
nanocarriers and pathogens (Hillaireau and Couvreur, 2009). It involves sequential 
instigation of receptors as a result of cell-surface recognition of cargo leading to 
internalization by encircling it into triggered cup-shaped cell membrane deformations, 
forming a phagosome (Kumari et al., 2010b). The pathway begins with opsonization of the 
nanoparticles which then attach to the cell-surface via Fc receptors and complement 
receptors (Groves et al., 2008), marking the beginning of actin polymerization and 
rearrangement  and membrane extension to form surface extensions that encapsulate the 
opsonized nanoparticles for internalization (Hillaireau and Couvreur, 2009; Park and Cox, 
2009) (Figure 2.4). A reduction and contraction of actin at the base of the cup allows for 
closure of the phagosome and the entire actin-lined phagosome is then internalized with its 
contents (Groves et al., 2008). In a macropinocytotic manner, the vesicle undergoes 
degradation after transporting the opsonized particle into the cell.  
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Figure 2.4: The mechanisms of caveolin-mediated endocytosis, macropinocytosis and 
phagocytosis. 
 
2.2.2. Transcellular delivery pathway 
As described by clathrin-dependent and clathrin-independent internalization, post-uptake, 
the vesicle undergoes degradation. However, through other pathways, the vesicle can be 
transported to the other end of the cell surface where its contents can be expelled into the 
extracellular environment as shown in Figure 2.1b (Bornsel et al., 1989). This pathway 
allows for lipophilic nanoparticles and molecules to move efficiently through the transcellular 
route by partitioning into and out of lipid bi-layers via vesicular carriers due to its lipidic 
nature (Gonzalez-Mariscal et al., 2008). The cargo to be transported binds to cell-membrane 
receptors to form a complex. Membrane invagination is then initiated and the deep pit is 
internalized as a vesicle containing nanoparticles (Mostov, 1994; Lu et al., 2012). Following 
internalization, the endocytosed vesicle is sorted into a transcytotic vesicle to prevent typical 
endosome degradation. The transcytotic vesicle is then transported to the other end of the 
cell where the vesicle membrane fuses with the cell membrane and the content of the 
vesicle is secreted externally (Mostov, 1994; Ferrati et al., 2014). 
 
2.2.3. Paracellular delivery pathway 
Paracellular delivery of drugs is a passive process that occurs between adjacent cells via 
tight junctions through the intercellular space and not through the cell as described by 
transcellular delivery (Figure 2.1c) (Hayashi et al., 1997). This route is specific for hydrophilic 
nanoparticles and molecules since hydrophilic molecules cannot cross biological 
membranes and aqueous pathways that normally absorb nutrients, vitamins or cofactors 
(Gonzalez-Mariscal et al., 2008). Hydrophilic molecules are unable to cross biological 
membranes in the manner of lipophilic molecules due to the lipid properties of the cell bi-
layer membrane; therefore, targeting the paracellular pathway can significantly affect their 
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transepithelial transport. Transit through this route is regulated by tight junctions (TJs) that 
have heterogeneous pores with a variety of diameters of up to 15Å (Hayashi et al., 1997) 
and charges of which the overall charge of the TJ is negative and is therefore more 
responsive to positively charged nanoparticles for paracellular permeation (Salamat-Miller 
and Johnston, 2005). 
 
2.3. Parameters and Characteristics of Nanostructures Governing Cellular 
Internalization 
 
The need for understanding the fundamental physicochemical characteristics of 
nanoparticles and their pivotal role in cellular uptake is essential when designing smart 
nanosystems. Ascertaining nanoparticle functionality provides basic and necessary 
information to influence the rational design of optimal nanocarriers by selectively delivering 
drug to targeted tissue to  increase the rate of cellular uptake and effectively reduce drug-
induced side-effects (Mohanraj and Chen, 2006; Reddy et al., 2006; Moghimi et al., 2012). 
Other determining factors relating to cellular uptake are 1) variation in the uptake pathways 
(Barua and Rege, 2009), 2) cell-specificity (Snijder et al., 2009), 3) nanoparticle interaction 
with cell-surface receptors (Reddy et al., 2006) and 4) nanoparticle interaction with plasma 
proteins leading to nanoparticle-protein complex formation (Aggarwal et al., 2009). 
 
2.3.1. Particle size 
An important consideration regarding particle size is the 4µm diameter of the smallest blood 
vessels of which a micrometer particle may cause an embolism. Acknowledging size should 
therefore not be limited to its internalization ability but also for its physical effects once inside 
the body (Gunaseelan et al., 2010; Torrano et al., 2013). Cells within the human body vary 
from 1-100µm and therefore have a low probability of internalizing particles of ~100µm. This 
particle size range for intracellular delivery is limited to the cells with a large enough capacity 
to host the particle. In addition to the higher rates of endocytosis of smaller sized 
nanoparticles (<100nm) (Luo et al., 2006; des Rieux et al., 2006; Sahay et al., 2010), 
experimental data also promotes higher bioavailability of the endocytosed drug-carrier at 
100-1000nm (Acosta, 2009; Patel et al., 2011). Various studies revealed that within a 1-
100nm range, 50nm nanoparticles shows maximum cellular uptake with 14-20nm 
nanoparticles having a higher endocytotic rate than the 100nm nanoparticles (Chithrani et 
al., 2006; Jin et al., 2009; Awaad et al., 2012). No significant difference in cellular uptake has 
been shown by the nanoparticles of the size range between 25-130nm (Roger et al., 2009) 
while some reports postulate that nanoparticles have higher internalization between 50-
100nm (Torchilin, 2006). On the contrary, from a cellular uptake research experiment using 
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thio-organosilica nanoparticles of 50nm-500nm, Awaad and associates (2012) concluded 
that 95-200nm is the ideal size for increased cellular uptake.   
 
In an in vitro study undertaken by Nicolete and co-workers (2011), after 4 hours of being 
culture-incubated, 6.5±3.9µm Poly (lactic-co-glycolic acid) (PLGA) microparticles were still 
attached to the cell surface and required more time for endocytosis to occur. Simultaneously, 
PLGA nanoparticles of size 389nm (polydispersity index=0.2) had already, within the same 
time period, been encapsulated in vesicles and endocytosed into the intracellular 
compartment (Figure 2.5). These results were coherent with the study conducted by Loh and 
co-workers (2012) which demonstrated poor internalization capability of chitosan particles 
that were >1µm, much unlike the extensive uptake of nanoparticles of sizes 110-390nm. 
Interestingly, Sahay and co-workers (2010) stated that microparticles also enter cells but not 
as rapidly as nanoparticles and concluded that Poly (ethylene glycol) (PEG) particles <5µm 
can gain entry into cells via pinocytosis. Likewise, considering the possibility of the 
aggregation of nanoparticles, the size of an aggregated nanocluster is larger than a single 
nanoparticle and will affect the internalization rate accordingly. In vitro, the stability of the 
nanoparticles should be controlled to promote a consistent nanosystem. 
 
 
Figure 2.5: Representation of the internalization potential dependent on particle size. The 
larger surface-area of the nanoparticle allows for increased surface contact with the cell 
membrane for higher internalization rates as described in the investigation of Nicolete et al. 
(2011). 
 
A research review compiled by Acosta (2009) predominantly concluded that nanoparticles 
with a size of 500nm and below produced higher cellular uptake than nanoparticles of a 
bigger size. These results, however, were also coherent with the penetration abilities of the 
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systems that housed the nanoparticles, which is evident that the nanocarrier system also 
impacted internalization profiles. The uptake of nanoparticles with a size of 500nm has a 
lower viability but may be promoted with the use of a constructive, complementary delivery 
system. Essentially, an assisting delivery system would have lipophilic properties or a 
suitable surface charge for enhanced internalization. 
 
Despite several studies promoting the use of smaller nanoparticles (<100nm), disparities 
exist in other studies providing evidence that particle size affects internalization as 
significantly as its complementary system. The variation in internalization profiles and 
nanoparticle size demonstrates that the influence of nanoparticle size is also dependent on 
the type of cells and the chemical composition of the nanomaterial (Sahay et al., 2010; Loh 
et al., 2012).  
 
2.3.2. Surface charge 
Charge parameters are vital in the characterization of nanoparticles as they determine 
aggregation in the blood or interaction with oppositely- and like-charged cell-membrane 
surfaces. A plethora of studies concluded that cationic and neutral particles show the highest 
transport efficiency compared to negatively charged particles due to the charge attraction 
between the positive nanoparticles and negative cell-membrane surface therefore increasing 
the rate and extent of internalization (des Rieux et al., 2006; Harush-Frenkel et al., 2008; 
Nan et al., 2008; Ilina et al., 2012). These electrostatic forces are long-range forces and can 
act across intervening aqueous space (Rand, 1981). 
 
2.3.2.1. Cationic and neutral nanoparticles 
In the study by Jallouli and associates (2007), the uptake of 60nm neutral and cationic 
maltodextrin porous nanoparticles with a phospholipid core were investigated in brain 
capillary endothelial cells. Neutral nanoparticles were endocytosed in the caveolae-mediated 
pathway while the cationic nanoparticles were found to utilise the paracellular pathway due 
to the rich anionic sites found on the luminal surface of the endothelial cells. The cationic 
nanoparticles had a stronger charge affinity to the collagen fibres on the surface of the 
endothelial cells, thus impeding drug delivery while the neutral nanoparticle sample showed 
better transcytosis into the targeted cells.  
 
2.3.2.2. Cationic nanoparticles 
Karlsson and co-workers (1999) showed that cationic particles had a 2.5-fold higher uptake 
than neutral particles and a 25-fold higher uptake than anionic particles concluding that 
cationic particles are transported using the paracellular pathway to a greater degree than 
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neutral or anionic particles. This study contradicts Lin and associates (2012) who concluded 
from their experimental study that cationic and neutral gold-coated nanoparticles were 
internalized via endocytosis while anionic nanoparticles showed lesser permeability and 
trafficked through the paracellular pathway. 
 
2.3.2.3. Anionic nanoparticles 
Contrary to the above mentioned research, many studies prove the successful internalization 
of negatively charged nanoparticles. An interesting study conducted by Harush-Frenkel and 
associates (2008) concluded that both anionic and cationic PEG-D-L-polylactide (PLA) 
nanoparticles accumulated within MDCK and human cervical cancer (HeLa) cells. The 
internalized anionic nanoparticles underwent a degradative lysosomal process and were 
unable to undergo further transcytosis, rendering cationic nanoparticles more suitable for 
cellular drug delivery. Likewise, negatively charged quantum dot nanoparticles were, in fact, 
endocytosed through a caveolae-mediated pathway and cationic quantum dot nanoparticles 
used a clathrin-mediated pathway, internalizing human epidermal keratinocyte cells (Zhang 
and Monteiro-Riviere, 2009). Both charged quantum dots were internalized via endocytosis 
with no specific rationalization to endocytic preference.  
 
Despite the hypothesis of nanoparticles with a negative charge having a slower uptake rate 
due to repulsive forces, research has shown that certain anionic nanoparticles internalize 
more readily. From this discussion, it can be deduced that anionic nanoparticles have the 
ability to undergo internalization via caveolae-pathways, whereas cationic nanoparticles 
commonly use the clathrin-pathways (Harush-Frenkel et al., 2008; Zhang and Monteiro-
Riviere, 2009).  Highly charged negative nanoparticles also favour good stability since the 
Columbic repulsion forces arising from their surface charge can overcome the Van der 
Waals attractive forces between them and prevent aggregation (Muthu and Singh, 2008). 
 
2.3.3. Particle shape 
Functional behaviour and internalization of particles in drug delivery is strongly influenced by 
its shape (Champion et al., 2007). Although few researchers have focused on shape, those 
who have made noteworthy contributions, but with contradicting results (Hao et al., 2012). In 
many of the following studies, nanoparticle shape was the key factor for enhanced 
internalization, proving its pivotal role in nanoparticle fabrication. Chithrani and co-workers 
(2006) investigated the uptake of gold spherical and rod-shaped nanoparticles. The 74nm 
and 14nm spherical nanoparticles had a higher uptake when compared to 74x14nm rod-
shaped nanoparticles by 500 and 375%, respectively, which support their claim that 
spherical particles have a higher internalization probability. The speculation is that the 
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difference in curvature between the two shapes determines cell surface binding. When the 
longitudinal axis of the rod-shaped nanoparticle is in contact with the cell surface, it has a 
larger area of contact with the cell-membrane receptors than compared to spherical 
nanoparticles and therefore blocks the remaining available membrane receptors, reducing 
the number of nanoparticles being internalized. Han and associates (2006) have reported 
similar results which prove that spherical particles internalize substantially quicker than 
asymmetrically-shaped particles. Champion and Mitragotri (2006) reported on the correlation 
between contact angle and particle internalization concluding that rod-shaped nanoparticles 
have a higher likelihood of internalization when their major axis is perpendicular to the cell 
membrane. The long axis of the rod aligned perpendicular to the cell will increase the 
internalization rate and the rate will decrease as ø (angle of orientation to the perpendicular) 
increases (Figure 2.6). This theory is based on the orientation of the nanoparticle to the cell 
membrane and could further dictate the synthesis of nanoparticle shapes with several short 
aspects to enhance internalization. 
 
 
Figure 2.6: Particle internalization based on orientation to the membrane. a) schematic 
showing the angle between the long axis of the particle and the bilayer normal; b) minimum 
driving forces required to guide the ellipsoid with different initial orientations of the long axis 
through the lipid bilayer; c) time evolution of particle orientations during the ellipsoid 
penetration processes with different initial orientations. (Reprinted with permission from 
Macmillan Publishers Ltd: Nature Nanotechnology (Yang and Ma, 2010)). 
 
Another theory was reported by Gratton and co-workers (2008b) through a study using 
various shaped PEG-based PRINT particles.  Among different shapes investigated, nano-
cylinders were internalized to a considerably larger extent than micro-cylinders and nano-
cubes. The higher cell uptake was speculated due to the larger surface area allowing for 
more multivalent ionic interactions with the cell membrane which then undergo endocytosis 
and phagocytosis (Gratton et al., 2008b). This theory was supported by Sadeghi and co-
workers (2012) who based the highest antibacterial activity of silver nano-plate nanoparticles 
compared to nano-spheres and nano-rods on the larger surface area that binds with the 
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bacterial cells, as well as by Hao and co-workers (2012) who proved that mesoporous silica 
long-rod nanoparticles had higher internalization and retention than spheres and short-rods. 
In addition, various nano-shaped particles have also shown to have diverse accumulation 
capabilities in different organ systems. Decuzzi and associates (2010) identified the shape-
effect of silicon nanoparticles and their accumulation in specific tissue, which they evaluated 
from their bio-distribution data that in the lung, discoidal-shaped nanoparticles tended to 
internalize more than spherical, cylindrical and quasi-hemispherical nanoparticles. In the 
liver, cylindrical nanoparticles accumulated more than the other three shapes, discoidal-
shaped nanoparticles accumulated most in the heart and discoidal and quasi-hemispherical 
nanoparticles had the highest internalization in the spleen tissue. These results were further 
corroborated by Park and co-workers (2009) who demonstrated that nano-worms had a 
higher tumour uptake in a fibro-sarcoma and breast cancer cell line compared with spherical 
nanoparticles and Devarajan and co-workers (2010) who showed preferential accumulation 
of irregular spherical nanoparticles in the spleen while regular spherical nanoparticles 
accumulated in the liver. 
 
Contrary to the above mentioned observations that promote non-spherical nanoparticles as 
possessing higher internalization, we cannot deduce that spherical nanoparticles are less 
conducive for internalization as several studies attest to their dynamic characteristics and 
unmatched high surface area to volume ratio. In fact, if considering therapeutic potential of 
nanoparticles then spheres would be superior to non-spherical nanoparticles due to their 
excellent drug loading capacity. Many researchers claim hypothetical theories on the 
internalization kinetics based on nanoparticle shape, however, we cannot deny that all of 
these nanoparticles investigated do not have constant additional nanoparticle parameters, 
and these would also impact on the rate of cellular uptake.  
 
2.3.4. Surface properties  
The surface properties of nanoparticles are as fundamental as the other key characteristics 
that dictate internalization. For targeted drug delivery, high circulation time of nanoparticles 
in the body is required for the nanoparticles to recognise its specific site of interest. 
Opsonins adsorbing to the surface of hydrophobic nanoparticles decrease circulation time by 
initiating the immune response cascade which allows phagocytosis of the nanoparticles 
following recognition as foreign objects. If the drug is unnecessarily taken up by the RES, 
drug bioavailability is reduced and undesirable effects are exerted on the immune system 
and pose the threat of toxicity within the host (Howard and Peer, 2013; Naahidi et al., 2013). 
Nanoparticle hydrophobicity may instigate redundant interaction with plasma proteins, 
phagocytic internalization, immune cell stimulation and particle clearance (Dobrovolskaia 
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and McNeil, 2007). Minimizing the recognition of nanoparticles by the RES and subsequent 
immune system will enhance the probability of uptake by the target cells. Hence, recent 
research is focused on modifying conventional hydrophobic nanoparticle surfaces with a 
hydrophilic protective layer. This layer creates a cloud of chains at the nanoparticle surface 
to cause steric repulsive forces against plasma proteins and increase the blood circulation 
half-life of targeted nanocarriers as shown in Figure 2.7 (Brigger et al., 2002; Mohanraj and 
Chen, 2006; Owens and Peppas, 2006; Chiu et al., 2010).Hydrophilic-coated nanoparticles 
can be fabricated by making use of polymer types such as PEG, PEG-based copolymers 
and poly-vinyl pyyrolidone (PVP) (Owens and Peppas, 2006; Gomes-da-Silva et al., 2013). 
 
 
Figure 2.7: Pathway of uncoated hydrophobic nanoparticle: 1a) nanoparticle in blood 
circulation; 1b) opsonins recognise nanoparticle as foreign body due to hydrophobic surface; 
1c) opsonization of nanoparticle; 1d) and 1e) phagocytosis by phagocyte and elimination of 
nanoparticle. Pathway of coated hydrophilic nanoparticle: 2a) hydrophilic polymer-coated 
nanoparticle in blood circulation; 2b) steric hindrance maintains repulsive forces between 
opsonins and nanoparticle; 2c) nanoparticle continues to circulate until target site reached; 
2d) and 2e) endocytosis by target cell. 
 
Physicochemical surface parameters can affect cellular uptake as reported in the recent 
study conducted by Loh and co-workers (2012). The study ascertained the theory of 
concentration-dependent chitosan molecules increasing nanoparticle transport through 
membranes by disrupting the integrity of intercellular tight junctions involved in paracellular 
transport (Sonaje et al., 2011).Chitosan redistributes cytoskeleton proteins such as actin and 
tubulin found in the apical membrane resulting in the opening of tight junctions (Sambruy et 
al., 2001). Using chitosan-coating as a surface modification for nanoparticles could optimize 
paracellular transport and deliver a higher amount of drug-loaded nanocarriers to the 
targeted site.  
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An interesting recent advance in research shows the coating of a polymeric nanoparticle 
core with red blood cell (RBC) membranes. Luk and co-workers (2014) synthesized a 
cloaked nanoparticle utilizing the RBC membranes to evade the immune response cascade 
resulting in a prolonged in vivo circulation time. This bio-inspired nano-system enhances the 
probability of nanoparticle uptake and if coupled with other nanoparticle factors to promote 
increased cellular uptake may prove to be yet another breakthrough drug delivery system. 
Therefore, modulating surface characteristics can control internalization rate, extent and 
even transport pathways. However, in order to achieve the desired outcome, the selection as 
well as manipulation of appropriate biomaterials for coating is imperative.  
 
2.3.5. Proteins and ligand attachments  
Cell-penetrating proteins or peptides (CPP) can increase cellular uptake of surface-modified 
drug-loaded nanoparticles by employing direct cell penetration or receptor-mediated 
endocytic pathways and localising nanoparticles at the required site (Lin et al., 2013; 
Loureiro et al., 2014). CPPs are small amphipathic or cationic polypeptides (10-30 amino 
acids long) inclusive of trans-activating (TAT) peptide, penetratin, transportan, toxins, poly-
arginine and rabies virus glycoprotein (RVG) (Patel et al., 2007; Jones, 2008). A possible 
mechanism of the TAT protein is that it binds to cell surface heparin sulphate proteoglycans 
and is then internalized through receptor-mediated uptake (Figure 2.8). 
 
 
Figure 2.8: Stimulating endocytosis through CPP- and antibody-conjugation of 
nanoparticles.  
 
Bareford and Swaan (2007) reviewed cell adhesion molecules (CAMs) which form part of the 
subfamily of immunoglobulins. CAMs bind to cell adhesion receptors (CARs) on cell-
surfaces and stimulate clathrin-mediated uptake. Peptides such as Arg-Gly-Asp (RGD) bind 
to CARs and have been used extensively to promote the uptake of drug-loaded 
nanoparticles. Furthermore, the cationic proteins have a higher affinity to the negatively 
charged cell membranes which further promotes cellular internalization (des Rieux et al., 
27 
 
2006; Bareford and Swaan, 2007). Ligands for enhanced cellular uptake include folic acid, 
albumin and cholesterol, which are internalized using caveolae-mediated uptake, and are 
common, attractive methods to stimulate spontaneous uptake through receptors (Bareford 
and Swaan, 2007). In contrast, Pujals and Giralt (2008) reviewed the highly improved 
internalization efficiency of fatty acids or silaproline, which is a hydrophobic derivative of 
proline-rich, amphipathic CPPs. Targeting tissue specific receptors and molecules by using 
antibodies has also proven to be useful for enabling internalization of drug-carriers intended 
for site-specific delivery. This strategy requires the conjugation of receptor-specific ligands 
and proteins to the nanoparticle coat. The potential for the binding to the target tissue is 
dependent on the abundance of the ligand and its specificity and affinity for binding to the 
target cell membrane (Parveen et al., 2012).  
 
By targeting the monoclonal antibody to the protein aminopeptidase P (APP) in the lung, in 
vivo transport across the endothelial barrier to lung tissue occurs within seconds (Oh et al., 
2007). Nanoparticles that are surface modified with cyclic RGD peptide binds to αvβ3 integrin 
receptors internalize more readily into HeLa cells than unmodified nanoparticles (Oba et al., 
2008). This concept can be applied to tumour cells that contain specific membrane antigens 
where the surface of the drug-carrier is modified with the corresponding antibody for 
increased binding and uptake. This is experimentally shown by targeting prostate specific 
membrane antigen (Liu et al., 2009), transferrin-conjugated nanoparticles that demonstrated 
higher cellular uptake in a prostate cancer cell line (Sahoo et al., 2004), and monoclonal 
antibody-conjugated PLGA nanoparticles for increased tumour cell uptake (Kocbek et al., 
2007). In contrast, quantitative and bio-distributive data from the study conducted by Huang 
and co-workers (2010) showed that three different ligands (single-chain variable fragment, 
amino terminal fragment and cyclic RGD peptide) only marginally improved gold 
nanoparticle accumulation in tumour tissue in comparison with non-targeted controls (Huang 
et al., 2010). Similarly, Temsamani and Vidal (2004) reviewed the construct of 
phosphopeptides linked with penetratin as having inhibitory effects on ligand-dependent 
transduction pathways in various cell lines, even though individually, these CPPs promote 
internalization. The use of serum protein attachments on gold nanoparticles where shown to 
improve their uptake half life, rate and extent (Chithrani et al., 2006). α- and β-globulin 
proteins are known to be internalized by cells and increasing the diversity of protein 
attachments may allow entrance into cells via the receptor-mediated pathways. However, 
another study reported that serum protein attachments inhibited the uptake of polyvalent 
gold nanoparticles, and that instead; uptake is dependent on scavenger receptors (Patel et 
al., 2010). 
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Taking note of the use of a cationic mixed monolayer of CPPs and PEG, Liu and co-workers 
(2007) proved its efficiency on internalization rates of gold nanoparticles by combining these 
factors. The multifunctional nanoparticles show superior uptake as compared to 
nanoparticles synthesized exclusive of the addition of CPP or having an anionic surface 
charge. Thus, drug delivery scientists have capitalized on the knowledge of receptors and 
ligands as targeting moieties for specific cellular organelle targeting (Bareford and Swaan, 
2007; Fortier et al., 2014). This principle is not only applied to general cells but also can be 
adopted for the specific targeting to tumours for increasing the bioavailability of drug to the 
target site.  
 
2.4. Current Advances in Transbarrier Internalization 
 
It has been discussed how the inherent physical and chemical properties of nanoparticles 
such as size, shape, surface charge, solubility, surface characteristics and ligand complexes 
can dictate the nanoparticles degree of biocompatibility and internalization kinetics, as well 
as the selectivity of these factors for specific cell types. The additional key parameter for 
consideration in the uptake of nanoparticles is the environment the nanosystem comes into 
contact with (Aggarwal et al., 2009), and the manner in which we can engineer these 
parameters to trigger different biological responses (Sonaje et al., 2011). As discussed by 
Brannon-Peppas and Blanchette (2012), the size of nanoparticles for crossing biological 
barriers is dependent on the tissue, target site and circulation. Likewise, all other 
nanoparticle characteristics need to be fabricated in consideration of inherent target-tissue 
requirements for cellular internalization. Barrier capacity and trans-compartment transport of 
particles vary considerably between different tissue types (Vllasaliu et al., 2011). Limited 
transport across the epithelia is one of the prime obstacles for therapeutic agents and 
nanomedicines reaching the adequate biological compartment (Alonso, 2004) as barrier 
systems are unable to evaluate and differentiate drug delivery systems for translocation from 
foreign particles and therefore restrict the entry of the drug-carriers, rendering the system 
invaluable and reducing its efficacy.  
 
The delivery of therapeutic agents requires successful negotiation of these barriers in order 
to attain a sufficient therapeutic index (Ferrari, 2010). To transverse these barriers using 
smart nanosystems, the development of efficient nanomedicines requires a thorough 
understanding of the characteristics of the body systems, biological barriers and 
mechanisms to evade foreign particle interactions in the body. Once the characteristics of 
the biological systems are defined, we can identify nanoparticle parameters that enhance 
trans-membrane transport or cellular uptake (Table 2.2). From the data reported in Table 
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2.2, it is evident that various nanosystems contributing different parameters and 
characteristics are able to transverse biological barriers dictated by the barrier’s set of 
limitations and specific nanoparticle criteria for internalization. 
 
Table 2.2: Overview of biological barriers and nanoparticle advances to overcome 
physiological limitations. 
Organ 
system 
Barriers to  
Internalization 
Physicochemical Nanoparticle 
modification 
(Trans)-Epithelial 
transport 
mechanisms 
Reference 
 
 
Skin 
 
Insoluble 
corneocytes and 
tight junctions in 
viable epidermis 
 
Chemical enhancers (oleic acid, 
ethanol, PEG) to surface-coat  
 
Pores, trans/inter 
cellular, follicular 
penetration 
 
Masaoka  et 
al., 2006; 
Kuo  et al., 
2009 
215.2nm  anionic quercetin-loaded 
lipid NPs  
Intercellular 
permeation 
Chen-yu  et 
al., 2012 
Pilosebaceous (10-
70mm) and sweat 
glands (60-80mm)  
<10nm metal maghemite NPs Lipidic matrix, follicular penetration 
Baroli et al., 
2007  
Intercellular lipidic 
matrix 
Hydrophilic 40nm irregular, spherical 
PEG-b-copolymer NPs  Follicular penetration  
Baroli et al., 
2007; Shim 
et al., 2004  
18nm hydrophobic cationic/neutral 
18nm ellipsoid/spherical quantum 
dots 
 
Pores, follicular 
penetration 
Ryman-
Rasmussen 
et al., 2006  
Blood  Complement 
system, 
phagocytosis 
Heparin-complexed cerium oxide 
NPs for monocyte drug delivery   
Wang et al., 
2012; Ting et 
al., 2013  
White blood cells 
Cell membranes contain regions of 
+ve and –ve charge, NPs of either 
charge can be internalized 
 
 
Ting et al., 
2013  
 
Ocular Blood-aqueous 
barrier  
180nm anionic sparfloxacin-loaded 
PLGA NPs 
Nasolacrimal 
drainage system 
Gupta et al., 
2010; 
Freddo, 
2013  
 
Blood-retinal barrier  
3.46µm surfactant-complexed  
multilamellar acetazolamide 
niosomes  
 
Freddo, 
2013; 
Guinedi et 
al., 2005  
Precorneal tear film 
(3-10µm)  
161nm PEG-coated poly-ε-
caprolactone nanocapsules  
 
Transcytosis 
de la Fuente 
et al., 2010  
 
 
Spinal cord Blood-spinal 
cord barrier (BSCB) 2-5nm cerium oxide NPs  
Mautes et 
al., 2000; 
Das et al., 
2007  
Astrocytic foot 
processes 
Ideal properties for penetrating 
BSCB/astrocytic foot processes  
Mautes et 
al., 2000 
NP size (<50nm), cationic, 
hydrophilic, CPP-complexed 
 
 
Sahay  et al., 
2010; 
Chithrani et 
al., 2006 
Ilina et al., 
2012; Patel 
et al., 2007; 
Brigger et 
al., 2002 
 
Brain BBB, blood-
cerebrospinal fluid 
barrier 
Hydrophilic PEG-coated 
polyhexadecylcyanoacrylate  
Caveolae-mediated 
endocytosis  
Garcia-
Garcia et al., 
2005; 
Costantino 
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and 
Boraschi, 
2012  
 
Chemical/biological/physical 
modulators for opening BBB 
Trans/Paracellular 
 
Hynynen, 
2008; Stam, 
2010  
Enzymatic BBB 
MAb 5C6, to CR3 receptor-a β2-
integrin present on microglia  
Receptor-mediated 
transcytosis 
Reid et al., 
1993  
RMP-7 (bradykinin analogue)-
coated 50nm NPs  
Kuo and 
Lee, 2012 
Polyether-copolyester dendrimers Clathrin/caveolae-
mediated uptake 
Dhanikula et 
al., 2008  
High 
transendothelial 
electrical resistance 
of 1500–2000V/cm2  
Cationization of antibodies to 
undergo active transport  
Absorptive mediated 
transcytosis                 
Reid et al., 
1993  
Anionic, 90nm transferrin(Tf)-
conjugated polymersomes  
Tf Receptor-mediated 
transcytosis 
Pang et al., 
2011   
Anionic, ≤200nm SLNs  Martins et 
al., 2012  
Cationic, 190-210nm nano-lipid 
emulsion 
Caveolae-mediated 
end/macropinocytosis 
Wen et al., 
2011  
Brain extracellular 
space of 38-64nm  
Anionic, 154nm PLGA-NPs via inner 
ear administration   Pinocytosis 
Thorne and 
Nicholson, 
2006; Zhang 
et al., 2013  
80nm TiO2 NPs administered 
through intranasal instillation 
 
Transcytosis Mistry et al., 2009  
 
 
Liver 
Tight junctions, 5-
10µm wide blood 
vessels (BVs) 
Filo-shaped micelles with high 
aspect ratios and cylindrical 
Clathrin/caveolae-
mediated endocytosis 
Geng et al., 
2007; 
Decuzzi et 
al., 2010; 
Jacobs et 
al., 2010  
20nm carboxylated-polystyrene  Johnston et 
al., 2010  
147.2nm cationic chitosan NPs of 
irregular shape modified with 
glycyrrhizin complexation 
Receptor-mediated 
endocytosis 
Lin et al., 
2008  
Phagocytic 
properties of 
juxtaposed Kupffer 
cells  
CPPs conjugated on <90nm cationic 
NPs to target AGP receptors on 
hepatocytes for direct drug delivery  
Receptor-mediated 
endocytosis 
Kim et al., 
2004 
Saturating Kupffer cells with excess 
of drug-loaded NPs  
Jacobs et 
al., 2010  
Particles of 1-3µm evade ruffled 
surface of Kupffer cells  
Doshi et al., 
2010  
Protective mucin 
layer  
 
Neutral, hydrophobic NPs <200nm  
 
 
Lai et al., 
2009  
Oral cavity Non-keratinized 
epithelia, saliva 
mucus, membrane 
coating granules of 
buccal mucosa 
  
NPs entrapped within solid 
lozenges, chewing gum, flexible 
adhesive patches, and viscous 
liquids to coat mucosa  
 
 
Madhav et 
al., 2009; 
Teubl et al., 
2013  
 
GIT Tight junction barriers, cell 
composition  
Coating drug-loaded NPs with 
bacterial invasive ligands to target M 
cell surface components  
Receptor-mediated 
endocytosis 
Masaoka et 
al., 2006; 
Kochut et al., 
2013  
Low pH gradients  
 
pH-sensitive cationic 343nm 
trimethylchitosan and 212nm PLGA-
PEG mannose NPs  
Receptor-mediated 
endocytosis 
Ferrari, 
2010; Coco 
et al., 2013  
Thick, anionic 
mucus layer  
154nm cationic poly-6-cationic 
amphiphilic cyclodextrin-DNA 
complex internalized by intestinal 
epithelial cells   
Macropinocytosis 
Yang et al., 
2011; O’Neill 
et al., 2011  
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Hydrophobic, neutral aminated NPs 
 
Transcytosis des Rieux et 
al., 2005  
 Macrophages    
 
Lungs 
Alveolar-capillary 
barrier, complex 
tight junctions  
15-100nm gold NPs  Transcytosis 
Brandenberg
er et al., 
2010 
Commercial multi-walled carbon-
NTs disrupt tight junctions  Paracellular 
Rotoli et al., 
2008  
Hydrophilic, surfactant-coated, 
enzymatic 20nm PEI-PLGA NPs in 
1.6µm microgel 
 
Wanakule et 
al., 2012  
Discoidal-shaped NPs  Decuzzi et 
al., 2010  
Alveolar lining fluid  200nm NPs complexed with Fc portion of IgG  
Receptor-mediated 
endocytosis 
Vllasaliu et 
al., 2012  
Macrophages  
235nm protein-based NPs (serum 
albumin and transferrin)  
 
Receptor-mediated 
transcytosis 
Brzoska et 
al., 2004; 
Wanakule et 
al., 2012   
 
Kidney 200-300nm thick 
glycocalyx layer 78-100nm spherical PLGA NPs 
Caveolae-mediated 
endocytosis 
Haraldsson 
et al., 2008; 
He et al., 
2013  
Phagocytic 
mesangial cells  
Albumin/streptavidin as ligands 
targeting renal tubular cells 
Receptor-mediated 
endocytosis 
Kocbek et 
al., 2007; 
Kerr et al., 
2009; Roger 
et al., 2009   
Cationic 
decomplexation 
 
 
Anionic derivatives carboxylated, co-
dimethyl maleic acid, acetylated low 
molecular weight chitosan or PVP as 
NP coating  
  
Receptor-mediated 
endocytosis 
 
Kodaira et 
al., 2004; 
Yamamoto 
et al., 2004 
Yuan et al., 
2008  
 
2.5. Concluding Remarks 
 
The scope for further research into this concept has immense potential to progress medical 
care by decreasing side effect profiles due to specific and targeted drug release, improving 
bioavailability and bypassing first pass metabolism. The use of sophisticated nanomedicines 
as effective vectors of drugs exerts beneficial effects at the molecular level providing 
targeted drug delivery. The forefront of nanomedicine research comprises diagnosis, 
treatment, monitoring and management of biological conditions. Independently, 
nanotechnology has surfaced as one of the most successful drug delivery concepts to date 
and it is obvious that applications for biomedical nanotechnology are broad. This review 
encompasses possible techniques of nanoparticle manipulation to furthermore improve 
intracellular delivery of drugs. The benefits of enhanced cellular internalization have been 
extensively motivated and the scope for further research in this domain is constant. 
Therapeutic advantages can be demonstrated by increasing nanoparticle cellular uptake, 
targeting site-specific organ systems by increasing selectivity and even altering the drug 
release kinetics of the nanosystem and bio-distribution. Taking this concept into 
consideration also allows for a single nanoparticle of ideal characteristics to encapsulate 
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several drugs for delivery to enhance efficacy and possibly reduce resistance. Furthermore, 
the diversity of nanoparticle parameters with regards to targeting ligands can be studied 
thoroughly to assist with the internalization of macromolecule drugs that primarily have 
difficulty penetrating the cell membrane.  
 
Apart from cellular internalization, focus has been placed on nuclear targeting via a nuclear 
localization signal (NLS) (Tkachenko et al., 2003; Chen et al., 2009; Narayanan et al., 2013). 
At a complex level, drug delivery targeting intracellular organelles post cellular internalization 
may prove to be a research area of high interest. Included in this paradigm is the possibility 
of the multistage drug targeting of nanoparticles from bypassing the cellular membrane to 
organelle level of therapeutics. By combining many physicochemical and mechanical 
nanoparticle parameters specific to certain cells types or organ systems, an optimal level of 
cellular uptake can be achieved. Research proves several nanoparticle characteristics that 
are pertinent for efficient internalization; however it is immensely limited on more detailed 
trans-barrier uptake kinetics that would crucially improve nanoparticle efficacy and 
intracellular targeting while maintaining stability and non-toxicity. Nano drug-carriers can be 
greatly exploited provided ex vivo and in vivo research is extensively conducted.   
 
Pertinent to the above mentioned nanoparticle factors, we need to understand that by 
optimizing nanoparticle parameters and characteristics that support internalization theories 
and studies for enhanced intracellular delivery, these designed systems may not promote 
optimal drug entrapment or have adequate drug release. The issue of drug delivery design 
can be addressed but other in vivo requirements such as adequate clearance from systemic 
circulation, release of drugs from non-targeted sites, drug release from the nanosystem and 
elimination of the nanocarrier from the body need to be adhered to. As the knowledge of 
physico-chemical and physiological in vivo processes improves, nanomedicine can be 
further specialised to attain the absolute effect intended.  
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CHAPTER 3 
NEO-GEOMETRIC COPPER NANOCRYSTALS BY  
COMPETITIVE, DUAL SURFACTANT-MEDIATED FACET ADSORPTION  
CONTROLLING SKIN PERMEATION 
 
3.1. Introduction 
 
Copper nanoparticles (CuNPs) have gained considerable research interest in the recent 
years for investigation in the biomedical and pharmaceutical sciences. The versatility of 
CuNPs facilitates its biomedical applications as a cytotoxic agent via oxidative stress 
(Galhardi et al., 2004; Laha et al., 2014), an antibacterial agent (Wu et al., 2010), an in vivo 
agent for imaging (Wegner et al., 2010) as well as for advanced drug delivery applications 
(Courant et al., 2009). In the last decade, researchers have proven that by manipulating the 
physicochemical, physicomechanical and morphological properties of CuNPs its industrial 
application expands and its extent of use. In particular, the geometrical shape and size of 
CuNPs has gained much interest (Zeng et al., 2004). Variation in the shape of CuNPs can 
be controlled via modification of synthesis processes and methods such as microemulsion 
(Solanki et al., 2010), reverse micelle method (Nomura et al., 2009), chemical reduction 
(Zhang et al., 2010), electrochemical reduction (Cioffi et al., 2005), metal vaporization (Lo et 
al., 2005), sonochemical processing (Dhas et al., 1998), solution plasma methods (Saito et 
al., 2011) and microwave-assisted synthesis (Ranu et al., 2007). 
 
However, utilizing these methods does not ensure specificity in controlling the shape of 
CuNPs. In the bottom-up synthesis of shape controlled inorganic nanocrystals, studies have 
proven that colloidal solutions and key parameters such as temperature fluctuation, 
concentration of polymers and stabilizers, reducing agents, copper salt type and 
concentration, inert or ambient conditions, reaction time and water content are efficient for 
the minimal organization of particle shape. The self-assembly control process is able to 
maintain the nano-shape within the colloidal dispersion by minimal chemical, physical or 
mechanical modification during synthesis. Despite these advances, it is still highly complex 
to optimize the shape of CuNPs. 
 
A few studies have confirmed the novel synthesis parameters of metal nanoparticles through 
the formation of shape-controlled nanoparticle fabrication. For instance, Sadjadi and co-
workers (2008) investigated the effect of temperature and reaction time on the morphology 
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and aspect ratios of silver nano-rods. Pileni and co-workers (1997) demonstrated the effect 
of water volume on the morphology of CuNPs. In order of low to high water content, 
spherical and cylindrical nanoparticles and planar-type lamellar were formed. Another group 
of researchers, Nomura and co-workers (2009), varied the raw ion concentration and 
addition of ethanol in the synthesis of self-assembled barium chromate nano-wires, 
nanodots and nanorods. Spherical CuNPs and nanorods were achieved by De and Mandal 
(2013) when altering the surfactant concentration. 
 
Despite the significant studies on metallic nanoparticle shape, these have been limited to 
two or three self-assemblies per formulation synthesis, partial synthesis of microparticles or 
formulations not displaying complete shape homogeneity due to the high chemical reactivity 
of the surface of the copper metal. Therefore, this chapter focuses on the exploits of the 
surfactants to partially reduce and cap CuNPs to stabilize and simultaneously dictate 
nanoparticle shape to produce samples of homogenous geometries. The study aimed to 
synthesize CuNPs of distinct shapes by manipulating two surfactant concentrations with 
homogeneity throughout each colloidal solution. This research also reports on the successful 
thermo-chemical reduction in the organised synthesis of neo-geometrical CuNPs and 
epidermal skin permeation kinetics based on nano-geometry. 
 
3.2. Materials and Methods 
 
Copper II sulphate pentahydrate (CuSO4·5H2O) was purchased from Merck (Darmstadt, 
Germany); hexadecetyl trimethylammonium bromide (CTAB) and sodium dodecyl sulphate 
(SDS) were purchased from Sigma-Aldrich Co. (Aldrich, Steinheim, Germany); L-ascorbic 
acid (98%) was purchased from Roche (Johannesburg, South Africa); and trypsin/EDTA was 
purchased from Lonza (Walkersville, MD, USA). All water used for the synthesis was 
deionized. All chemicals were analytical grade and used without further purification. 
 
3.2.1. Synthesis of copper nanostructures 
The thermal-reduction method of synthesizing nanocrystals included a standard 
CuSO4·5H2O solution added to varied molar concentrations of aliquot CTAB and SDS 
solutions heated at 50 °C. Solution was further heated between 85 and 90°C and a standard 
ascorbic acid solution was added as the reducing agent in a drop-wise manner to allow for 
spontaneous copper formation without a reducing agent overload. The temperature was then 
maintained at 80 °C using a mercury thermometer (Brannon Thermometers, Cumbria, UK). 
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3.2.2. Determination of the effect of surfactant concentration on particle morphology 
TEM (FEI T12 Spirit Transmission Electron Microscope (120 kV), Hillsborough, CA, USA) 
and HR-TEM (JEOL JEM 2100F (200 kV), Tokyo, Japan) confirmed the synthesis of self-
assembled neo-geometrical nanoparticles. Samples were also subjected to TEM-Energy 
Dispersive Spectroscopy (EDS) for high-speed elemental analysis. 
 
3.2.3. Crystallinity and composition characterization of synthesized copper 
A powder X-Ray Diffractometer (XRD) (MiniFlex 600, Tokyo, Japan) was used to monitor 
diffraction patterns of the CuNP samples to validate the synthesis of crystalline copper. A 
continuous scan rate of 0.1°/min from 0 to 90° was used with copper Kα radiation (λ = 1.54 
Å). 
 
3.2.4. Determination of the stability of the copper nanoparticles 
The zeta potential measured the surface charge of the CuNPs, thus indicating the stability 
and aggregation potential of the nanoparticles. Each suspension was diluted 1:15 in distilled 
water, filtered through a 0.22μm Millipore filter, transferred into a capillary cell and was 
analyzed by a Zeta sizer (DTS (nano), Malvern instruments Ltd., Worcestershire, UK). 
 
3.2.5. Molecular and structural transitional analysis of the surfactant-coated copper 
nanoparticles 
Fourier-Transform Infrared (FTIR) analysis of ascorbic acid, CTAB, SDS and synthesized 
surfactant-coated CuNPs was undertaken to evaluate and compare vibrational 
characteristics of the chemical functional groups in response to infrared light interactions. 
FTIR spectra were recorded on a Perkin Elmer Spectrum 2000 FTIR spectrometer with a 
MIRTGS detector (PerkinElmer Spectrum 100, Wales, UK) at a wavenumber range of 650–
4000cm−1 with a resolution of 4cm−1 and 10 scans per spectrum. 
 
3.2.6. Determination of nanoparticle yield 
Yield studies were conducted to elucidate the effect of surfactants in the investigation of 
copper reduction. The yield of the CuNPs was determined by weighing the dried CuNP 
samples using an electronic balance (Mettler, Model AE 240, Greifensee, Switzerland) with 
readings recorded to 2 decimal places. Percentage yield was calculated using Equations 
(3.1-3.3).  
 
Number of moles = C × V 
(3.1) 
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Reacting mass of copper (theoretical yield) = n × M (3.2) 
% Yield =  
actual yield
theoretical yield
× 100 (3.3) 
  
3.2.7. Thermal degradation analysis of the surface surfactant-coating of the copper 
nanoparticles 
Thermogravimetric Analysis (TGA) using a 4000 TGA (PerkinElmer Inc., Waltham, MA, 
USA) was conducted to evaluate the surfactant-coating of the CuNP samples as the function 
of temperature in nitrogen atmosphere under a flow of 40ml/min and heating rate of 
10°C/min from 30 to 900°C. The Pyris 6 software (PerkinElmer Inc., Waltham, MA, USA) 
was used to perform the thermal analysis. Each test consisted of a powder weighing 
approximately 10–20mg and produced similar results among all samples. 
 
3.2.8. Ex vivo permeation evaluation of five distinct nano-shapes 
Ex vivo studies were conducted to determine the skin permeation efficiency of five 
nanosystems with the most constructive structures. The study served to identify the nano-
shape with the highest potential of crossing the stratum corneum barrier and entering the 
epidermal layer of BALB/c mice skin samples. The hair from the dorsal aspect of the mice 
was shaved and the skin was thereafter excised. The skin was washed and incubated in 
trypsin/EDTA at 37°C for 2 hours in an incubator controlled in a 5% CO2 environment 
allowing for the detachment of the dermal layer thereafter. Skin integrity testing was 
conducted before and after permeation studies using a Seven Multi S40 pH/electrical 
conductivity meter (Mettler-Toledo, Zurich, Switzerland). The permeation studies were 
carried out utilizing a Franz Diffusion Cell (FDC) apparatus (PermeGear Inc., Bethlehem, 
PA, USA) equipped with a 12ml receptor compartment, clamp, stirrer-bar and a thermostat 
controlled water jacket. Epidermal BALB/c mice skin samples were placed between the 
donor and receptor compartments of the FDC. Samples of simulated plasma (100µL) in the 
receptor compartment (PBS; 12ml; pH 7.4; 37°C) were withdrawn at suitable time intervals 
over 24 hours. Post permeation studies, the skins were digested with nitric acid at 70°C for 
analysis to determine copper content retained by the dermal skin tissue. Receptor samples 
and skin samples were analyzed by Inductively Coupled Plasma-Optical Emission 
Spectroscopy (Activa S) (Horiba Scientific, Munich, Germany). 
 
3.2.9. Data analysis and confirmation of statistical significance of all assays 
performed 
All synthesis and characterization studies including TEM analysis, nanoparticle counting, 
XRD, zeta potential, yield, TGA and ex vivo permeation studies were carried out in 3 
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independent experiments in duplicates for each evaluation. Data were expressed as mean 
(±standard error (SE)) and analyzed by 1-way analysis of variance (ANOVA). p values less 
than 0.05 was considered statistically significant. 
 
3.3. Results and Discussion 
 
CuNP synthesis involves the reduction of a copper precursor, Cu(II) species, by ascorbic 
acid in solution leading to the nucleation and growth of metal nanoparticles. In addition to its 
use as a reducing agent, ascorbic acid also functions as a capping agent (Mushran et al., 
1974; Xiong et al., 2011). 
 
3.3.1. Influence of variation in surfactant concentration on copper nanoparticles 
shape 
The scope for change and sensitivity to an external parameter was ascertained to determine 
the geometries that could be derived from the crystalline cubic structure of nanocrystals and 
to assist with the synthesis of uniform neo-geometric CuNPs. After the nucleation of the 
copper crystal, the growth of the nanocrystal facets is controlled to synthesize the various 
shapes. In this study, the major influence involved in the dictation of nanoparticle shape is 
the organization of the surfactant molecules on specific faces to preferentially grow facets of 
certain dimensions and the induction of truncation of the CuNPs. The surfactants adsorb on 
the solid-liquid interface of particular nanocrystal facets imparting various energies on the 
different facets and the controlled, elevated reaction temperature allow for the deviation from 
the shape formation during synthesis using standard reaction parameters (Xia et al., 2009; 
Personick and Mirkin, 2013). Previous research studies show that CTAB can act as a soft 
template, this study proves that the simultaneous use of various concentrations of CTAB and 
SDS in the presence of heat can dictate and control the shape of seeded CuNPs. The varied 
surfactant molar concentrations used to synthesize neo-geometrical CuNPs are listed in 
Table 3.1. 
 
Table 3.1: Surfactant variations corresponding to physicochemical characteristics of 
synthesized CuNPs. Data presented are mean ± SE of three experiments performed in 
duplicate. *p ≤ 0.05. 
Formulation [CTAB] (M) [SDS] (M) Yield (%) 
Geometrical 
Structures 
Size of 
Nanostructures (nm) Figure 
S1 a 0.00 0.000 81.0 Spheres 90 ± 9 3.1a 
S2 b 0.01 0.087 83.6 Combination Shape dependent 3.1b 
S3 b 0.01 0.100 85.0 Spheres and rods Shape dependent 3.1c 
S4 a 0.02 0.000 86.0 Rods 150 × 20 3.1d 
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S5 a 0.02 0.087 89.8 Cubes 200 × 200 ± 13 3.1e 
S6 a 0.02 0.100 90.5 Pyramids 100 ± 12 3.1f 
S7 b 0.03 0.000 87.0 Irregular spheres 300 ± 11 3.1g 
S8 b 0.03 0.087 92.2 Combination Shape dependent 3.1h 
S9 b 0.03 0.100 96.2 Combination Shape dependent 3.1i 
S10 b 0.04 0.000 89.7 Irregular spheres 500 ± 8 3.1j 
S11 b 0.04 0.087 96.8 Irregular spheres 200–250 ± 10 3.1k 
S12 a 0.04 0.100 97.1 Spheres 5 ± 3 3.1l 
 
a
 Sample with ideal, homogenous nano-geometries; b Sample with irregular or combination 
geometries.  
 
As the copper nanocrystals nucleate in aqueous solution, surfactant molecules adsorb onto 
the surface of facets dictating the shape formation by inhibiting or stimulating facet growth. It 
is suggested that shape of a Face-Centred Cubic (FCC) nanocrystal can be influenced by 
the ratio of the growth rates along the (100) and (111) directions (Borchardt-Ott, 1993; Kim 
et al., 2004). According to Personick and co-workers (2011), CTAB is a cationic surfactant 
which displays preferential facet adsorption altering growth rates along crystallographic 
planes. In water, the critical micelle concentration of CTAB is 9 × 10−4mmol/L and SDS is 8 × 
10−3M, rendering the number of surfactant molecules sufficient to provide a micellar 
environment for the newly synthesized CuNPs forming an adsorption layer around the 
nanoparticles (Li et al., 2006). Table 3.1 and Figure 3.1 particularly demonstrate the 
dependence of surfactant concentration on nanoparticle shape formation. The relative 
percentage co-existence of the shapes in the poly disperse samples are obtained from a 
population of 100 nanoparticles as per Anova analysis.  
 
Whilst maintaining a constant concentration of CTAB, the difference in morphology using 
0.02M CTAB is far more sensitive than the samples using 0.01M CTAB as shown in Figure 
3.2. Homogenous samples of geometries with varying aspects from rods to cubes and 
pyramids can be attributed to the variation in SDS concentration. Upon addition of SDS 
whilst maintaining 0.02M CTAB, the aspect ratio of the nanoparticles showed a fundamental 
decrease in aspect ratio of the nano-rods and nano-cubes. Further increasing the SDS 
concentration reduced the number of geometric aspects resulting in a change from a four-
aspect structure to a three-aspect structure and additionally reducing the size dimensions of 
the nanoparticles. The number of sharp aspects increases and decreases spontaneously, 
showing responsiveness to increasing SDS in the presence of 0.02M CTAB. 
 
55 
 
 
 
Figure 3.1: a) sample S1, spherical nanoparticles (90nm); b) sample S2, combination of 
spheres and rods; c) sample S3, combination spheres and rods with predominant rods; d) 
sample S4, rod-like nanoparticles; e) sample S5, cubic-shaped nanoparticles; f) sample S6, 
pyramidal nanoparticles; g) sample S7, irregular spherical particles; h) sample S8, 
combination of neo-geometrical nanoparticles; i) sample S9, combination of neo-geometrical 
nanoparticles at reduced size range; j) sample S10, irregular nanospheres; k) sample S11, 
spherical nanoparticles (250–300nm); l) sample S12, spherical nanoparticles (5nm).  
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Figure 3.2: Schematic of growth of homogenous shapes according to surfactant variation: a) 
growth of a rod structure from the decahedral precursor; b) tetrahedral precursor geometry; 
c) polyhedral precursor geometry; d) cuboctahedral precursor geometry growing from the 
(100) and (111) planes.  
 
The morphology difference between different CuNP samples in the current study is a result 
of the interaction achieved by the coordination bonds between copper ions, CTAB and SDS. 
Prior to nucleation of Cu, the CuSO4·5H2O salt interacts with CTAB and SDS molecules at 
concentrations above the critical micelle concentration which then surrounds the copper 
ions. The chemically adsorbed surfactant molecules and ions mediate the morphological 
changes of the CuNPs as well as act as stabilising agents by coating the nanocrystals and 
prevent oxidation of the metal copper under ambient conditions (Pileni, 2003). The 
adsorption of surfactant promotes facet growth and, as shown in Table 3.1, facet growth is 
dependent on surfactant concentration. Considering this concept, copper nuclei are most 
stable in the cuboctahedral, decahedral and tetrahedral and polyhedral precursor nuclei and 
assume these geometries during synthesis (Salzemann et al., 2004a). 
 
The structure of the rod-shaped nanoparticle grows from a decahedron and exists with a 
five-fold symmetry (Salzemann et al., 2004a). The induction of the decahedron formation is 
mediated by the truncation of the five subunit edges of the decahedra nucleus in the (111) 
planes and additional intermediate faces in the (100) planes as shown in Figure 3.2a. 
Growth along the facet of the {100} surface results in an elongated structure with two 5-fold 
symmetry points on either end. The stable tetrahedral geometry with a threefold axis acts as 
the precursor nucleus in the formation of the pyramidal-shaped nanoparticles (Salzemann et 
al., 2004a) as shown in Figure 3.2b. The facets are dominated by {111} suggesting that the 
growth of the tetrahedral geometry is directed by this facet unlike the decahedron and 
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cuboctahedron geometries. It can be assumed that the spherical nanoparticles are formed 
from the truncated polyhedral precursor nuclei and are composed of several {100} and {111} 
facets as shown in Figure 3.2c. The cuboctahedral precursor is defined by its {100} and 
{111} facets as shown in Figure 3.2d. Cubic nanoparticle geometry arises from the selective 
growth of the {111} facet of the cuboctahedral nucleus. The selective growth of this facet 
suggests that it has a particularly higher surface energy than the {100} facet. Selective 
adsorption of surfactant on {100} retards its growth, allowing for the exaggerated growth of 
this slow growing surface resulting in a cubic geometry (Salzemann et al., 2004a). Slow 
growth of (100) results in this dominant facet producing cube shaped nanoparticles. 
 
In the absence of CTAB and SDS, spherical nanoparticles are formed. It can be assumed 
that polyhedrons (Figure 3.2c) as the initial stable precursor nuclei with equal dimensions 
are formed. Thereafter, upon the addition of surfactant, there is preferential facet growth due 
to surface energy and surface adsorption. It is evident from other research (Biçer and 
Şişman, 2010) and these results that the surface energy varies between the different facets 
and displays competitive and selective adsorption of ions and molecules. The molecular and 
ionic affinity to certain facets could also be used to rationalise the geometry of nanocrystals. 
Due to the presence of the surfactants in the solution before, during and after the seeding 
process, the precursor nuclei geometries are uniform and can be controlled. After the 
seeding of the nuclei, the formation of the precursor nuclei is dictated by the type of 
surfactant molecules and ions and its concentration. Thereafter, its growth is also mediated 
by surface adsorption onto specific facets. In the study conducted by Pileni and co-workers 
(1997), the research team suggested the reverse micelle synthesis of shaped CuNPs 
involves the initial formation of decahedral, cuboctohedral or tetrahedral precursor shape 
followed by the favoured adsorption of surfactants on the facets of the nanocrystals to 
stimulate facet growth of certain dimensions. Thus, the growth rates of specific nanoparticle 
facets can be controlled during synthesis to direct the required nano-shape. 
 
The {111} planes are more energetically favourable when directing tetrahedral growth 
compared to the decahedron and cuboctahedron which have high-energy facets specific to 
each geometry (Kim et al., 2004). The results indicate that directing tetrahedral, decahedral 
or cuboctahedral growth can be achieved by the ionic and molecular adsorption on (100), 
(110) and (111) planes while spherical CuNPs are directed by polyhedral structures. The 
affinity of these ions and molecules to certain planes plays the key role in geometry dictation. 
Surfactant adsorption on a facet reduces the growth of the facet and the remaining facets 
grow steadily becoming the least dominant facet (Borchardt-Ott, 1993). 
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During the synthesis of blank copper nanocrystals (Sample S1), polyhedral precursor nuclei 
are directed. Excess ascorbic acid and its degradative products promote the growth of this 
crystal nucleus. When CTAB at 0.01M and SDS at 0.087M are introduced into solution, 
decahedral and polyhedral precursor nuclei are grown. This is a clear indication that 
competitive inhibition of facet adsorption occurs by CTAB and SDS. When CTAB is 
increased to 0.03M at SDS 0.087M, a sample consisting of combinatorial geometries are 
synthesized. It can be assumed that the increased CTAB reduces the growth of (111) to 
promote the tetrahedral structure, as well as the polyhedral structure. According to the 
results, when CTAB is used at 0.02M, the geometry of the nanocrystals is the most 
responsive to surfactant concentration, hence, highly controlled. When CTAB at 0.01M is 
reacted with SDS at maximum concentration (0.1M), rod and spherical nanocrystals are 
formed. When compared to the sample synthesis of SDS at 0.087M (42% rods, 58% 
spheres), the composition of rods and spheres are now significantly different (78% rods, 
22% spheres) implying that the excess SDS competes for adsorption on the {100} facet 
when used simultaneously with CTAB since the rod:spherical nanocrystal ratio has 
increased. 
 
Regarding the neo-geometrical CuNP synthesis, it is suggested that at 0.02M the aqueous 
CTAB surfactant environment is ideal for the generation of single-shaped geometrical 
precursor ions (Figure 3.2). Specific to 0.02M CTAB, monodisperse rods, cubes and 
pyramids were formed in solution when compared to samples of other CTAB concentrations. 
The rod-shaped nanoparticles indicate CTAB adsorption on the (100) plane which can be 
accurately presumed due to CTAB being the independent surfactant during nano-rod 
synthesis. Adsorption on (100) prolongs the growth of the facet allowing for the elongation of 
the decahedron as shown in Figure 3.3.1a. In the absence of SDS, the formation of the 
decahedral precursor structure is clearly dominant. Upon introducing 0.087M SDS to 0.02M 
CTAB the cuboctahedral precursor nuclei is directed and the effect of selective CTAB 
adsorption on (100) is maintained resulting in cube shaped nanocrystals. As shown by the 
results, when SDS is used at 0.1M there is competitive inhibition of CTAB adsorbing onto the 
(100) facet. The SDS at 0.1M when used simultaneously with 0.02M CTAB promotes the 
synthesis of the tetrahedral precursor stimulating the synthesis of pyramidal nanocrystals, 
adsorbing on the (111) facet. 
 
When CTAB is used at 0.03M in the absence of SDS, the formation of irregular polyhedrons 
is evident as shown in Figure 3.1j. This is shows the non-selective surfactant adsorption in 
this concentration range. Similar to the sample S10 where CTAB is used independently at 
0.04M, the higher concentration can be rewarded of its excess by producing more regular 
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surface adsorption and also reducing the crystal size by 100nm. CTAB at 0.03M and SDS at 
0.087 and 0.1M both produce samples various geometries showing non-selective precursor 
nuclei and facet growth. The increased SDS, however, is able to control the size of all 
geometries indefinitely. The tetrahedral size reduction is 400nm, rods by an aspect ratio of 7 
and spheres by 50nm in diameter. 
 
At the specific CTAB concentration of 0.04M, the growth of polyhedrons is constant. The 
excess CTAB adsorbs on all faces unselectively resulting in a geometrical structure with 
several facets. The addition of SDS at 0.087M partially assists with the control of CTAB 
adsorption equally on facets resulting in polyhedral nanostructures that are slightly more 
regular than spheres. At 0.04M CTAB, 0.087M SDS also affects the size of the nanocrystal, 
reducing the polyhedron diameter by 200nm affirming the use of SDS as a size controlling 
agent in the synthesis of nanocrystals (De and Mandal, 2013). When SDS is used in an 
excess of 0.1M at CTAB 0.04M, the polyhedral structure is at its most stable spherical 
structure. The SDS enhances equal adsorption of CTAB while reducing the nanocrystal size 
significantly by 90nm. 
 
3.3.2. Nanocrystal lattice spacing 
Individual nanoparticle geometry and crystallinity was analyzed to determine the lattice fringe 
spacing. A single rod nanocrystal (Figure 3.3.1a) consists of lattice fringes along (111) with a 
spacing of 2.09Å and (100) with 1.81Å as shown in Figure 3.3.1b indicating the copper 
nanocrystals are of FCC structure. The inset in Figure 3.3.1a clearly shows the 5-fold centre 
of the rod tip with the rod orientated to display its {111} facet. Figure 3.3.2a shows a single 
cube-shaped nanocrystal consisting of an inter-fringe distance of 1.81Å which is attributed to 
the lattice space along (100) (Figure 3.3.2b). The pyramidal-shaped nanoparticle (Figure 
3.3.3a) shows a monodisperse 2.09Å (111) lattice fringe (Figure 3.3.3b). Spherical 
nanocrystals 3.3.4a) have lattice fringes along (111) with a spacing of 2.09Å and (100) with 
1.81Å as shown in Figure 3.3.4b. Selected Area Electron Diffraction (SAED) patterns of the 
single nanocrystal illustrate ordered diffraction spots indicating high crystalline features of 
the capped CuNPs (Figure 3.3 (1c, 2c, 3c, 4c)). 
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Figure 3.3: 1a) rod-shaped nanoparticle and inset showing 5-fold center of the decahedral 
geometry at (111); 1b) lattice fringes and spacing of rod-shaped nanoparticle; 1c) uniform 
SAED patterns; 2a) Cube-shaped nanoparticle; 2b) lattice fringes and spacing of cube-
shaped nanoparticle; 2c) uniform SAED patterns; 3a) Pyramid-shaped nanoparticle; 3b) 
lattice fringes and spacing of pyramid-shaped nanoparticle; 3c) uniform SAED patterns; 4a) 
Spherically-shaped nanoparticles; 4b) lattice fringes and spacing of spherical nanoparticles; 
4c) uniform SAED patterns. 
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3.3.3. X-ray and electron diffraction analysis 
The powder X-Ray diffraction patterns of the CuNPs as shown in Figure 3.4a are indicative 
of highly oriented crystalline CuNPs and are similar amongst all samples. It corresponds to 
phase-pure copper according to the literature pattern (JCPDS, File No. 04-0836) with strong, 
prominent peaks at 43.1°, 50.3° and 74° correlating to (111), (200) and (220) planes of 
copper crystals, respectively. The 100% pure-crystalline copper characteristic peaks are 
indexed to a FCC crystal structure. A small proportion of impurity, copper oxide, was 
detected at 35.5° (002) and is owing to formation of copper oxide following interactions with 
air during the XRD analysis. 
 
As indicated by enlarged views, rods (Figure 3.3.1a), cubes (Figure 3.3.2a), pyramids  
(Figure 3.3.3a) and spheres (Figure 3.3.4a) have well-defined edges and aspects. The 
lattice fringes and SAED patterns corresponding to Figure 3.3.1a–3.3.4c indicate FCC 
copper and differ according to their individual orientation. According to the Bragg equation 
(Equation 3.4), 
 
nλ = 2dsin(θ) (3.4) 
  
can be rearranged to determine the spacing, d, between corresponding lattices (Equation 
3.5), 
 =   x
ℎ
2!"#θ%
 
(3.5) 
  
Using θ  from the crystalline peaks arising from the X-ray diffraction data (Figure 3a), the 
lattice distance can be calculated from the (111), (200), (220) and (311) planes as 2.09Å 
(0.209nm), 1.81Å (0.181nm), 1.27Å (0.127nm) and 1.09Å (0.109nm) respectively. These 
values correspond ideally with the figures associated to the lattice fringe spaces giving a 
clear indication that copper of the correct domains were formed. 
 
The EDS plots of CuNPs (Figure 3.4b) exclusively exhibits the characteristic peaks of ideal 
elemental copper. Strong signals of copper atoms show at a dominant Kα1 peak at 
8.0477keV followed by a smaller Kβ1 peak 8.0905keV. The peak at 0.9498keV demonstrates 
the Lβ1 peak for electrons in the L-shell. The EDS plots for all CuNPs samples resulted in 
similar spectra. Thus, both metal characterization analysis indicate the synthesis of pure 
copper. The strong FCC copper peaks from XRD and elemental copper peaks from EDS 
(Figure 3.4b) demonstrates that the thermal-chemical reduction method used in conjunction 
with ascorbic acid serving the dual function of reducing agent and capping agent; and two 
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surfactants coating the CuNPs in the aim of preventing oxidation results in the synthesis of 
pure copper nanocrystals without additional impure phases. 
 
 
Figure 3.4: a) powder X-Ray diffraction patterns of synthesized copper nanocrystals; b) 
energy dispersive spectra showing pure elemental copper. 
 
3.3.4. Surface charge analysis 
Zeta potential, as an indicator of surface charge, gives the probability of stability of the 
sample. The greater the potential of the CuNPs, the higher the stability and reduced 
likeliness to aggregate due to the repel of the charged nanoparticles. Ascorbic acid has a 
negative charge, hence sample S1 has a negative potential (Roy et al., 2003). The reducing 
agent also serves as a stabilising agent by binding to the surface of the synthesized 
a 
b 
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nanocrystal, preventing aggregation of the nanoparticles (Personick and Mirkin, 2013). The 
results indicate a change in surface charge with different surfactant types and 
concentrations. The use of cationic CTAB and anionic SDS manipulates the surface charge 
from the standard negative charge (sample S1 = −28.3mV) of the CuNPs synthesized 
without surfactant as shown in Table 3.2. The surface charge of the CuNPs synthesized with 
CTAB as the independent surfactant (S4, S7 and S10) are fairly stable with positive 
potentials and the least stable values are due to the high concentrations of both surfactants 
simultaneously used in CuNP synthesis. Samples S2, S6, S8 and S11 where SDS is used at 
0.087 or 0.1M has characteristics of least stabile profiles and may possess the highest 
aggregation while relatively low concentrations of CTAB (S3, S5 and S9) displayed strongly 
negative charges as expected. The samples synthesized with one surfactant with a 
dominant concentration prove to be most stable with potentials less than −25mV or 
exceeding +25mV. 
 
Table 3.2: Zeta potential data collated from all CuNPs samples. 
Formulation [CTAB] [SDS] Zeta Potential (mV) 
S1 0.00 0.000 −28.3 
S2 0.01 0.087 −19.9 
S3 0.01 0.100 −25.7 
S4 0.02 0.000 26.9 
S5 0.02 0.087 −30.3 
S6 0.02 0.100 −21.3 
S7 0.03 0.000 27.1 
S8 0.03 0.087 −6.75 
S9 0.03 0.100 −34.5 
S10 0.04 0.000 33.1 
S11 0.04 0.087 −18.4 
S12 0.04 0.100 16.7 
 
3.3.5. Yield analysis 
Yield analysis was conducted on the CuNPs samples with differing results as shown in Table 
3.1. An additional aspect of interest noted in this study regarded the variation in yield 
between the samples. The percentage of CuNPs synthesized is influenced by the 
surfactants and possibly potentiates the synthesis of the copper nanocrystals and enhances 
the capping effect. Typically, CTAB has been shown to increase the number of nanocrystals 
formed during reduction while using an independent reducing agent (Salzemann et al., 
2004b). This confirms the use of CTAB as a catalyst reducing agent. CTAB samples 
prepared without ascorbic acid did not produce CuNPs reiterating that CTAB is not an 
independent reducing agent; however, samples that contained higher CTAB increased the 
CuNP yield. CuNP samples that contained a constant CTAB concentration varied in yield 
when the SDS concentration differed. The results show that SDS may have also functioned 
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as a catalyst and the samples increased in yield with an increase in SDS concentration. 
Additionally, an increase in yield seen with SDS may be due to the surfactant adsorption on 
the crystal facets and coating of the nanoparticle surface. 
 
3.3.6. Evaluation of chemical and structural changes of the surfactant-coated copper 
nanoparticles 
FTIR analysis was conducted on the reducing agent, surfactants and coated CuNPs to 
determine the adsorption of the excess ascorbic acid, CTAB and SDS on the CuNPs (Figure 
3.5). The capping effect of the surfactants also promotes stability towards aggregation 
allowing for the optimal function of the nanoparticles. Similar characteristic peaks found 
between ascorbic acid (Figure 3.5a) and sample S1 (Figure 3.5b) and between CTAB 
(Figure 3.5c), SDS (Figure 3.5d), sample S4 (Figure 3.5e) and S5 (Figure 3.5f) give an 
indication of the adsorption on the CuNPs. Common peaks found on the ascorbic acid and 
sample S1 spectra include CH stretching at 2943cm−1, carbonyl groups at 1711cm−1, 
aromatic rings at 1408cm−1, ether groups at 1137 and 1177cm−1. The FTIR spectrum of 
sample S4 (Figure 3.5e) and selective peaks of sample S5 (Figure 3.5f) can be attributed to 
the adsorption of CTAB (Figure 3.5c) on the surface of the CuNPs.  
 
Both spectra exhibited CTAB characteristic peaks of CH bending in the 1400–1500cm−1 
region, stretching vibrations of C–CH2 in the methylene chains at 2848cm−1 (Riccardi et al., 
2009) and 2916cm−1 (Campbell et al., 2004). Sample S5 displays a peak at 3018cm−1 
assigned to the antisymmetric stretching modes of the trimethylammonium headgroup of 
CTAB (Campbell et al., 2004) indicating facet adsorption of CTAB. When comparing the 
spectrum of sample S5 (Figure 3.5f) with the SDS (Figure 3.5d) spectra, several 
corresponding peaks are definite indicating the presence of the surfactant in the CuNP 
sample. The bands on spectrum Figure 3.5f correspond to the OSO3− bands at 1215 and 
1247cm−1 (Yada et al., 1996) and peaks at 2918 and 2954cm−1 assigned to the CH2 group 
on the SDS spectrum (Sperline et al., 1992). The FTIR data are indicative of reducing agent 
and surfactant adsorption on the CuNPs and is further corroborated by the following TGA 
data. 
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Figure 3.5: FTIR spectra of: a) ascorbic acid; b) sample S1; c) CTAB; d) SDS; e) sample 
S4; f) sample S5. 
 
3.3.7. Thermal degradation analysis of surfactant-coated copper nanoparticles 
TGA was used to assess the relative composition of the capping agents on the CuNPs.  
Figure 3.6a and b shows the representative TGA curves obtained for samples S1 and S2 
which were heated from 30 to 900°C in the presence of nitrogen gas. The curve in Figure 
3.6a shows one key degradation point between 110 and 320°C, which can be related to the 
decomposition of the ascorbic acid on the surface of the CuNPs. Sample S2 (Figure 3.6b), 
capped with ascorbic acid, CTAB and SDS, displays two key degradation steps. The first 
weight loss step in Figure 3.6b curve occurs between 110 and 240°C indicating the 
degradation of ascorbic acid as the capping agent and between 300 and 410°C, which is 
attributed to the degradation of the adsorbed surfactants. All remaining samples have TGA 
profiles similar to Figure 3.6b. 
 
The degradation of the ascorbic acid in sample S1 occurs at temperatures between 100 and 
320°C and between 110 and 240°C in sample S2. This data indicates the capping effect of 
the ascorbic acid and the intramolecular interactions between ascorbic acid and the 
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surfactants resulting in a slightly raised degradation temperature in sample S2. After analysis 
at the end temperature of 900°C, an average of 95.7% of sample remains. Copper degrades 
at temperatures higher than 900°C indicating that the degradation that occurred is attributed 
to the supporting surfactants in the samples and that the synthesized CuNPs are thermally 
stable. The change in mass can be translated to the ratio of capping agents to CuNPs. A 
shell of about 2% ascorbic acid and 6% surfactant adsorption was determined from 
thermogravimetric analysis, resulting in 93%–96.4% of the mass due to the copper. 
 
 
Figure 3.6: TGA curves of: a) sample S1 showing degradation of reducing agent; b) sample 
S2 showing degradation of surfactants on the nanoparticle surface. 
 
3.3.8. Effect of nano-shape on skin permeation through excised mice skin 
Permeation studies were conducted to determine the effect of nanoparticle geometry on 
transcellular drug delivery. Pre- and post-ex vivo characterization, conductivity analyses 
confirmed maintenance of skin integrity of the mice skin tissue samples. Analyses of the ex 
vivo permeation results (Figure 3.7) within the first 2 hours show the CuNPs reaching a state 
of equilibrium in the epidermal tissue. No CuNPs permeation is detected in the first hour and 
a mere 0.0149mg·cm−2 CuNPs is detected in the rod nanoparticle sample, 0.05mg·cm−2 of 
the pyramid nanoparticle sample and 0.17mg·cm−2 of the 5nm sphere nanoparticle sample 
at 2 hours. The first CuNP detection of the 90nm spheres and cubes occurs at 4 hours at 
0.122 and 0.254mg·cm−2, respectively. The permeation lag can be explained by the CuNPs 
reaching a state of concentration equilibrium in the epidermal tissue and thereafter 
permeating into the receptor compartment. Interestingly, the skin permeation and 
transcellular transport due to shape kinetics of the spheres are higher than the other 
geometrical nanoparticles. The 90nm spheres have the highest cumulative diffusion per unit 
area (0.78mg·cm−2) (Figure 3.7) but have a lower nanoparticle flux (4.20 x10−2mg·cm−2·hr−1), 
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as shown in Table 3.3, compared to the 5nm spheres which have a lower cumulative 
diffusion per unit area (0.73mg·cm−2) with a higher nanoparticle flux (5.88 
x10−2mg·cm−2·hr−1). The initial CuNP permeation of the 5nm spheres supersedes the 90nm 
spheres and eventually stabilizes at a concentration below the 90nm spheres while the rods 
have an initial lower flux than the pyramids and cubes but steadily increase with all 
geometries reaching system equilibrium after 14–16 hours. The 5nm spheres show a long 
burst release permeation as opposed to the rods, pyramids and cubes which is followed by 
the 90nm spheres. Interestingly, the pyramids show a short burst release until 6 hours, 
thereafter reaching a stable flux. 
 
Figure 3.7 confirms the hypothesis of the nano-shape effects on cellular permeation where 
the geometrical structure of the nanoparticle affects cellular and transdermal permeation. 
Cellular internalization and epidermal tissue localization of the CuNPs also show nano-
shape to be a dictating factor when considering this drug delivery system for specific 
transdermal or dermal use. Table 3.3 lists the concentration of neo-geometric CuNPs 
retained by the epidermal tissue post-internalization after analysis using Inductively Coupled 
Plasma Optical Emission Spectrometry (ICP-OES). The cube-shaped CuNPs shows the 
highest retained concentration at 0.34mg with 90nm spheres being the lowest at 0.09mg. 
Having the highest retention potential, cubes also have the lowest permeation potential with 
an average flux indicating a system application for epidermal drug delivery. The 90nm 
spheres retain the least amount of CuNPs but have the highest permeation with an above 
average flux when compared with other neo-geometric CuNPs giving the probability of its 
use as a transdermal drug delivery system. The alternative nano-shapes can be dually used 
as systems requiring dermal and transdermal drug delivery depending on application 
specificities as can be extrapolated from Figure 3.7 and Table 3.3. The results of the CuNPs 
retained correlate with the CuNPs diffusion through the epidermal skin tissue. The high 
permeation of the CuNPs accounts for the low concentration of CuNPs retained and vice 
versa. The results do not indicate a superior system for drug delivery but rather results 
based application of the neo-geometric CuNPs. Previous studies identified hollow copper-
sulphide nanoparticles as a skin disruption mechanism to enhance transdermal drug delivery 
of human growth hormone upon application of a near-infrared laser (Ramadan et al., 2012). 
In addition, Ahamed and associates (2014) recently studied the antibacterial effects of 
CuNPs which can be included in medical devices similar to the study conducted by Sankar 
and co-workers (2015) who investigated the antibacterial effects of CuNPs on wound 
healing. Having the benefit of inhibiting pathogenic bacterial growth, the future goals of this 
study will also focus on the toxic properties of CuNPs in transdermal drug delivery. 
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Figure 3.7: Ex vivo permeation profiles of geometric copper nanoparticles through excised 
BALB/c mice dermal tissue. Data presented are mean ± SE of three experiments performed 
in duplicate. *p ≤ 0.05. 
 
Table 3.3: Copper nanoparticle flux and associated permeability coefficients for the 
geometric copper nanoparticles through excised BALB/c mice dermal tissue. Data presented 
are mean ± SE of three experiments performed in duplicate. *p ≤ 0.05. 
Formulation Geometrical Structure 
Flux, JS, 
(mg·cm−2·hr−1) 
CuNPs Retained in Dermal 
Tissue (mg) 
S1 Spheres (90 nm) 4.20 x10−2 0.09 
S4 Rods 3.61 x10−2 0.14 
S5 Cubes 3.75 x10−2 0.34 
S6 Pyramids 2.66 x10−2 0.28 
S12 Spheres (5 nm) 5.88 x10−2 0.11 
 
3.4. Concluding Remarks 
 
The fabrication of non-agglomerated, monodispersed and exquisite geometrically organised 
CuNPs has been successfully demonstrated by reducing a copper salt using ascorbic acid in 
the presence of two key surfactants. Homogenous samples of cubes, pyramids, rods and 
spheres were synthesized proving shape control of the method. Particle morphologies could 
be controlled by manipulating the surfactant concentration, as well as by utilizing the 
degradation products of ascorbic acid to assist with capping and shape dictation of the 
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nanoparticles. It can be concluded that CTAB at 0.02 and 0.04M are most stable when 
synthesizing homogenous geometries in one pot. The SDS variation thereafter plays the key 
role in inhibiting or stimulating the adsorption of CTAB by its own adsorption. The function of 
the SDS can be assumed to be a vital one as an additional geometry and size dictator. The 
shape organization of the CuNPs is remarkable despite the small increase in surfactant 
concentration between the samples. The epidermal permeation, flux and tissue-retained 
CuNPs clearly show a shape-dominated trend and the drug delivery uses of the CuNPs 
thereof prove to be varied. This approach in the synthesis of neo-geometric copper 
nanocrystals offers the controlled shape formation of copper nanocrystals and reproducibility 
of heterogeneous and homogenous shape-formation based on the surfactant concentration. 
In addition to nano-shape, the surface chemistry of the CuNPs also affects ex vivo kinetics 
related to drug delivery and will be considered for functionalization. The CuNPs will be 
further applied in drug delivery as a function of its shape and toxicity. Considering the 
CuNPs retaining potential or transbarrier transport, the nanosystems will be applied to 
human keratinocytes in the determination of ideal nano-shape for enhanced cell uptake. 
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CHAPTER 4 
CELLULAR INTERNALIZATION KINETICS AND CYTOTOXIC PROPERTIES OF 
STATISTICALLY DESIGNED AND OPTIMIZED 
NEO-GEOMETRIC COPPER NANOCRYSTALS 
 
4.1. Introduction 
 
Surface engineering of nanotherapeutics is considered as the frontrunner in biomedical 
applications and drug delivery as a smart means of delivering drugs and dictating their fate.  
Nanoparticles as a drug carrier have been exploited in the delivery of biomedical agents 
owing to their nano-size allowing for drugs to be delivered at a cellular level thereby 
increasing  drug deposition intracellularly, reducing the amount of drug required and more 
importantly, reducing the side effects of drugs by targeting nanoparticles to diseased cells. 
With this emerged field of research gaining significant momentum since its inception, the 
pathway has been paved for improvements on the original concept of nanoparticles as a 
drug delivery system.  
 
With recent advances in nanotechnology, studies show that manipulating the 
physicochemical and physicomechanical parameters of nanoparticles have an effect on the 
cellular internalization (Zhao et al., 2011; Sami et al., 2012). Modifying the characteristics of 
nanoparticles assist with the enhanced internalization and improving therapeutic time. 
Engineering nano features such as size, shape, surface charge, chemical chemistry, 
hydrophobicity and ligand attachments are a few parameters of nanoconstructs that can be 
manipulated (Sahay et al., 2010; Venkataraman et al., 2011). If focused on during synthesis, 
these characteristics may be the dictating factor in improving nanoparticle internalization 
kinetics, thus, positively affecting intracellular drug delivery.  
 
Amongst these possible nanoparticle modifications, nanoparticles with engineered 
geometries seem to be an interesting one with varying rates of internalization based on the 
interactions between the scaffold design and cell membrane. Nano-shape and geometry-
related parameters form factors inclusive of aspect ratios or edges that affect nanoparticle 
internalization kinetics and influence cell-particle interactions (Champion et al., 2007; Yang 
and Ma, 2010). By varying the shape of nanoparticles having the same volume, or varying 
the volume of particles of the same shape, it can be studied that nanoparticles with different 
shapes penetrate the lipid bilayer of the cell membrane differently and geometric 
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internalization may even vary between different cell types (Yang and Ma, 2010). Nano-vector 
design as a function of its shape has been proven to have diverging effects on cell uptake 
which also ranges from active and passive translocation mechanisms such as phagocytosis, 
macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated endocytosis, and 
clathrin- and caveolae-independent endocytosis (Venkataraman et al., 2011). 
 
Hence, the aim of the study was to engineer neo-geometric CuNPs in the investigation of 
nano-shape in drug delivery application. As for any formulation, design criteria including 
material selection and network fabrication are crucial for drug delivery. In this study, these 
criteria are essential in governing the outcome of the geometrical structure and charge 
stability of the CuNPs. Prior to the synthesis of the CuNPs, these criteria have to be 
evaluated based on the two independent variables. In order to achieve the aim of formulating 
homogenous, stable CuNPs, extensive shape elucidating characterization and zeta potential 
analyses were conducted. The use of the two key surfactants offered shape dictation and 
varying surface charge of the formulations in the statistical design for its use in further 
studies to investigate the effect of shape on cell uptake, simultaneously improving drug 
delivery. As a result, in this investigation a new strategy for the preparation of novel 
geometric CuNPs, with optimization through a full factorial experimental design is reported 
on. 
 
Based on the concept of nano-geometry influencing cell uptake, after optimization of the 
nano-systems, this study investigated the internalization kinetics of neo-geometric CuNPs in 
normal human epidermal keratinocytes (NHEK) and cytotoxic analyses using NHEK and 
HeLa cells. The successful optimization of the bottom-up synthesis of geometric CuNPs 
synthesized by selective surfactant-mediated surface adsorption on preferential crystal 
facets serves as the geometric nano-vector. 
 
4.2. Materials and Methods 
 
Copper II sulphate pentahydrate (CuSO4.5H2O) was purchased from Merck (Darmstadt, 
Germany), CTAB, SDS and MTT, LDA, GSH and MDA assays were purchased from Sigma-
Aldrich Co. (Aldrich, Steinheim, Germany) and L-ascorbic acid (98%) was purchased from 
Roche (Johannesburg, South Africa). NHEK cells, keratinocyte basal medium, growth 
factors and supplements including bovine pituitary extract, human epidermal growth factor, 
insulin, hydrocortisone, epinephrine, gentamicin, amphotericin B, transferrin, trypsin/EDTA 
were all purchased from Whitehead Scientific (Cape Town, South Africa). HeLa cells and 
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Dulbeccos Modified Eagles Medium (DMEM) were purchased from Separations 
(Johannesburg, South Africa). All chemicals and assay kits were analytical grade and used 
without further purification. 
 
4.2.1. Synthesis of geometric copper nanocrystals 
The thermal-reduction method of synthesizing nanocrystals included a standard 
CuSO4.5H2O solution added to varied molar concentrations of aliquot CTAB and SDS 
solutions heated at 50°C. Solution was further heated between 85-90°C and a standard 
ascorbic acid solution was added as the reducing agent in a drop-wise manner to allow for 
spontaneous copper formation without a reducing agent overload. The temperature was then 
maintained at 80°C using a mercury thermometer (Brannon Thermometers, Cumbria, 
England).  
 
4.2.2. Experimental design and constraint optimization of neo-geometric copper 
nanoparticles 
A full factorial design was used to optimize the neo-geometric nanoparticles. Optimization 
using the two variable design model was employed to ascertain the ideal combination of dual 
surfactants (CTAB and SDS) as the independent variables to achieve optimal homogenous 
geometries and zeta potential to ensure stable nanosystems.  For each of the two 
parameters selected, two factors were fixed, an upper and a lower level as summarized in 
Table 4.1 and these values were obtained from preliminary studies undertaken with 4 levels 
for CTAB and 3 levels for SDS. Also shown in Table 4.1 are the responses and the 
optimization constraints for each variable. The design was both generated and analyzed 
using Minitab V15 software (Minitab® Inc, PA, USA) and for the design 12 experimental 
formulations were obtained as summarized in Table 4.2. 
 
Table 4.1: Formulation variables and responses applied in the Full Factorial design. 
 Levels Objective 
 Upper Lower 
 
Parameters    
CTAB (M) 0.040 0.000  
SDS (M) 0.100 0.000  
Responses    
Shape uniformity   Maximise 
Surface charge   ≤25≥ 
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Table 4.2: Statistically generated formulations obtained from a Full Factorial Design of 
optimization. 
Formulation Variable 1 Variable 2 
 
[CTAB] (M) [SDS] (M) 
1 0.04 0.000 
2 0.00 0.087 
3 0.02 0.000 
4 0.04 0.100 
5 0.00 0.100 
6 0.00 0.000 
7 0.02 0.100 
8 0.04 0.087 
9 0.02 0.087 
10 0.03 0.000 
11 0.03 0.087 
12   0.03 0.100 
 
4.2.3. Geometric and morphological characterization of the copper nanoparticles   
TEM (FEI T12 Spirit TEM (120kV), Hillsborough, USA) and HR-TEM (JEOL JEM 2100F 
(200kV), Oregan, USA) were conducted to confirm the synthesis of self-assembled neo-
geometrical nanoparticles. CuNPs were dispersed on a copper grid coated with 
Formvar/carbon (200 mesh, BAL-TEC, EMTechnology and Application, Witten, Germany). 
Excess sample was removed by solvent evaporation under ambient conditions. Samples 
were also subjected to TEM-EDS for high-speed elemental analysis. 
 
4.2.4. Zeta potential and stability analyses of copper nanoparticles 
The zeta potential measured the surface charge of the CuNPs, thus indicating the stability 
and aggregation potential of the nanoparticles. Each suspension was diluted 1:15 in distilled 
water, filtered through a 0.22μm Millipore filter, transferred into a capillary cell and was 
analyzed by a Zeta sizer (DTS (nano), Malvern instruments ltd, Worcestershire, UK).   
 
4.2.5. Crystal and elemental analysis of the optimized copper nanoparticles 
A powder X-Ray diffractometer (MiniFlex 600, Tokyo, Japan) was used to monitor diffraction 
patterns of the CuNP samples to validate the synthesis of crystalline copper. A continuous 
scan rate of 0.1°/min from 0-90° was used with copper Kα radiation (λ=1.54Å). Percent 
crystallinity of distinctive peaks was computed employing PDXL software (Rigaku, Tokyo, 
Japan). Concurrent characterization was carried out using an Oxford INCA EDS system 
coupled to a TEM which monitored diffraction patterns to determine the elemental 
composition of the CuNP samples.  
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4.2.6. Thermal degradation analysis of the surface surfactant-coating of the copper 
nanoparticles 
TGA using a 4000 thermogravimetric analyzer (PerkinElmer Inc., Massachusetts, USA) 
evaluated the surfactant-coating of the CuNP samples as the function of temperature in 
nitrogen atmosphere under a flow of 40ml/min and heating rate of 10°C/min from 30-900°C. 
The Pyris 6 software (PerkinElmer Inc., Massachusetts, USA) was used to perform the 
thermal analysis. Each test consisted of a powder weighing approximately 10-20mg and 
produced similar results among all samples. 
 
4.2.7. Optimization of the neo-geometric copper nanoparticles 
Following generation of the polynomial equations relating to the dependent and independent 
variables, the formulation process was optimized under constrained conditions for the 
measured responses of shape uniformity and surface charge. Response surface analysis of 
various response variables was carried out employing Minitab® statistical software (V15, 
Minitab Inc., PA, USA). The results were demonstrated using residual plots, interaction plots 
and response surface plots derived for the measured responses 
 
4.2.8. Cell culturing and copper nanoparticle-cell incubation 
Primary NHEK cells were sub-cultured until passage 6 and used for all internalization and 
cell viability assays. HeLa cells were used as a comparison for the cytotoxicity evaluation 
giving a perspective on the toxicity of the CuNPs on a cancer line. The NHEK cells were 
cultured in keratinocyte basal medium and supplemented with bovine pituitary extract, 
recombinant human epidermal growth factor, insulin, hydrocortisone, epinephrine, 
transferrin, gentamicin and amphotericin B. The HeLa cells were cultured using DMEM and 
5% Foetal Bovine Serum (FBS) solution with both cell lines incubated in a humidified 37°C 
environment controlled at 5% CO2. At 80% confluence, the cells were harvested using 
trypsin/EDTA and were subcultured into 75cm2 flasks, 12-well plates on circular glass cover-
slides for internalization studies, and 96-well plates for the toxicity assays. The cells were 
allowed to attach to the surface for 48 hours prior to treatment. 
 
4.2.9. Qualitative and quantitative cellular internalization studies  
NHEK cells were cultured on circular glass cover slips in 12-well plates at 1x103 cells per 
well. After 48 hours of seeding, the cells were exposed to the geometric CuNPs (12.5µg/ml) 
for 12 hours. At suitable time intervals, the samples were dehydrated using 50%, 60%, 70%, 
80% and 90% ethanol solution for 10 minutes each, consecutively and finally 100% ethanol. 
Once dehydrated, the glass cover slips were mounted on cover slides and analyzed for 
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CuNPs internalization imaging using a BX63 light microscope (Olympus, Tokyo, Japan) 
equipped with a DP 80 camera (Olympus, Tokyo, Japan). In addition, quantitative analysis of 
internalized CuNPs was conducted to quantify internalization of the geometric nanoparticles 
at set time-points. 1x103 cells/well were seeded in 96-well plates and exposed to the CuNPs 
for 1, 2, 4, 8 and 24 hours. At the end of the respective exposure periods, cells were 
detached from the wells using trypsin/EDTA, centrifuged, rinsed to remove non-internalized 
CuNPs and collected for Inductively-Coupled Plasma Optical Emission Spectroscopy  
(Activa S) (Horiba Scientific, Munich, Germany) analysis to determine the amount of copper 
internalized. 
 
4.2.10. Geometric dependency of copper nanoparticles on cell viability 
A MTT assay was conducted on the cells exposed to various geometric CuNPs to determine 
the effect of concentration, geometry and cell type on cellular viability and mitochondrial 
function. 1x103 cells/well were seeded in 96-well plates and exposed to different 
concentrations (6.25, 12.5, 25, and 50µg/ml) of CuNPs for 24 hours. At the end of exposure, 
10µL of MTT dye (3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide) (5mg/ml) 
was added to each well and incubated for 3 hours at 37°C. As a result, formazan crystals 
were formed and then dissolved using MTT solubilising solution. The plates were further 
incubated for 30 minutes and then analyzed at 570nm using a Powerwave XS multiplate 
spectrophotometer (BioTek, Vermont, USA). Untreated cells were run under identical 
conditions and served as controls.  
 
4.2.11. Lactate dehydrogenase activity 
Lactate dehydrogenase (LDH) activity was determined using an assay kit which measured 
the levels of LDH production and subsequent cell damage. NHEK cells were seeded in 96-
well plates for 48 hours (6x106 cells/well) and thereafter exposed to geometric CuNPs for 24 
hours at different concentrations (6.25, 12.5, 25, and 50µg/ml). After exposure, cells were 
homogenized and 50µL samples were collected for analysis. LDH activity was assayed 
using LDH substrate mix and assay buffer and its absorbance read at 450nm with 5 readings 
at 3 minute intervals using a Powerwave XS multiplate spectrophotometer. 
 
4.2.12. Glutathione assay 
As a marker of oxidative stress, reduced glutathione (GSH) was measured to determine 
intracellular free-radical damage. NHEK cells were seeded in 96-well plates for 48 hours 
(6x106 cells/well) and thereafter exposed to geometric CuNPs for 24 hours at different 
concentrations (6.25, 12.5, 25, 50µg/ml). After exposure, cells were centrifuged and 
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collected in a pellet. To the pellet, three times the volume of 5% sulfosalicylic acid was 
added and vortexed. The cell suspension was frozen in liquid nitrogen and thawed in a 37°C 
water bath twice before temporary storage at 2-8°C. The sample was then centrifuged and 
the supernatant collected. To 10µL of supernatant, 150µL of assay buffer and 5,5-dithio-bis-
(2-nitrobenzoic acid (DTNB) solution was added. After 5 minutes of incubation, 50µL of 
nicotinamide adenine dinucleotide phosphate (NADPH) was added to each well and the 
absorbance was read at 412nm for 5 minutes at 1 minute intervals using a Powerwave XS 
multiplate spectrophotometer. 
 
4.2.13. Lipid peroxidation activity 
Lipid peroxidation activity (LPO) was determined by measuring the formation of 
malondialdehyde (MDA) which is a product of membrane LPO. NHEK cells were seeded in 
96-well plates for 48 hours (6x108 cells/well) and thereafter exposed to geometric CuNPs for 
24 hours at different concentrations (6.25, 12.5, 25, 50µg/ml). After exposure, cells were 
centrifuged, collected in a pellet and lysed. The resultant supernatant was used for analysis. 
Thiobarbituric acid (TBA) was added to the supernatant to form a MDA-TBA adduct, 
thereafter incubated for 60 minutes at 95°C and its absorbance read at 532nm using a 
Powerwave XS multiplate spectrophotometer. 
 
4.2.14. Data analysis and confirmation of statistical significance of all assays 
performed 
The 4 assays were carried out in 3 independent experiments in duplicates for each 
evaluation. Data were expressed as mean (±SE) and analyzed by 1-way Anova. p values 
less than 0.05 was considered statistically significant. 
 
4.3. Results and Discussion 
 
4.3.1. Geometric analyses of copper nanocrystals 
It is ascertained that parameters of nanoparticles can be controlled to achieve desirable 
characters. As is with this study, the novelty of using two surfactants during the synthesis of 
CuNPs yielded nanoparticles of various geometric structures (Table 4.3). The aim of the 
design, however, focused on streamlining the synthesis parameters to produce nano-
systems of homogenous shapes. The CuNPs were synthesized using a thermal-chemical 
reduction method as per Table 4.2 and characterized to confirm nano-shape fabrication. 
Figure 4.1 includes TEM images of all 12 experimental formulations in the design and 
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compares the variable surfactant concentration to establish the optimal responses according 
to the surfactant concentrations employed in the study. 
 
 
Figure 4.1: TEM images of the nanoparticles synthesized from 12 formulations as per the 
Full Factorial Design. 
 
Surfactant-driven growth of geometric nanoparticles has been successfully conducted by 
exploiting its surface-adsorbing nature. Adapting Tah and associates (2011) theory of 
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cationic complex formation, the surfactants form aggregates in specific ratios baring specific 
energy profiles. It can be assumed that these cationic complexes have preferential 
adsorption based on its energy and affinity for certain charged facets of the nanocrystal and 
its own energy profile. The dual surfactants used compete preferentially for the various faces 
of the nanocrystals during synthesis after nucleation controlled facet-growth and consequent 
shape formation. Slight surfactant concentration variation significantly affects nano-shape of 
crystals as shown in this design and may be attributed to the anisotropy of the cationic 
complex adsorption on preferential crystal facets. Evolving nanoparticle morphology is 
clearly evident in the comparison of the experimental formulations. As a result of 
manipulating CTAB and SDS ratios, the surface energy of the nanocrystals, adsorption 
energy of the surfactants and interaction sites provided by the dominant molecules in 
solution consequently give way to the growth of neo-geometric nanoparticles.  
 
According to distinguished mathematical physicist J. Willard Gibbs, matter will attain a shape 
in which the total surface energy is minimal (Gibbs, 1878). The general shape of a 
nanocrystal will therefore assume polyhedron geometry (Figure 4.2c) when the CuNPs were 
synthesized deficient of either surfactant to interfere with facet growth or energy alteration 
within the system. There were no additional factors to deviate the standard growth of the 
nanocrystals. Gibbs adsorption equation  based on the conditions of equilibrium in a system 
is given as: 
 
& + Г. μ = 0                                                                                                      (Equation 4.1) 
 
Where d is range of intermolecular force, σ is surface tension, Г is adsorption and µ is 
chemical potential, supplements the theory of minimising surface energy of a crystal. It can 
then be supposed that faces with a relatively low surface energy will dominate the 
equilibrium shape (Barmparis et al., 2015) and addition of surfactant subsequently obstructs 
the stable geometry and influences surface energy variation on the crystals facets. In 
addition, theoretical simulations and considerations based on the Wulff theorem classify 
characteristic nanocrystal shapes according to surface energies (Barmparis et al., 2015). 
The concept of this theory allows for the analysis and includes the application of surfactants 
tailoring nano-shape. With regards to Wulff’s theory, the equation: 
 
+ℎ, =  +ℎ, +  - ./01
2/3
                                                                                           (Equation 4.2) 
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where γ(hkl) refers to the interface tension between the hkl facets, Eads is the adsorption 
energy, θ is the surface coverage and Aat is the area per surface atom, interactions between 
the adsorbing agents are crystal are crucial (Barmparis et al., 2015). Thus, preferential 
adsorption of surfactant molecules reduces the surface energy of particular facets and 
typically adopts a state of equilibrium supporting the growth of neo-geometric CuNPs (Figure 
4.1). The CTAB and SDS complex evidently compete for adsorption on the crystal facets 
based on energy profiles and varying molar concentrations assist with providing a principal 
adsorbent. In the synthesis of nanocrystals, the high-energy facet grows at a higher rate 
than low-energy facets concluding in the fast growing faces disappearing resulting in a 
nanocrystal with low-energy facets (Liao et al., 2014) which supports the equilibrium theory 
as per Gibbs.  
 
 
Figure 4.2: Precursor nuclei and geometric structures from which nanocrystals arise. 
 
In this study, the growth of the neo-geometric CuNPs is in congruence with the adsorption of 
dual surfactants competing for preferential facets, adsorption on certain facets causing a 
reduction of surface energy, hence, directing geometric growth of the nanocrystals. 
Formulations 1 (Figure 4.1a), 5 (Figure 4.1e), 8 (Figure 4.1h) and 10 (Figure 4.1j) produced 
irregular spherical nanoparticles arising from the polyhedron nucleus (Figure 4.2c). The 
difference in irregularity can be explained by the unequal adsorption of the surfactants and 
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due to the variant concentrations, the degrees of irregularities are obvious. CTAB or SDS 
adsorb onto preferential faces causing certain faces to appear larger than others.  
Formulations 2 (Figure 4.1b), 4 (Figure 4.1d) and 6 (Figure 4.1f) are also initiated from the 
polyhedron, however, the ratios of the different surfactants are equal resulting in perfect 
spherically shaped nanocrystals. The size discrepancy is due to the different surfactant 
concentrations used and its rate of adsorption. Observation of the shape formation between 
Formulation 2 and 6 also clearly indicates the size reduction of the spheres upon the 
addition of SDS corroborating the use of SDS in controlling nano-size (De and Mandal, 
2013). 
 
Formulations 3 (Figure 4.1c), 7 (Figure 4.1g) and 9 (Figure 4.1i) are all homogenous 
samples of idealistic geometries with varying aspects from rods to cubes and pyramids due 
to the variation in SDS concentration. Upon addition of SDS whilst maintaining 0.02M CTAB, 
the aspect ratio of the nanoparticles showed a fundamental decrease in aspect ratio 
between the nano-rods and nano-cubes. Further increasing the SDS concentration reduced 
the number of geometric aspects resulting in a change from a four-aspect structure to a 
three-aspect structure and additionally reducing the size dimensions of the nanoparticles. 
The numbers of sharp aspects increase and decrease spontaneously, showing 
responsiveness to increasing SDS in the presence of 0.02M CTAB.  
The elongated decahedron (Figure 4.2c) which forms the rod-shaped nanoparticle (Figure 
4.1c) is obtained by lowering the {100} surface energy (Ringe et al., 2013). From this, it can 
be deduced and applied that lowering the surface energy of a facet will potentiate its ability 
to become the dominating facet, hence, eventually acquiring properties of distinguished 
geometries. This theory allows for the dictation of shape through surface energy, tension and 
selective adsorption of surfactants. The pyramidal nanocrystals (Figure 4.1g) grow from the 
tetrahedral nucleus (Figure 4.2a) by competitive adsorption on the {111} facets creating the 
dominant faces of the crystal. Upon the addition of SDS to the stable 0.02M CTAB, cube-
shaped nanocrystals are fabricated from the cuboctahedron precursor nucleus (Figure 4.2b) 
and are characterized by the selective adsorption onto the {100} face causing the {111} face 
to grow rapidly and eventually disappear due to maintaining its high surface energy. The 
homogenous geometries synthesized at 0.02M CTAB is an indication of complete adsorption 
control and surface energy direction when synthesizing geometric CuNPs. 
 
Formulations 11 (Figure 4.1k) and 12 (Figure 4.1l) consist of heterogeneous geometrical 
CuNPs when 0.03M CTAB is used with varying SDS concentrations and  differ in size which 
can be correlated to the size-controlling factors of SDS. The heterogeneous sample is 
described as such owing to the possible erratic adsorption of surfactant when used at that 
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particular CTAB concentration. Concentration variation of the dual surfactants gives 
eccentric formulations based on surface energy which has been exploited in this design.  
 
4.3.2. Analyses of the stability and aggregation potential of copper nanoparticles 
Zeta potential, as an indicator of surface charge, gives the probability of stability of the 
sample. A potential greater than +25mV or lower than -25mV indicates a higher stability and 
reduced likeliness to aggregate due to the repel of the charged nanoparticles. Ascorbic acid 
has a negative charge, hence formulation 6 (Table 4.3) synthesized devoid of surfactant has 
a negative potential (Roy et al., 2003). The reducing agent also serves as a stabilising agent 
by binding to the surface of the synthesized nanocrystal, preventing aggregation of the 
nanoparticles. The results indicate a change in surface charge with surfactant additions and 
concentrations.  The use of cationic CTAB and anionic SDS manipulates the surface charge 
from the standard negative charge of the CuNPs synthesized without surfactant as shown in 
Table 4.3. The surface charge of the CuNPs synthesized with CTAB as the independent 
surfactant are fairly stable with positive potentials and the least stable values are due to the 
high concentrations of both surfactants simultaneously used in CuNP synthesis. 
Formulations with outlying potential values have CTAB and SDS concentrations cancelling a 
strong positive or negative value resulting in surface charge readings that are minimally 
unstable.   
 
Table 4.3: Measured responses as per a Full Factorial Design. 
Formulation  [CTAB] (M) 
[SDS] 
(M) 
Geometrical 
structures  
Size of nanostructures 
(nm) 
Zeta potential 
(mV) Figure  
1 0.04 0.000 Irregular spheres 500 ±30 33.5  4.1a 
2 0.00 0.087 Spheres 60 -32.8  4.1b 
3 0.02 0.000 Rods 500 x 40 27.0  4.1c 
4 0.04 0.100 Spheres  5 ±3 16.9  4,1d 
5 0.00 0.100 Irregular spheres  500±60 -36.1  4.1e 
6 0.00 0.000 Spheres 100 ±9 -28.6  4.1f 
7 0.02 0.100 Pyramids 150 ±12 -21.2  4.1g 
8 0.04 0.087 Irregular spheres 200±10 -18.4  4.1h 
9 0.02 0.087 Cubes 200 ±13 -30.6  4.1i 
10 0.03 0.000 Irregular spheres 300 ±11 27.1  4.1j 
11 0.03 0.087 Combination  Shape dependent -6.72  4.1k 
12 0.03 0.100 Combination Shape dependent -34.4  4.1l 
 
4.3.3. Evaluation of copper nanoparticle crystallinity and elemental composition of 
copper nanoparticles  
The powder XRD patterns of the CuNPs (Figure 4.3a) correlate with highly oriented 
crystalline CuNPs. Patterns across all 12 formulations share the same peaks of similar 
intensity and conclude that crystallinity is maintained in all samples. All spectra correspond 
to phase-pure copper according to the literature pattern (JCPDS, File No 04-0836) with 
strong, prominent peaks at 43.1°, 50.3° and 74° related to the (111), (200) and (220) planes 
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of copper crystals, respectively. The results confirm the crystalline copper peaks are indexed 
to an FCC crystal structure which is congruent with the native crystal structure and 
orientation. At 35.5° (002) a small proportion of copper oxide is detected across all samples 
and is accounted for by minimal interaction with oxygen. The CuNPs composition uniformity 
is maintained and the low oxide presence does not significantly affect the function of the 
CuNPs as a drug delivery system. Essentially, the synthesis of the nanocrystals yields highly 
crystalline nanostructures and the surfactant adsorption maintains crystallinity by preventing 
oxidation by the environment. 
 
The CuNPs were also analyzed for elemental composition via EDS plots as shown in Figure 
4.3b. The plots exclusively display the characteristic peaks of elemental copper and 
complement the XRD spectra with composition and crystallinity analyses. A dominant Kα1 
peak at 8.0477keV followed by a smaller Kβ1 peak 8.0905keV show strong signals of copper 
atoms confirming pure copper formation. The peak at 0.9498keV demonstrates the Lβ1 peak 
for electrons in the L-shell. As expected, EDS plots for all CuNPs samples resulted in similar 
spectra of prominent copper peaks. Thus, both XRD and EDS metal characterization 
indicate the synthesis of pure copper.  The strong FCC copper peaks from XRD and 
elemental copper peaks EDS (Figure 4.3) demonstrates that the thermal-chemical reduction 
method used in conjunction with ascorbic acid serving the dual function of reducing agent 
and capping agent and two surfactants results in the synthesis of pure copper nanocrystals 
without additional impure phases.  
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Figure 4.3: a) XRD patterns of the neo-geometric nanosystems; b) energy dispersive 
spectra indicating elemental analysis. 
 
4.3.4. Investigation of surface surfactant-coating due by thermal degradation of 
copper nanoparticles 
TGA assessed the relative composition of the ascorbic acid, CTAB and SDS as capping 
agents on the CuNPs. Representative TGA curves obtained for formulations 6 (Figure 4.4a) 
and 9 (Figure 4.4b) indicate the degradation of the respective capping agents. These curves 
were selected for representation as formulation 6 was synthesized devoid of surfactant and 
formulation 9 depicts an average surfactant concentration. Figure 4.4a shows one key 
degradation point between 100-340°C which can be related to the decomposition of the 
ascorbic acid on the surface of the CuNPs. Formulation 9 (Figure 4.4b), capped with 
ascorbic acid, CTAB and SDS, displays two key degradation steps. The first weight loss step 
in Figure 4.4b occurs between 150-230°C indicating the degradation of ascorbic acid as the 
capping agent and between 300-410°C which is attributed to the degradation of the 
adsorbed surfactants. All formulations synthesized with surfactant have TGA profiles similar 
to Figure 4.4b. 
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The degradation of the ascorbic acid in formulation 6 occurs at temperatures between 100-
340°C and between 150-230°C in formulation 9. This data indicates the capping effect of the 
ascorbic acid and the intramolecular interactions between ascorbic acid and the surfactants 
resulting in a slightly raised degradation temperature in formulation 9. At the end 
temperature of 900°C, an average of 95.7 - 97% of sample remains. Copper degrades at 
temperatures higher than 900°C indicating that the degradation that occurred is attributed to 
the supporting surfactants in the samples and that the synthesized CuNPs are thermally 
stable. The change in mass can be translated to the ratio of capping agents to CuNPs. A 
shell of about 3% of ascorbic acid and 5% of surfactant adsorption was determined from 
thermogravimetric analysis, resulting in a remaining 95-97% of the mass due to the copper.  
 
 
Figure 4.4: TGA analysis confirming the surfactant adsorption on the CuNPs. 
 
4.3.5. Analysis of a full factorial response surface design 
The nanoparticle geometry and zeta potential for the experimentally synthesised 
formulations were included in the statistical design for identification of formulations with a 
homogenous, distinctive nano-shape and a stable surface charge. Residual analysis (run 
order, predicted values) for the nanoparticle geometry and zeta potential data (Figure 4.5) 
generally showed random scatter i.e. no trends, indicating none of the underlying 
assumptions of the multiple regression analysis were grossly violated; however a drastic 
discrepancy was noted in the histogram of the residuals (Figure 4.5a) indicative of a degree 
of non-constant variance. This, however, was expected due to the nanoparticle shape 
formation being independent of ordered surfactant addition. The normal probability plots of 
the residuals fell on a straight line indicating the data to be normally distributed with no 
evidence of unidentified variables. 
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Figure 4.5: Residual plots: a) shape uniformity per sample; b) zeta potential.  
 
4.3.6. Response surface analysis 
Main effects, interaction and response surface plots were obtained for the measured 
responses (shape uniformity and zeta potential) based on the experimental model. The 
relationship between the independent variables and the responses can be further explained 
through graphical illustration of the effect of the independent variables and their interactions. 
The interaction effects are estimated by subtracting the mean positive response values from 
the mean negative response values and the estimated interaction effects of the responses 
studied are shown in Figures 4.6b and 4.7b. The main effects plots (Figures 4.6a and 4.7a) 
determine the relative significance of the effects across factors and the surface plots 
generated (Figure 4.8) represent the functional relationship between the response and the 
experimental factors (du Toit et al., 2008). 
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4.3.6.1. Main effects and interaction effects plots on the formulation responses 
Interaction effects represent the combined effects of factors on the dependent measure 
where the impact of one factor depends on the level of the other factor when an interaction 
effect is present. The plot displays both the levels and mean of each level of one variable on 
the X axis, ultimately testing the moderation. A “main effect” is the effect of one the 
independent variables on the dependent variable, ignoring the effects of all other 
independent variables (Dawson, 2014). 
 
The main effects plots (Figures 4.6a and 4.7a) depict a horizontal line drawn at the overall 
mean. The effects of the variables on the formulation are represented by the differences 
between the mean and the reference line. Both CTAB and SDS have a definite effect on the 
geometry control and surface charge of the nanosystems (Figures 4.6a and 4.7a). The main 
effects for shape uniformity (Figure 4.6a) did not drift significantly from the overall mean at 
CTAB concentrations of 0M, 0.02M and 0.04M much unlike the shape uniformity behaviour 
when using CTAB at 0.03M. This substantiates the heterogeneous growth of geometric 
CuNPs indicating minimal shape controlling activity. With SDS, however, all 3 concentrations 
used lie near the mean showing stability with regards to crystallizing homogenous 
geometries. SDS undoubtedly has an effect on CuNPs geometric organization but this is 
nominal in comparison with CTAB. The main effects for zeta potential analysis (Figure 4.7a) 
show the difference in effect that SDS has with CTAB. Anionic SDS has a major effect on 
zeta potential but is highly influenced by the presence of CTAB and variation in effect occurs 
due to surfactant concentration differentiation. CTAB has fairly more stable effect than SDS 
having the main effects plot points close to the zeta potential mean.      
 
In all interaction plots disordinal interactions were observed indicating that the interaction 
effect between the variables is significant. The greater deviations imply higher degrees of 
interaction as can be seen especially with varying CTAB concentration. In the concurrent 
use of CTAB and SDS as can be seen in Figure 4.6a when CTAB is used at 0.02M and 
0.04M, irrespective of SDS concentration, the shape uniformity maintains 100% shape 
uniformity verifying the competence of the high shape controlling activity of CTAB at these 
concentrations. The interaction plot for zeta potential shows much higher interactions 
between the different design formulations compared to the surfactant interaction plots for 
shape uniformity. CTAB and SDS have a strong cationic and ionic charge, respectively, and 
the fluctuation of the surface charge is noteworthy. The sharp increase of zeta potential 
when using 0.087-0.1M SDS shows the effect of this surfactant, especially in the absence of 
CTAB. In the presence of 0.02M CTAB, the effect is not as significant confirming the 
equalising effect of the surfactants when used concurrently. 
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Figure 4.6: a) main effects; b) interaction plots for shape uniformity. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: a) main effects; b) interaction plots for zeta potential. 
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4.3.6.2. Response surface and contour plots on the formulation responses 
Contour plots were used to represent the functional relationship between the experimental 
variables and the responses achieved. The effects of CTAB and SDS on shape uniformity 
are depicted in Figure 4.8a. It is obvious that CTAB plays the crucial deciding role in shape 
formation and shape uniformity. The highest control of shape uniformity is seen at CTAB 
concentrations 0-0.02M which is also where the most distinctive nano-geometries are 
formed. Increased concentrations of CTAB (>0.02M) and SDS (>0.02M) resulted in the least 
ideal formulations consisting of heterogeneous samples. Reducing the concentration of SDS 
while maintaining a high CTAB concentration show to yield homogenous samples of CuNPs. 
A striking characteristic is the inability of forming uniform shapes throughout one CuNP 
formulation at SDS concentrations of 0.04-0.1M which may indicate a higher ability of SDS 
to competitively dislocate the adsorption of CTAB from certain facets or SDS providing an 
unstable energy in the system. The 100% shape uniformity at CTAB <0.02M is slightly 
reduced upon the addition of SDS and the reduction increases with an increase in SDS. It is 
apparent that SDS has the energy to displace CTAB from its adsorption sites resulting in 
formulations of low homogeneity, however, at different CTAB concentrations SDS may play 
the key role in shape dictation and uniformity. 
 
Contour and response surface plots for zeta potential (Figure 4.8b) is highly dependent on 
both surfactants. It has a very large characteristic region showing anionic SDS responsible 
for low zeta potential values (≤25mV) and 2 smaller regions showing cationic CTAB 
responsible for the higher zeta potential values (≥25mV). As seen in the plots, SDS 
maintains the stability of the CuNPs but the potential fluctuates upon the addition of CTAB. 
In the presence of SDS, as CTAB concentrations increase, the stability reduces. However, a 
notable occurrence in the zeta potential occurs when CTAB is introduced into the system at 
low SDS concentrations of ≤0.02M where stability is maintained. Potential values are seen to 
fall most out of the stable range when CTAB is 0.02-0.035M in the presence of SDS at 0.02-
0.06M and increases in stability upon reducing SDS. With opposing charges, both 
surfactants used simultaneously may neutralise the system and contribute to the 
aggregation of the CuNPs. The pattern is observed again when SDS concentrations are 
≥0.09M and it can be presumed that the stability will continue to fluctuate when CTAB is 
used at 0.02-0.035M at higher concentrations of SDS to neutralise the charge effect and 
reduce stability. At CTAB ≥0.04M, the cationic charge is sufficient enough to overcome the 
anionic charge of SDS and resume stability of the CuNPs nanosystem. 
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Figure 4.8: Contour plot and response surface plots. a) shape uniformity per sample; b) zeta 
potential. 
 
4.3.7. Response optimization of the neo-geometric copper nanoparticles  
A response optimization procedure was used to obtain the preferred levels of the selected 
formulation components to yield specific shapes. Optimal formulations were developed 
following simultaneous constrained optimization of geometric shape uniformity and zeta 
potential. Maximization of shape uniformity and targeting of zeta potential values based on 
the specific shapes required were used for response optimization. The optimized levels of 
the independent variables and their predicted responses were then determined. Optimal 
levels of the independent variables and constraint settings were utilized as well as goals for 
the response that would achieve the desired characteristics are listed in Table 4.1. Based on 
the analysis and aims of the study to generate homogenous samples of CuNPs using the 
necessary parameters (Table 4.1), the optimized formulations are listed in Table 4.4. 
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Table 4.4: Optimized formulations or representing homogenous samples of stable neo-geometric CuNPs.  
Formulation [CTAB] (M) [SDS] (M) Shape Uniformity 
(%) 
Zeta potential 
(mV) 
Surface area per 
nanoparticle (nm2) 
Volume per 
nanoparticle 
(nm3) 
TEM 
Images 
3 0.02 0.000 100% Rods 27.0 62831.85 611 563.37 
 
 
4 0.04 0.100 100% 5nm Spheres 16.9 78.54 65.45 
 
 
6 0.00 0.000 100% 90nm 
Spheres 
-28.6 31415.93 523 598.78 
 
 
7 0.02 0.100 100% Pyramids -21.2 38712.00 421 875.80 
 
 
9 0.02 0.087 100% Cubes -30.6 240000.00 8 000 000.00 
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The formulation parameters were finalised based on the shape uniformity behaviour and 
stability of the systems. In varying the surfactant concentrations, heterogeneous and 
irregular samples were also achieved. Samples providing stable CuNPs of homogenous 
geometries were the idealistic characteristics as per the aim of the study. The required zeta 
potential values were primarily based on nano-shape but as an important parameter, the 
surface charge needed to correlate with stability. 
 
4.3.8. Qualitative and quantitative analyses of cellular internalization studies based on 
nano-geometry 
Cell uptake was conducted by incubating the optimized geometrical CuNPs with NHEK cells 
over a 24 hour period to elucidate the effect of nano-shape on endocytosis rates. Qualitative 
(Figure 4.9) and quantitative characterization (Figure 4.10) depicts the variation in 
internalization kinetics in the determination of nano-shape with the highest cellular 
internalization for use as an optimized drug delivery carrier with elevated uptake over the 
shortest time period.  
 
Within the first hour of CuNPs incubation with the keratinocytes, it was noted that the 
nanoparticles began the endocytosis process by adhering to the cell membrane. Interactions 
between the nanoparticles to be endocytosed and receptors in the cell membrane assist in 
triggering recognition and uptake of the nanoparticles which consists of two processes, 
adherence to the outer cell membrane and actual internalization (Lesniak et al., 2013). 
CuNPs detected via ICP-OES analysis within the first hour (Figure 4.10) can be attributed to 
CuNPs that have started the adhesion process and attached to the cell membranes. 
 
Within the second hour, the process of adherence and attachment to the cell membrane 
increased and by the end of the fourth hour of cell-nanoparticle incubation, the CuNPs had 
internalized. The initiation of CuNP endocytosis steadily resulted in the complete uptake of 
the nanocrystals with small yet distinctive differences in rates of cell uptake and can be 
accounted for in conjunction with qualitative data. Internalization kinetics differs slightly with 
the cubic CuNPs persisting with the highest uptake throughout each period in the 24 hours 
of incubation. The rate of uptake of the 5nm spherical CuNPs remained steadily behind the 
200x200nm cubes; with the pyramids, 90nm spheres and rods following, respectively 
(Figures 4.9 and 4.10). Time-dependent internalization is clearly indicated by the results 
showing more particle-cell associations with longer incubation time (Zhao et al., 2013). The 
uptake kinetics display a slight initial transient uptake followed by steady uptake at 4 hours 
after initial attachment, thereafter pursuing a linear uptake pattern. The cube-shaped CuNPs 
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having higher copper concentrations post analysis also shows the higher capability of cell 
membrane adhesion as compared to the other nano-shapes. 
 
 
Figure 4.9: Phase contrast images of geometric CuNP internalization over a 24 hour 
incubation period. 
 
The mechanism of physical penetration into the cell differs between the various geometries 
due to the actual structures of the different nanoparticles. Pertaining to the spheres where 
there is no sharp end or aspect ratio, endocytosis occurs regardless of any internalization 
mechanism. However, with rods, cubes and pyramids it is dependent on the number of faces 
for attachment, the aspect ratio of the shape and the angle of orientation. This study on the 
geometric effect of nanoparticles investigated and challenged the claim by Némethová and 
associates (2017) that size is the primary determinant factor for cell uptake.  
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Figure 4.10: Quantitative analysis of cell internalized CuNPs over 1, 4, 8 and 24 hours. Data 
presented are mean ± SE of three experiments performed in duplicate. *p ≤ 0.05. 
 
The increase in volume of the geometric nanoparticles (Table 4.4) consequently requires 
more energy for the internalization to occur as the surface area between the nanoparticle 
and the cell membrane increases. However, the effect of the orientation and aspect of the 
shape on its attachment to the cell membrane also shows to have a key role. After the 
nanoparticle has attached to the surface of the membrane, according to Yang and Ma 
(2010), under the influence of the elastic deformation of the bilayer, the long axis of the 
nanoparticle is compelled to be as perpendicular as possible to the cell membrane plane. 
This occurrence will increase the contact area between the nanoparticle and membrane to 
allow for quicker uptake and will then only require the minimum amount of energy for the 
endocytosis with respect to the different nano-geometries and volumes involved. Agreeing 
with increasing contact area for quicker uptake, Venkataraman and co-workers (2011) 
showed that a larger surface area allows for more multivalent ionic interactions with the cell 
membranes to undergo clathrin- and caveolae-mediated endocytosis as well as to a lesser 
extent, macropinocytosis. This was also supported by Munoz and associates (2013) who 
stated that an increased contact area with the cell surface provides potentially more sites for 
interaction and has been previously identified as an important contributor to enhance 
nanoparticle targeting effects. In support of this theory, several researchers (Venkataraman 
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et al., 2011; Hao et al., 2012; Kolhar et al., 2013; He and Park, 2016; Wang et al., 2016) 
proved that higher aspect ratios resulted in higher internalization rates.  
Taking the results into consideration, it may be argued that the nanoparticle volume does not 
play a significant role when compared to the geometry and effect of particle surface structure 
on cell uptake. The geometry of the nanoparticles is an independent factor and the 
endocytosis process may be dependent on this completely. In addition, the shape anisotropy 
and initial orientation of the particle are crucial to the nature of the interaction between the 
particle and lipid bilayer. The endocytic potential of nanoparticles across a lipid bilayer is 
also determined by its contact area, local curvature of the particle at the contact point, 
nanoparticle volume affecting translocation indirectly and nanoparticle rotation which can 
complicate the penetration process (Yang and Ma, 2010). Li and co-workers (2012) 
indicated that nano-shape affects the kinetics of endocytosis, also reiterating that 
nanoparticle rotation regulates the competition of receptor binding and membrane 
deformation. The internalization process comprises membrane invagination and nanoparticle 
wrapping where the strong binding energy results in the rotation of nanoparticles to 
maximise contact area with the membrane during the invagination stage (Li et al., 2012). 
Rotation of the nanoparticle after attachment leads to an arrested internalization state 
explaining the delayed uptake of the rods as compared to the cubes and pyramids due to the 
rods having a higher rotation because of its high aspect ratio, also dependent on its 
orientation to the cell membrane. The wrapping stage is doctored by the largest local mean 
curvature of the part of the nanoparticle bound to the membrane, hence, the varying uptake 
rates of the different nano-shapes with spherical nanoparticle uptake being the exception 
due to a continuous geometry. 
 
The results from this uptake study oppose the theory of the rods having the highest uptake 
rates and show rods to have slow uptake in comparison to the other geometric CuNPs used. 
Cubes have the highest uptake and may be attributed to certain cells preferring sharp edges 
and recruiting actin filaments to wrap around the nanoparticle (He and Park, 2016). 
Pyramids and rods also have sharp edges explaining the higher internalization than 90nm 
spheres. With rod CuNPs, internalization depends on the orientation to the cell membrane 
as the pyramids are equilateral. After adhesion, the cell membrane maintains attachment 
and will rotate the nanoparticle during the internalization process therefore affecting uptake 
rates. Rods take longer to rotate if on an unfavourable axis and with the pyramid, the 120° 
outer angle takes longer to rotate than the 90° outer angle of the cube if incorrectly 
orientated.  The internalization of the nanoparticle is also based on the curvature energy of 
lipid-bilayer membrane combined with contact adhesion energy for the particle−membrane 
interaction. Thus, the total energy is given by: 
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ε tot =∫s dS[2κH2 + σ] − w ∫Sad dS               (Equation 4.3) 
 
where S is the entire membrane area, Sad the adhered membrane area, H the mean 
membrane curvature, κ the bending rigidity, σ the membrane tension, and w the adhesion 
strength for the interaction between membrane and nanoparticle (Dasgupta et al., 2014).  
 
It is noted that the CuNPs with varying zeta potential values do not influence attachment or 
uptake kinetics whereby in order of highest internalization rates, -30.6mV (cubes), 16.9mV 
(5nm spheres), -21.2mV (pyramids), -28.6mV (90nm spheres) and 27mV (rods) there is no 
pattern during analyses. Typically, having a negatively charged cell membrane, it is 
expected that there would be higher uptake profile for the positively charged CuNPs, 5nm 
spheres and rods, due to electrostatic interactions with the cell membrane. In addition to 
surface charge variation, colloidal instability during the biological experiment affects uptake 
kinetics (Némethová et al., 2017) and has been considered. This is especially seen after the 
CuNPs have been internalized and is predominantly viewed in clusters or aggregates. This 
finding also assists with confirming the type of uptake pathway. It is most probable that 
nanoparticles with negative surface charges are likely to have the greatest affinity for 
caveolae-based uptake. Although surface chemistry and functional groups can influence 
CuNP-cell interaction, it has been reported that negatively charged nanoparticles can 
interact with cationic lipid domains in the lipid raft (Adjei et al., 2014). Irrespective of 
researchers confirming the rod shape for highest internalization due to the high aspect ratio, 
the principle theory of larger nanoparticle surface areas allowing for more attachment on cell 
membranes is the basis for the results obtained in this study with cubes having the highest 
surface area as compared to the other nano-geometries. The uptake kinetics is thereafter 
followed by the volume per CuNP relative to its geometry. 
 
4.3.9. MTT assay 
To examine the cytotoxicity of the geometric CuNPs, cell viability was analyzed using NHEK 
and HeLa cell models. The viability data of a normal cell line was compared with a cancer 
cell line to elucidate the difference in toxicity and the effect of the CuNPs when applied on 
healthy and cancerous cells for application purposes. The effect of nano-geometry of the 
CuNPs was analyzed as the primary toxicity factor, as well as at increasing concentrations to 
determine a toxic dose.  
 
Figures 4.11a and 4.11b shows the clear differences in toxicity after incubation at increasing 
concentrations, with differences in nanoparticle shape and across both cell lines. Cell 
viability % reduced steadily in a CuNP dose dependent manner with a noted difference in 
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toxicity between the geometrically structured nanoparticles and the two cell lines. With an 
initial CuNP concentration of 6.25µg/ml serially increasing to 50µg/ml, the apparent change 
in cell viability indicates dose dependent toxicity having an average of 92.56% cell viability at 
a CuNP concentration of 6.25µg/ml, 73.56% at 12.5 µg/ml, 52.22% at 25 µg/ml and 33.33% 
cell viability at the highest CuNP concentration on the NHEK cell line. CuNP exposure to the 
HeLa cell line shows 79.16% cell viability at 6.25µg/ml, 55.18% at 12.5 µg/ml, 37.62% at 25 
µg/ml and 26.23% cell viability at 50µg/ml. The median lethal concentration (LC50) values of 
the CuNPs on the two cell lines occur at approximately 12.5µg/ml and 25µg/ml respectively 
for NHEK and HeLa cells. In general, irrespective of nano-shape and cell line, toxicity 
increased with an increase in CuNP concentration. The results confirm dose dependent 
toxicity and can be further considered for biological application.  
 
The obvious variation in cell viability dependent on the geometric nanoparticles give an 
indication that nano-shape has an effect on cell toxicity. A similar tendency for toxicity based 
on nano-shape is seen with both cell lines; however, the viability % differs while the viability 
ratios between the different shapes remain constant. The MTT data in Figure 4.11a and 
4.11b indicates slight but notable differences in viability percentage with regards to cube-
shaped nanoparticles. A pattern occurs whereby at all concentrations and across both cell 
lines the cubic CuNP displays the lowest cell viability indicating highest toxicity followed by 
the 90nm spheres. The rod shaped nanoparticles demonstrate higher cell viability than the 
cubes and 90nm spheres but are clearly more toxic to both cell lines than the pyramidal and 
5nm spherical nanoparticles. The order of LC50 for shape-dependent toxicity on cell lines 
were cubes > 90nm spheres > rods > pyramids > 5nm spheres. 
 
Taking the volume per nanoparticle into consideration (Table 4.4), the number of copper 
atoms in each geometrically organised nanoparticle would be directly proportional to its total 
volume. It can then be assumed that the increase in copper atoms would increase the cell 
toxicity due to the DNA degradation properties of copper as well as the nano-shape with the 
highest internalization rates. This is congruent with the cubic nanoparticles having the 
highest rate of internalization and occupying the largest volume compared to the other nano-
geometries and displaying the highest toxicity potential. The increase in concentration of 
CuNPs internalized potentiates the toxicity due to its influence on producing reactive oxygen 
species (ROS) promoting DNA cleavage and subsequent metabolic inactivity (Jose et al., 
2011). This principle can also be adapted for the other key shapes and their corresponding 
volumes irrespective of the number of CuNPs internalized.  
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Shape has an effect on cell toxicity that is directly related to shape volume. The structure of 
the nanoparticle forms a vehicle for the volume and will pose a possible medium for the 
entrapment of drugs in these geometrical nanoparticles assuming a Trojan Horse approach 
to drug delivery. Distinguishing the impact of the geometric factor on cytotoxicity is based on 
several other surface chemistry paradigms, therefore, when elucidating nano-shape and 
cellular toxic effects, it is completely dependent on maintaining many aspects such as the 
nanoparticle material, shape, surface charge and surface reactivity. Chithrani and associates 
(2006) and Han and co-workers (2006) both attributed the highest internalization rates to the 
spherical nanoparticle while Champion and Mitrogotri (2007) owed the nanoparticle 
orientation on the cell surface to internalization kinetics. Therefore, it can be deduced that 
several factors dictate cell uptake results unless consistency is maintained. In the instance 
that nanoparticles are specifically tailored for functional use, the concept is plausible. 
 
The HeLa cells showed a higher susceptibility to toxicity to the copper than the NHEK cell 
line ranging from 15.55% to 13.36% over the concentration difference. The difference in 
toxicity across the two cell lines was expected, however, the degree of variation far exceeds 
the hypothesis. Despite the variation in toxicity between the nano-shapes, the consistent 
ratio of toxicity between the two cell lines is interesting. Mutational asymmetries between the 
two DNA strands in a cancer cell (Haradhvala et al., 2016) indicate current DNA damage in 
the HeLa cell line. CuNPs exerts a mechanism of DNA damage by ROS thereby inducing 
cell death. It can then be postulated that the CuNP-exerted toxicity may be easily potentiated 
due to the already damaged DNA of the cancer cells as opposed to the healthy DNA strands 
in the keratinocytes. 
 
 Comparatively, in a study conducted by Wang and associates (2015) on alumina nanotubes 
of varied aspect ratios and their toxic effects on mouse macrophage cells and human breast 
cancer cells, it was demonstrated that macrophage cells were more sensitive and 
responsive to the nanotubes showing higher toxicity than the breast cancer cells. Their 
results also distinctively identify nano-shapes with longer aspect ratios with high toxicity, very 
much unlike the data acquired in our study which shows the cube of low aspect ratio to be 
most toxic. Hence, the importance of tailoring nano-characteristics for stream-lined 
purposes. A recent study by Zong and co-workers (2017) showed a cell proliferation effect of 
copper-incorporated titanium nanotube arrays in addition to research by Bagchi’s research 
group (2012) who concluded that at concentrations under 100mg/ml, CuNPs adsorbed onto 
ceramic composites had negligible toxicity in cancer cell lines. This differed to the current 
study as concentrations below 100mg/ml exhibited significant toxicity. Lin and associates 
(2016) also confirmed dose dependent toxicity when copper ions were released into an 
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osteogenic cell line while Zhang and research group (2015) studied titanium-copper alloys 
on MG63 cells confirming no toxicity or proliferation after incubation. 
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Figure 4.11: Cell viability after 24 hour neo-geometric CuNP exposure to a) NHEK cells and 
b) HeLa cells. Lactate dehydrogenase leakage after 24 hour neo-geometric CuNP exposure 
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to c) NHEK cells and d) HeLa cells. Glutathione levels after 24 hour neo-geometric CuNP 
exposure to e) NHEK cells and f) HeLa cells. Malondialdehyde levels after 24 hour neo-
geometric CuNP exposure to g) NHEK cells and h) HeLa cells. Data presented are mean ± 
SE of 3 experiments performed in duplicate. *p ≤0.05 versus control. 
 
4.3.10. Lactate dehydrogenase activity 
Extracellular LDH levels found in the cell media were measured to determine the extent of 
cell membrane damage induced by geometric CuNPs on two cell lines. Upon cell membrane 
damage, intracellular LDH is released into the culture medium and is considered an indicator 
of irreversible cell death. The geometric CuNPs were assessed for its effect on plasma 
membrane integrity to elucidate an extension of cell death by DNA damage.  
 
Figures 4.11c and 4.11d outlines the LDH leakage into the cell medium as a correlation to 
the control. The LDH leakage by the cells exposed to the CuNPs in increasing concentration 
far exceed the LDH leakage of the control, except for the 6.25µg/ml CuNP concentration 
which shows LDH release similar to the control. Furthermore, leakage increases as a 
function of the increase in CuNP concentration. The slightest increase in leakage is due to 
the low concentration of CuNPs when compared with the controls. We also took note of the 
geometric effect of cell membrane damage by acknowledging the fluctuation in LDH leakage 
values between the different shapes. Similarly, the order of damage can be represented by 
cubes > 90nm spheres > rods > pyramids > 5nm spheres and may be associated with the 
difference in volume leading to the variation in LDH release. The difference cell membrane 
damage between the two cell lines can be analyzed by the lower LDH leak for NHEK 
compared to the HeLa cells.  Although not significant, the difference exists and can be 
exploited when taking the cytotoxic effects of the CuNPs into consideration.  
 
After 24 hours of CuNP-cell incubation, uptake of the CuNPs induces damage by oxidation 
of the metal. Essentially, based on a reduction-oxidation reaction where the oxidation of 
Cu(s) to Cu2+ which is energetically favourable along with production of H2O2 from oxygen 
and protons give the redox equation: 
 
Cu(s) + O2 + 2H+ = Cu2+ + H2O2             (Equation 4.4) 
 
H2O2 production at the oxygen-rich cell membrane induces the membrane damage signified 
by the LDH release (Kumar and Müller, 1999) in Figures 4.11c and 4.11d. In a recent study 
by Alarifi and associates (2013), copper oxide nanoparticles (CuONPs) also displayed LDH 
release in a dose-dependent manner but with differing leakage of 200% of the control at 
30µg/ml whereas the cube CuNPs in this study induce LDH release of a maximum 180% of 
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the control at 50µg/ml on the NHEK cell line and 188% on the HeLa cell line. The possible 
difference in dose-dependency may be due to the oxidised copper in their nanoparticles; 
however, it endorses this study’s geometric CuNPs for having a lower toxicity. Li and co-
workers (2012) showed the size-dependent membrane damage of silver nanoparticles on 
human lung fibroblast cells. Interestingly, the nano-size played a role in the difference of 
necrosis or apoptosis by the measurement of loss of membrane integrity with the 25nm 
nanoparticles causing more damage than 70nm nanoparticles. Using the same principle, our 
geometric nanoparticles cause higher LDH release as a function of shape-volume 
dependency on cell toxicity. 
 
4.3.11. Glutathione activity 
Change in glutathione production assisted with supplementary toxicity analysis and 
breakdown in mechanism of toxicity of the NHEK and HeLa cells. The levels of reduced form 
of GSH are a measure of oxidative stress occurring intracellularly. Figures 4.11e and 4.11f 
displays the reduction in GSH following the dose-increasing exposure of the geometric 
CuNPs. In comparison to the control, GSH levels decrease consistently as the CuNPs 
concentration increases illustrating dose-dependent intracellular stress. The minor 
differences in GSH levels using different nano-shapes at constant concentrations indicate 
the shape effect of CuNPs on oxidative stress highlighting the cube-shaped nanoparticle as 
inducing the highest degree of oxidative stress when compared to the other shapes.  In 
addition, the GSH levels vary slightly between the NHEK and HeLa cell lines with an 
average of 1.1% reduction in GSH in the HeLa cells indicating minimal but important 
difference. 
 
The depletion in GSH due to CuNP exposure suggests oxidative stress as the primary 
mechanism of toxicity in both cell lines. Post endocytosis and subsequent release of the 
ionic species into the intracellular compartment leads to spontaneous generation of ROS at 
the surface of the nanoparticle which promotes the formation of free radicals.  In the cellular 
environment, radicals oxidise and reduce macromolecules such as DNA, lipids and proteins 
resulting in oxidative damage to the cell, DNA damage and apoptosis (Alarifi et al., 2013). 
High levels of ROS disrupt cellular processes by non-specifically attacking DNA, proteins 
and lipids. It can be assumed that this mechanism precedes and further leads to the toxicity 
as identified by the MTT data. Arora and co-workers (2016) recently also confirmed the 
triggering of ROS leading to induced nuclear damage at 100mg/ml when copper adsorbed 
chitosan nanoparticles were applied to a human kidney cell line. 
 
105 
 
Srikanth and co-workers (2016) recently reiterated the toxicity effects of internalized 
nanoparticles and macromolecule damage due to copper accumulation within the cell. Their 
MTT toxicity results pertaining to CuONP exposure to cells closely resemble that of the study 
by Alarifi and associates (2013), however, their GSH levels are unusually lower when 
compared to Alarifi’s and our study. The difference in GSH levels can be repeatedly 
explained by the difference in cell lines used where Alarifi and associates (2013) used 
human keratinocytes, Srikanth and co-workers (2016) used Chinook salmon cells while 
keratinocytes and HeLa cells were used in this study, as well as the geometry difference of 
the CuNPs. 
 
4.3.12. Lipid peroxidation activity 
The extent of membrane LPO was measured as an indicator of cellular oxidative stress, 
supplementary to the analysis of GSH release. The formation of MDA is measured as it a 
product of membrane LPO, oxidation of cellular lipids. The MDA formation increases in both 
cell lines as a function of dose-dependency with minimal MDA detection in the 6.25µg/ml 
concentration, not diverging significantly from the control readings (Figures 4.11g and 
4.11h). The shape effect is obvious at 25 and 50µg/ml where the cubes and 90nm spheres 
induce the most membrane LPO and the 5nm spheres show the least toxicity. The greatest 
difference in MDA detection is noted at 50µg/ml between cubes and 5nm spheres at 1.1nm 
MDA/ml protein on both the NHEK and HeLa cell lines. The difference in membrane LPO 
also exists between the two cell lines where the MDA readings for the HeLa cell line is 
0.2nm MDA/ml protein higher than the NHEK cell line indicating more membrane LPO 
damage exerted on the HeLa cell line. These results indicate that the shape effect on cell 
toxicity is consistent across all assays and the cervical cancer cell line is more sensitive to 
the ROS inducing effects of neo-geometric CuNPs. 
 
The geometric CuNPs showing activity of lactate dehydrogenase, GSH release and 
membrane LPO detection, can assist with deducing the mechanistic approach to cellular 
toxicity. Induction of ROS by the CuNPs includes the superoxide radical (O2-), hydrogen 
peroxide (H2O2), and hydroxyl radical (OH-) which promote the intracellular changes 
observed leading to cell death. The observation of MDA production indicates the lipid 
oxidative damage caused by the CuNPs in response to its concentration, geometry and 
change in cell type. Supplementary to GSH release, LPO also confirms oxidative stress 
exerted on the intracellular components which can further give rise to more free radicals and 
damage biomolecules such as the cell’s DNA, protein, lipids and cell membrane as is 
indicated by the LDH release, in conjunction with ROS (Alarifi et al., 2013).  
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4.4. Concluding Remarks 
 
The ordered synthesis of geometric CuNPs was successfully completed with the determining 
factors of the study including a completely homogenous sample of one geometry, as well as 
CuNPs with a stable surface charge. CTAB and SDS significantly affected nano-shape, 
uniformity and zeta potential. The design aimed to yield stable CuNPs of single geometries 
per sample in order to serve as drug delivery systems in a study elucidating the ideal nano-
shape for enhanced internalization and in effect, determining the cytotoxic properties of the 
nanosystems as a function of its shape.  
 
Nano-shape has a promising ability in dictating cellular uptake, therefore, the cube-shaped 
CuNPs will be considered for futher experiments. By combining the shape properties of the 
CuNPs to internalize at different rates and the cytotoxic activity of the copper, the novel neo-
geometric CuNPs nanosystem may prove to be a dual system for enhanced cellular uptake 
simultaneously using the copper to exert cytotoxic activity on proliferating cells in an 
inflammatory environment. Future developments in the study include the formulation and 
statistical design of a SOPN vehicle for the promoted stimulation of the cubic CuNPs across 
the stratum corneum of the skin. 
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CHAPTER 5 
TRANSPORT OF A NOVEL GEOMETRIC COPPER NANOSYSTEM ACROSS THE SKIN 
BARRIER EMPLOYING A SELF-OSCILLATING POLYMERIC NETWORK  
IN THE TOPICAL TREATMENT OF PSORIASIS 
 
5.1. Introduction 
 
Psoriasis is a chronic inflammatory disease predominantly affecting the skin and concerns 2-
5% of the world’s population. Plaque formation and skin scaling is a consequence of the 
conditions epidermal hyper-proliferation, incomplete cornification and retention of nuclei in 
the stratum corneum (Perera et al., 2012). Histopathological hallmarks are epidermal 
hyperplasia with keratinocyte differentiation, prominent inflammatory infiltrate, and increased 
vascularization (Boehncke, 2015). Well defined, erythematous scaly skin lesions severely 
affects patients quality of life and is possibly triggered by a combination of genetic (family 
background) and environmental factors (alcohol, tobacco, infections, medications, stress) 
(Sala et al., 2016). 
  
Sala and associates (2016) extensively reviewed polymeric nanotherapeutics in the 
treatment of psoriasis that has been formulated to increase the percutaneous absorption of 
active agents without damaging the skin barrier function. Enhancing stability, efficacy and 
increasing residency time is a prime factor in the chronic disease while maintaining safety 
and a suitable risk/benefit ratio. This correlates with a recent study surrounding natural 
curcumin which has been studied based on its anti-inflammatory, antioxidant, chemo-
preventive and chemo-therapeutic activity (Kang et al., 2016). 
 
Nanoparticle delivery through the stratum corneum of diseased skin has been shown to be 
modest at best (Gattu and Maibach, 2010) and proposed concepts in overcoming this barrier 
include low-frequency ultrasound, electroporation by high voltage pulses and microneedle 
arrays (Vogt et al., 2016). These strategies, however, are not as convenient an application to 
the patient in the aim of increasing nanoparticle permeation. This study therefore focuses on 
the application of cube-shaped CuNPs by exploiting the nano-shape effects of enhancing 
cellular internalization rates of nanocarriers and the cytotoxic properties of copper in the 
inflammatory environment provided by the autoimmune disorder. A mechanism in the form of 
a self-oscillating gel was formulated and designed to improve the transport of the bio-active 
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geometric CuNPs across the stratum corneum of the skin by investigating mass transport of 
nanoparticles in a biological application. 
 
Structural deformation at micro-level may potentiate CuNPs permeation rate through a rate-
limiting innate barrier by manipulating chemical changes resulting in a mechanical effect. 
Automatic transportation of object on the surface of oscillating gels has been studied 
(Murase et al., 2008); in addition to oscillating devices forming components of nanomachines 
(Ito et al., 2006). Utilizing polymers and gels responsive to external stimuli are a field of 
significant interest in drug delivery research particularly in the control of drug release 
quantity and alteration of drug release and permeation rates. Stimuli-responsive polymers 
require an external factor to regulate the action of the system; however, employing a self-
oscillating system which functions on a chemical to physical oscillatory change eliminates 
the reliance on an external trigger. Actuating systems using a self-oscillating mechanism 
employs a built-in arrangement of energy conversion from the chemical oscillations of the BZ 
reaction to mechanical oscillations of polymer chains (Hara and Yoshida, 2005).  
 
The self-oscillating phenomenon is ruthenium-catalyzed where the subsequent process is 
the product of oxidation of an organic substrate in the presence of a metal ion catalyst in 
acidic conditions (Hara and Yoshida, 2005). The catalyst ion fluctuates between its oxidised 
and reduced states due to the oxidation process resulting in the chemical oscillatory 
mechanism. The chemical reaction translates into a mechanical reaction when the catalyst 
ion is polymerized with a polymer that is responsive to changes in hydrophilicity. Swelling of 
the polymerized responsive-polymer to the catalyst moiety as a result of hydrophilic changes 
of the polymeric chain is caused by the (Ru(bpy)3 2+ ↔ Ru(bpy)3 3+ oscillations (Pullela et al., 
2013). The periodic swelling of the responsive polymer exhibits a peristaltic motion which is 
the basis of self-oscillating systems. 
 
The geometric CuNPs and SOPN system has not yet been applied to pharma-engineering 
applications owing to its unknown cytotoxic effects when applied to an in vivo bio-form or the 
mechanical oscillations seizing when the oxidation substrates have been reacted. The 
system becomes irrelevant after a short period of time and cannot function effectively in vivo 
without continuously replacing the reaction substrates. Therefore, this system serves to 
oscillate for a longer period than other reported oscillating gels where oscillations last 40 
minutes (Ito et al., 2003), in addition to the dual functionality of neo-geometric and cytotoxic 
CuNPs as a bio-active with higher internalization kinetics.  
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5.2. Materials and Methods 
 
Copper II sulphate pentahydrate (CuSO4.5H2O) was purchased from Merck (Darmstadt, 
Germany), CTAB, SDS, N-isopropylacrylamide (NIPAAm, Mw113.16, 97%), carboxymethyl 
cellulose (CMC) (sodium salt, Mw250,000), tris(2,2’bipyridyl) dichlororuthenium (II) 
hexahydrate (Ru(bpy)3 monomer), N′-methylenebisacrylamide (MBAAm, ≥99.5%), 
ammonium persulfate (APS, ≥98%), sodium bromate (≥99%),  malonic acid (98%) and MTT 
assay were all purchased from Sigma-Aldrich Co. (Aldrich, Steinheim, Germany). L-ascorbic 
acid (98%) was purchased from Roche (Johannesburg, South Africa). NHEK cells, 
keratinocyte basal medium, growth factors and supplements including bovine pituitary 
extract, human epidermal growth factor, insulin, hydrocortisone, epinephrine, gentamicin, 
amphotericin B, transferrin, trypsin/EDTA were all purchased from Whitehead Scientific 
(Lonza Walkersville facility, USA). All chemicals were analytical grade and used without 
further purification. BALB/c mice (6 weeks old) were provided by the Central Animal Service 
(CAS), University of the Witwatersrand, South Africa. The study protocol was evaluated and 
approved by the Research Animal Ethics Committee. 
 
5.2.1. Synthesis of cube-shaped copper nanocrystals 
The thermal-reduction method of synthesizing nanocrystals included a standard 
CuSO4.5H2O solution added to 0.02M CTAB and 0.087M SDS solutions heated at 50°C. 
Solution was further heated between 85-90°C and a standard ascorbic acid solution was 
added as the reducing agent in a drop-wise manner to allow for spontaneous copper 
formation without a reducing agent overload. The temperature was then maintained at 80°C 
using a mercury thermometer (Brannon Thermometers, Cumbria, England).  
 
5.2.2. Confirmation of cubic geometric copper nanocrystals 
TEM (FEI T12 Spirit Transmission Electron Microscope (120kV), Hillsborough, USA) and 
HR-TEM (JEOL JEM 2100F (200kV), Oregan, USA) confirmed the synthesis of self-
assembled neo-geometric NPs.  Samples were also subjected to TEM-EDS for high-speed 
elemental analysis. 
 
5.2.3. Polymerization of self-oscillating cross-linked polymer 
2g NIPAAm as the swelling/deswelling polymer, 0.04g Ru(bpy)3, 0.05g MBAAm as a cross-
linker and 0.035g APS as an initiator were each prepared by dissolving the powders in 
distilled water while a 3-necked flask was allowed to come to equilibrium under nitrogen flow 
conditions  at 60°C. The aqueous solutions of NIPAAm, ruthenium salt and MBAAm were 
added to the flask to reach equilibrium before adding the APS solution. Polymerization of the 
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NIPAAm and ruthenium salt was conducted over 8 hours in a closed nitrogen system and 
thereafter dialysed for 2 days against distilled water to remove unreacted monomers. The 
resulting gel was lyophilized and used as a powder.  
 
5.2.4. Synthesis validation and investigation of the structural and molecular vibrations 
of the self-oscillating cross-linked polymer 
FTIR utilizing a Spectrum 100 FTIR Spectrometer (Perkin-Elmer, Beaconsfield, BUCKS,UK) 
was used to detect the vibration characteristics of chemical functional groups in the 
oscillating polymer samples. FTIR was performed on the native polymers involved in the 
system as well as the oscillating polymer formulations as a means of validating the 
successful synthesis of the poly-N-isopropyl acrylamide from the NIPAM. Samples were 
placed on a diamond crystal and processed by the universal ATR polarization accessory for 
the FTIR spectrum series at a resolution of 4cm−1. Each sample was analyzed at wave 
numbers ranging from 650 to 4000cm−1. 
 
5.2.5. Fabrication of the polymeric network and incorporation of cube-shaped copper 
nanoparticles 
Reaction substrates, 2.1g malonic acid and 4.22g sodium bromide, were solubilised in 30ml 
distilled water and added to hydrated CMC. The substrates and gelling polymer served as 
the initiating force of the oscillating mechanism as well as the delivery vehicle for the self-
oscillating cross-linked polymer. The geometric CuNPs were sonicated systematically with 
the complete SOPN system. 
 
5.2.6. Application of a Box–Behnken design for the copper nanoparticle-loaded self-
oscillating polymeric network 
For designing an optimum formulation, a 3-factor, 3 tiered Box–Behnken experimental 
design was generated using Minitab®V15 statistical software (Minitab®Inc., PA, USA). The 
final self-oscillating polymeric network was fabricated using quantities and ratios as per a 
Box-Behnken experimental design which generated 15 formulations (Table 5.1). The 
independent variables employed in the experimental design were quantities of the self-
oscillating polymer, reaction substrates and CMC. These formulations were evaluated with 
the aim of acquiring high statistical scientific significance. 
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Table 5.1: 15 Formulations generated by Box–Behnken design. 
Formulation Oscillating Polymer (mg) Reaction Substrate (parts) Gel (parts) 
1 17.5 0.250 0.250 
2 5.00 0.250 0.250 
3 30.0 1.625 1.625 
4 30.0 0.250 0.250 
5 5.00 1.625 0.250 
6 30.0 1.625 1.000 
7 5.00 1.625 1.000 
8 5.00 3.000 0.625 
9 17.5 1.625 0.625 
10 17.5 1.625 0.625 
11 17.5 3.000 0.250 
12 17.5 3.000 1.000 
13 17.5 1.625 0.625 
14 17.5 0.250 1.000 
15 30.0 3.000 0.625 
 
5.2.7. Response surface analysis as per Box–Behnken design 
Response surface analysis of various response variables was carried out employing 
Minitab®V15 statistical software. The results were demonstrated using response surface 
and contour plots derived for the measured responses (average oscillation amplitude, 
duration of oscillations, permeation rate and cytotoxicity) based on the experimental model. 
 
5.2.8. Lower critical solution temperature measurements of the self-oscillating cross-
linked polymer 
Differential scanning calorimetry (DSC) was used to determine the Lower Critical Solution 
Temperatures (LCST) of the Self-Oscillating Cross-Linked Polymer. DSC (model DSC 2910, 
TA Instruments, New Castle, DE) experiments were performed on swollen specimens of 
15mg by heating from 15 to 60°C at 2°C/min. The temperature-sensitive collapse of the 
polymer was identified as an endotherm in the thermograms. The onset of the thermogram 
corresponded to the LCST transition. 
 
5.2.9. Determination of the degree of crystallinity of synthesized and native polymers  
A powder XRD (MiniFlex 600, Tokyo, Japan) was used to monitor diffraction patterns of the 
polymer samples to validate the synthesis of the self-oscillating cross-linked polymer and 
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compare crystallinity with the native PNIPAM and NIPAM. A continuous scan rate of 
0.1°/min from 0-90° was used with copper Kα radiation (λ=1.54Å).  
 
5.2.10. Measurement of optical vibrations to detect oscillations of the self-oscillating 
polymeric network 
The 15 SOPNs were prepared by dissolving the polymer powder into an aqueous gel 
solution containing the BZ substrates and CMC gel according to concentrations in Table 5.1. 
The optical transmittance oscillations for the polymer solutions were measured under a 
constant temperature of 25°C to mimic skin temperature and a once-off stirring mechanism 
upon introducing the polymer to the reaction gel and reading the optical vibrations. The time 
course of transmittance at 570nm (isobestic point) was monitored by a multiplate 
spectrophotometer (Powerwave XS, BioTek, Vermont, USA) to detect the transmittance 
changes on the basis of conformational changes of the synthesized polymer signifying 
mechanical oscillations of the system. 
 
5.2.11. In vitro studies in the determination of permeation rate controlled by the 
oscillations of the self-oscillating polymeric network 
Permeation studies to determine the effect of the self-oscillating phenomenon promoting 
delivery of drug through a semi-permeable membrane were performed using FDC (Perme 
Gear, Amie Systems, USA). 15 SOPN formulations with substrates for the initiation of the 
oscillations (Table 5.1) were loaded with 1.2mg of geometric CuNPs and mounted in the 
donor compartment of the FDC. Buffer solution of pH 5 was added to the receptor cell and at 
time intervals of 1, 2, 4, 8, 24 hours sample was removed for analysis to investigate the 
amount of CuNPs that permeated the membrane. Fresh buffer solution replaced the volume 
that was removed to maintain sink conditions in an environment maintained at 25°C to mimic 
body skin temperature.  An ICP-OES (Activa S-Horiba Scientific, Munich, Germany) was 
used to measure the quantity of copper from the samples taken from the receptor half-cell.  
 
5.2.12. Ex vivo analyses of the biocompatibility of the self-oscillating polymeric 
network via cell viability studies  
Primary NHEK cells were sub-cultured until passage 6 and used for the cell viability study 
using a MTT assay. The NHEK cells were cultured in keratinocyte basal medium and 
supplemented with bovine pituitary extract, recombinant human epidermal growth factor, 
insulin, hydrocortisone, epinephrine, transferrin, gentamicin and amphotericin B. The cells 
were incubated in a humidified 37°C environment controlled at 5% CO2. At 80% confluence, 
the cells were harvested using trypsin/EDTA and were sub-cultured into 75cm2 flasks and 
96-well plates for the toxicity assay. 1x103 cells/well was allowed to attach to the surface for 
117 
 
48 hours prior to treatment. The cells were then incubated with the SOPN formulations for 24 
hours after which the MTT dye was added followed by the solubilising solution after 4 hours 
of incubation and analyzed at 570nm using a multiplate spectrophotometer. Untreated cells 
were run under identical conditions and served as controls. 
 
5.2.13. In vivo investigation of the cube-shaped copper nanocrystal-loaded self-
oscillating polymeric network in the BALB/c induced-psoriasis model 
BALB/c mice arrived at CAS, were weighed, examined by CAS staff, caged individually and 
acclimatized in CAS labs. All mice were provided with a standard mouse diet and water and 
weighed weekly so as to indicate their general state of well-being. In vivo studies were 
conducted on 75 mice randomly divided into 5 groups with 15 mice per group. The psoriasis-
model was induced by applying imiquimod (Aldara 5%) on the shaved dorsal aspect of the 
mice daily for 5 days. Post-induction, the 5 groups were sorted as follows and the respective 
treatments were applied daily: 
 
Group 1 (CuNPs experimental group): Geometric CuNPs-loaded aqueous cream at a 
concentration of 100µg/ml was topically applied to the inflamed, shaved area of each mouse. 
 
Group 2 (CuNPs control group): This group of animals were administered the topical 
aqueous cream without CuNPs as the placebo dose on the affected area. Results from this 
group were used to determine the efficacy of the CuNPs experimental formulation and its 
comparison to the commercial product. 
 
Group 3 (SOPN experimental group): The geometric CuNPs were loaded into the SOPN gel 
and topically applied to the psoriatic area of each mouse at 60µg/ml of CuNPs. 
 
Group 4 (SOPN control group): The SOPN gel without CuNPs was administered as the 
placebo dose. Results from this group were used to determine the efficacy of the CuNPs in 
the SOPN experimental formulation in addition to the SOPN itself as an active agent, and its 
comparison to the commercial product. 
 
Group 5 (commercial product evaluation): This group of mice were topically administered 
with a commercial corticosteroid (0.5% hydrocortisone). This study was undertaken in the 
determination of the potential of the prepared CuNPs and SOPN formulations in comparison 
to the topical market formulation, thereby determining the efficacy between these different 
delivery systems. 
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Photography and Psoriatic Area and Severity Index (PASI) scoring were conducted at the 
end of the three phases on days 3, 7 and 14. In addition, on days 3, 7 and 14 of treatment 
interventions, 5 mice from each group were euthanized for excision of treated skin and blood 
sampling at the different time points. Histopathology investigations analyzed the effect of the 
treatments on the psoriatic skin and treated skin and blood samples were collected for ICP-
OES analyses to determine the in vivo residual CuNPs and fate thereof.  
 
5.2.14. Data analysis and confirmation of statistical significance of all assays 
performed 
All quantitative investigations were carried out in 3 independent experiments in duplicates for 
each evaluation. Data were expressed as mean (±SE) and analyzed by 1-way analysis of 
variance (Anova). p values less than 0.05 was considered statistically significant. 
 
5.3. Results and Discussion 
 
Cube-shaped geometric CuNPs for enhanced cellular internalization were synthesized using 
the thermal reduction method in the presence of two key surfactants to direct the growth of 
the CuNPs. The copper nanocrystals also play a role in exerting cytotoxic effects on the 
inflamed cells of the psoriatic area, therefore reducing the plaque thickness. The self-
oscillating polymer was synthesized by polymerization of native NIPAM with the 
incorporation of Ru(bpy)3. The resulting polymer forms the oscillating component of the 
complete SOPN system when incorporated with the reaction substrates. The polymerization 
of NIPAM and the catalyst ion results in chemical modification to PNIPAM which 
encompassed the required properties of the new polymer necessary to satisfy the aim of the 
SOPN system and incorporation of the geometric CuNPs which completed the bio-active 
system. The following characterization and design ensured the formulation of an ideal 
system to enhance CuNPs delivery through the stratum corneum to improve psoriasis 
treatment. 
 
5.3.1. Box-Behnken experimental design and constrained optimization of the copper 
nanoparticle-loaded self-oscillating polymeric network 
Optimization of the CuNP-loaded SOPN is as a result of the specific characterization of the 
15 formulations generated by the software (Table 5.1). The design program generated 
responses from the results of each formulation for determining the greatest correlation with 
response elements for the optimized formulation. Residuals were used for evaluating 
differences in observed values and predicted responses, thereby correlating results 
according to the programs desired outcome (Stewardson and Whitfield, 2004).  The ideal 
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histograms represent bell shaped curves for the responses; how-ever, slight variations are 
evident in the responses obtained due to the variation in ratios of the polymer, substrates 
and gel.  
 
Minitab®V15 statistical software was used for producing optimal responses for the amplitude 
and duration of the wave-like oscillations created by the SOPN, rate of CuNP permeation 
through a semi-permeable membrane affected by the oscillations and cell toxicity of the 
system. High, low and optimal factors were generated yielding a desirability value of 1, to 
produce optimal factor levels for the most desirable response behaviour. The above 
evaluation yielded responses for the optimized formulation, inputting the oscillation 
vibrations, duration of oscillations, permeation flux as a direct result of the oscillations and 
cell toxicity data  into the Box–Behnken design, for an optimum formulation of desirability of 
94.426%. Figure 5.1 indicates the software specifications with profiles generated for the 
optimized formulation, taking into consideration the responses which are further discussed in 
subsequent sections. 
 
 
 
Figure 5.1: Optimization plot for the response optimization of the SOPN formulation. 
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The experimental values of average permeation flux, oscillation wavelengths, duration of 
oscillations and cell toxicity were 0.186mg.cm-2.hr-1, 0.0156nm, 225.83 minutes and 70.4%, 
respectively. The desirability plot describes the influence of each independent variable for 
formulating the optimized CuNP-loaded SOPN with the desired targeted responses. The 
optimization approach resulted in a formulation constituting oscillating polymer (30mg), 
reaction substrates (3 parts) and CMC gel (0.250 parts). 
 
5.3.2. Response surface analysis 
Response surface and contour plots (Figure 5.2) were derived for the measured responses 
based on the experimental model. Plots were used to represent the functional relationship 
between the experimental variables and the responses achieved. The correlating effects of 
the oscillating polymer, reaction substrates and gel on the responses are shown with respect 
to the targeted responses. Response surface plots clearly indicate an increase in oscillation 
amplitude when the oscillation polymer and reaction substrates are at maximum 
concentrations while an increasing concentration in the gel reduces the oscillation amplitude. 
Similarly, the duration of the reaction and permeation kinetics is at its desired range when 
the oscillatory components are maximal but is predominantly reliant on the quantity of 
reaction substrate to propel the reaction. Considering the use of CMC as the gelling agent to 
promote a suitable topical delivery system for ideal application, the CMC concentration is 
inversely proportional to the oscillation amplitude and subsequent permeation kinetics; and 
may affect oscillation duration based on the concentration of the self-oscillating polymer and 
reaction substrates. With regards to biocompatibility, in contrast, the increased 
concentrations of the oscillatory polymer and reaction substrates negatively affect cell 
viability; however, it gives an indication of the LD50 and ideal toxic dose. 
 
Based on a full ANOVA analysis of the measured formulation responses it was determined 
that the only factors which exhibited significant influence (p≤0.05) were the duration of 
oscillation involving the correlation between the reaction substrates and oscillating polymer, 
and cell toxicity.  Despite no statistical significance between the formulation variables and 
average oscillation amplitude and permeation kinetics (p≥0.05), response surface plots 
showed that the relative and definitive effects of the measured responses were reliant on the 
formulation variables. 
 
The normal probability plots of the residuals (left panel of Figure 5.2) showed clusters of 
residuals; however these clusters fell on a straight line, signifying the normal distribution of 
data with no evidence of unidentified variables. Furthermore, a residual plot of the 
121 
 
standardized residuals of the responses show a random distribution of points fluctuating 
around zero, with no discernible pattern, indicating a non-violation of the assumptions of 
zero means and constant variance of the regression model despite the presence of outliers 
in these plots. Evidence of this non-violation was provided by histograms of the residuals of 
average oscillation amplitude, duration of oscillations, permeation rate and cell toxicity. The 
residuals versus the order of data showed a random distribution, with rapid changes in signs 
(+/-) between consecutive residuals for all responses (Figure 5.2). The right panels of Figure 
5.2 give an indication ofeach of the limits of the variables with regards to the effect on the 
responses. 
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Figure 5.2: Residual (left panel) and surface plots (right panel) of a) average oscillation 
amplitude; b) duration of oscillations; c) permeation rate; d) cell toxicity. 
 
5.3.3. Cube-shaped copper nanocrystals synthesized by dual surfactant mediated 
adsorption 
Geometric CuNPs were employed in this study primarily due to the ability of cubic 
nanoparticles to internalize at a higher rate as compared its counterpart nano-shapes. Nano-
cubes were synthesized using CTAB and SDS at specified concentrations during the 
reduction of the copper salt using ascorbic acid resulting in cube shaped crystalline CuNPs 
which has been adapted for use in drug delivery. In our previous research, nano-shapes 
studied for uptake kinetics included 90nm spheres, rods, pyramids, 5nm spheres and cubes 
in which each nano-shape displayed its own mechanism of cell entry and rate of 
internalization in human keratinocyte cells. A notable variation in uptake kinetics as a 
function of nano-shape resulted in 200x200nm cubes having the highest rate of cellular 
internalization followed by 5nm spheres, pyramids, 90nm spheres and rods, respectively, 
over a 24 hour incubation period.   
 
The TEM micrograph showing cubic CuNPs (Figure 5.3a) was analyzed under high-
resolution for crystallinity evaluation of lattice fringe spacing (Figure 5.3b) which correlates 
with the 1.811Å spacing of the (100) plane. Growing from the cuboctahedron precursor 
nucleus, the surfactants adsorb preferentially on the {100} facets resulting in this face 
becoming the dominant slow growing face while the {111} facets become fast growing and 
eventually the smallest faces on the nanocrystal, ceasing to appear. The lattice fringes also 
confirm crystallinity of the copper and promote its characteristics in order to be used as an 
active agent. Toxicity studies confirmed the use of the CuNPs as a cytotoxic agent and are 
targeted in this study at the keratinocytes which form the hyper-keratinized plaque of the 
autoimmune disease. In the inflammatory environment, copper is cytotoxic at 25µg/ml by 
superoxide and hydroxyl ion production initiating cell death by DNA and cell membrane 
damage. 
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Figure 5.3: a) cube-shaped copper nanocrystals; b) lattice fringes and spacing of 1.811Å 
(100). 
 
5.3.4. Chemical synthesis validation of the responsive synthesized self-oscillating 
polymeric network 
The polymerization of NIPAM with Ru(bpy)3 resulted in a PNIPAM-like polymer of which 
FTIR investigated the differences in the synthesis of the self-oscillating cross-linked polymer. 
Figure 5.4 compares the synthesized SOPN with its native polymers and desired PNIPAM 
characteristics. The peaks attributed to the N–H stretching vibration and bending vibration 
were observed at 3500–3100cm-1 and indicate PNIPAM and NIPAM resemblance with the 
SOPN. The sp3 C–H and C––O stretching vibrations also appeared at 2971 and 1650cm-1, 
respectively, further corroborating PNIPAM characteristics of the synthesized polymer. The 
similar characteristic peaks of PNIPAM and the SOPN share desirable, necessary properties 
in order for the SOPN to feature similar activity as the thermo-responsive PNIPAM with 
sensitivity to hydrophobic phase changes. 
 
Essentially, MBAam and APS as the initiator and cross-linker are not detected in the 
synthesized SOPN as required and served the only purpose of its functionality. MBAam and 
APS were used completely during the polymerization reaction and residual amounts were 
removed during dialysis of the synthesized polymer.  
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Figure 5.4: FTIR spectra of the synthesized SOPN and native polymers.  
 
5.3.5. Lower critical solution temperature measurements of the oscillating polymer 
DSC was employed to determine the LCST of the synthesized polymer and subsequent 
sensitivity to thermal change. The LCST is observed in the reduced state of the polymer only 
and is related to the solubility of the polymer chain (Hara and Yoshida, 2005). The 
temperature-responsive property of the self-oscillating polymer can be investigated by the 
determination of cloud points, that is, LCST (Figure 5.5). The appearance of LCST depends 
on the aggregation of the hydrophobic portions of the co-polymers at a certain temperature. 
The hydrophobic/hydrophilic properties of the polymer are pertinent in creating the 
mechanical oscillations of the SOPN. Thermo-sensitivity is attributed to the 
hydrophilic/hydrophobic balance of the polymer chains which will subsequently be 
responsible for the swelling/deswelling action in the SOPN.  
 
The endothermic transition at 27-35°C of the synthesized SOPN in the thermogram (Figure 
5.5c) gives an indication of the LCST. In Figure 5.5a, NIPAM has a distinct transition at 66°C 
while native PNIPAM exhibits a broad transition at 80-90°C (Figure 5.5b). Having 
polymerized the NIPAM with Ru changed the thermal properties and gave the required 
characteristics for thermal sensitivity. These results indicate that the self-oscillating polymer 
has been successfully synthesized from NIPAM incorporating Ru ions and possess 
temperature-responsive behaviour. The LSCT within this range allows the system to function 
optimally at skin temperature affirming its use as a topical drug delivery system.  
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Figure 5.5: DSC thermograms of the a) NIPAM; b) PNIPAM; c) synthesized SOPN 
a 
b 
c 
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5.3.6. X-Ray diffraction analysis to determine crystallinity changes 
XRD investigated the change in crystallinity properties between NIPAM and the polymerized 
SOPN. In addition, native PNIPAM was compared to the SOPN to elucidate possible 
similarities with the new polymer to assess its amorphous-crystalline chemical structure. The 
XRD spectra of NIPAM (Figure 5.6a) shows distinct, sharp peaks of a highly crystalline 
polymer while that of PNIPAM shows an amorphous polymer. An analysis of the polymerized 
SOPN (Figure 5.6c) indicates the polymer to exhibit properties of the PNIPAM (Figure 5.6b) 
of an amorphous nature. This change in polymerization will therefore lend its thermo-
responsive characteristics allowing for the swelling/deswelling of the gel. 
 
 
 
 
Figure 5.6: XRD spectra of a) NIPAM; b) PNIPAM; c) SOPN 
a 
b 
c 
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5.3.7. Measurement of optical vibrations to detect oscillations 
This self-oscillating phenomenon characterized by the BZ reaction creates a system of 
autonomous change in the gel without external stimuli. Reaction substrates driving the 
reaction potentiate the swelling and deswelling properties of the polymerized polymer and 
metal ion catalyst. In this investigation, exploiting the swelling-deswelling action of the gel 
makes functional use of the system in drug delivery by creating microscopic motion in the 
system enhancing drug delivery through a physical barrier. Dermal delivery of nanoparticles 
have shown to be unsuccessful whereby the nanoparticles deposit on the external surface of 
the stratum corneum and do not penetrate the deeper stratum corneum layers (Gamer et al., 
2006; Cross et al., 2007; Larese et al., 2009). Hence, the adoption of the BZ reaction to 
create a self-oscillating mechanism which may stimulate the motion and permeation of 
nanoparticles through the outermost surface of the epidermal layer due to the physical 
disturbance in the system. After the incorporation of the oscillating polymer, reaction 
substrates, gel part and geometric CuNPs, the reaction promotes the oscillations as a result 
of the reduction and oxidation of the Ru ions causing changes in the hydrophobic phase of 
the PNIPAM which stimulate the swelling and deswelling properties of the polymer (Figure 
5.7). 
 
 
 
 
a 
b 
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Figure 5.7: Redox function of the BZ reaction creating an oscillatory action within the 
polymer showing a) reduction-oxidation reaction of the ruthenium catalyst ion; b) swelling-
deswelling action of the SOPN as a result of the BZ reaction; c) resultant oscillations of the 
CuNP-loaded SOPN promoting movement in the system and subsequent permeation of 
CuNPs across the stratum corneum. 
 
The oscillatory amplitude was investigated to identify and optimize the formulation variables 
for maximum oscillation while taking into consideration other formulation responses. As is 
with the 15 formulations, the wave-like nature of the oscillations and volume changes of the 
polymer is clearly visible in Figures 5.7 and 5.8. Essentially, to potentiate the redox reaction, 
nitric acid forms the acid component of the system; however, its toxic properties are 
detrimental when used biologically. In the psoriasis application of the SOPN, psoriatic 
keratinocytes forming the bulk of epidermis express the neuronal form isoform of nitric oxide 
synthase (NOSI) (Kadam et al., 2010) providing the acidic component to drive the reaction 
allowing for the exclusion of nitric acid from the SOPN gel promoting biocompatibility. 
 
As the SOPN shrinks as a result of the oxidised state of the Ru ions, the transmittance 
decreases and increases upon reduction of the ion (Figure 5.8). Measuring the oscillations at 
a wavelength of 570nm attributes the conformational change of the PNIPAM component 
(Pullela et al., 2013) of the SOPN illustrating the volume change of the polymer and 
subsequent macroscopic oscillation of the whole SOPN. Figure 5.8 shows the oscillations at 
570nm and depicts the change in amplitude and duration of the oscillations based on the 
variables at differing concentrations.  The formulations vary in the oscillatory amplitude 
showing the effect on concentration of the SOPN in response to changes in reaction 
c 
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substrate concentration and CMC, especially where amplitude reduction is noted upon 
higher CMC concentrations. Table 5.2 compiles the data analyses of the oscillations for all 
15 formulations and includes the average oscillation amplitude for each formulation. 
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Figure 5.8: Self-oscillating vibrational frequency of the 15 Box-Behnken Design 
formulations. Data presented are mean ± SE of 3 experiments performed in duplicate. *p 
≤0.05 versus control.  
 
Formulations 3, 5 and 15 have the highest average oscillations of 13.88, 15.34 and 14.76E-
3nm, respectively, indicating a trend of the highest oscillating polymer concentration, highest 
substrate reaction concentration or lowest gel concentration. Conversely, formulations 2, 7 
and 12 have the lowest average oscillations of 7.94, 6.53 and 8.38E-3nm, respectively, 
containing the lowest oscillating polymer and reaction substrate concentrations or highest 
gel concentration, decreasing the oscillatory vibrations of the SOPN system and reducing 
the duration of the oscillatory phenomenon. Theoretically modelling the BZ reaction, Yashin 
and Balazs (2007) employed the Tyson and Fife version of the Oregonator model in the 
following sequence of reactions: 
 
          k1H2 
A + Y → X + P, 
         k2H 
X + Y → 2P, 
         k3H 
A + X → 2X + 2Z, 
          k4 
X + X → A + P, 
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          k5 
B + Z → 1/2fY , 
 
where A=[BrO3−], B=[all oxidisable organic species], H=[H+], P=[HOBr], X=[HBrO2], Y=[Br−], 
and Z=[Mox]. The stoichiometric factor f is considered as a model parameter. The Oregonator 
treats the concentrations of the major reactants A, B, and P, as well as the concentration of 
the hydrogen ion H, as constants. The reaction rate equations for the species X, Y, and Z 
are  
 
dX/dt = k1H2AY − k2HXY + k3HAX − 2k4X2,             (Equation 5.1) 
dY/dt = − k1H2AY − k2HXY + 1/2 fk5BZ,             (Equation 5.2) 
dZ/dt = 2k3HAX − k5BZ              (Equation 5.3) 
 
In a swollen SOPN gel, the self-oscillating polymer network with the attached metal-ion 
catalyst occupies a volume fraction of the total system. The remaining BZ reaction 
substrates and CMC gel form the volume fraction (1-ø). The variable concentrations X, Y, 
and Z are defined with respect to the total volume of the system. In contrast, the 
concentrations of the reactants are more convenient to define with respect to the volume of 
the solvent. Recalculating sodium bromate, malonic acid, and nitric acid relative to the total 
volume is achieved through multiplication by the factor (1-ø). As a result, the following 
substitutions should be made in the right-hand sides of the reaction rate equations 5.1-5.3 
 
k1H2A → k1 (1-ø)3H2A, 
k2H → k2 (1- ø)H, 
k3HA → k3 (1- ø)2HA, 
k5B → k5 (1-ø)B 
 
Thus, in the derived model, the polymer acts as a diluent (Yashin and Balazs, 2007) which 
affects the reaction rates through changing the concentrations of the reaction substrates 
explaining the higher oscillatory amplitude in the formulations containing higher SOPN 
concentrations. The oscillations lasted 170-225 minutes due to the depletion of reaction 
substrates per formulation. It can be noted that maximum oscillations last during that period 
with a sudden reduction in amplitude indicating the end of the reaction. The duration of the 
oscillations also depend on the formulation variables and can be tailored to output the 
longest duration which would improve drug delivery through a barrier as time is a 
consideration. 
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Table 5.2: Experimental design formulation analysis of the oscillating phenomenon and biocompatibility of the SOPN. Data presented are 
mean ± SE of 3 experiments performed in duplicate. *p ≤0.05 versus control. 
Formulation 
 
Oscillating 
Polymer (mg) 
Reaction Substrate 
(parts) 
Gel 
(parts) 
Average Oscillation 
Amplitude (nm * E-3) 
Duration of Oscillations 
(Minutes) 
Permeation 
(Js)(mg.cm-2.hr-1) 
Cell Toxicity 
(%) 
1 17.5 0.250 0.250 08.98 170 0.0842 64.44 
2 5.00 0.250 0.250 07.94 170 0.0825 64.26 
3 30.0 1.625 1.625 13.88 210 0.0917 67.30 
4 30.0 0.250 0.250 09.19 185 0.0865 69.42 
5 5.00 1.625 0.250 15.34 190 0.0923 64.56 
6 30.0 1.625 1.000 09.22 225 0.0887 71.99 
7 5.00 1.625 1.000 06.53 175 0.0796 66.19 
8 5.00 3.000 0.625 11.77 195 0.0906 71.40 
9 17.5 1.625 0.625 11.43 200 0.0900 70.64 
10 17.5 1.625 0.625 10.43 205 0.0899 70.28 
11 17.5 3.000 0.250 12.70 220 0.0916 72.14 
12 17.5 3.000 1.000 08.38 220 0.0809 72.27 
13 17.5 1.625 0.625 09.61 205 0.0891 70.19 
14 17.5 0.250 1.000 08.58 185 0.8300 68.29 
15 30.0 3.000 0.625 14.76 225 0.0922 72.58 
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5.3.8. Appraisal of nanoparticle permeation in relation to the self-oscillating polymeric 
network 
In creating a biocompatible system for mass transport of nanoparticles across a barrier, 
permeation studies employing the Frans Diffusion Apparatus were imperative. The cellulose 
membrane served as the rate-limiting barrier component of the stratum corneum while buffer 
of pH 5 was used to simulate the inflammatory environment of the psoriatic lesion. 
Translocated CuNPs were quantified to determine the oscillatory effect of the SOPN in the 
enhancement of drug delivery through a biological barrier. The peristaltic kinetics of the 
SOPN allows for the permeation of the geometric nanocrystals as seen in Figure 5.9 and 
clearly shows the peak permeation due to the oscillatory vibrations of the polymer.  
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Figure 5.9: SOPN potentiated diffusion of CuNPs diffusion through a membrane barrier. 
Data presented are mean ± SE of 3 experiments performed in duplicate. *p ≤0.05. 
 
It is noted in most formulations that there is a burst CuNP permeation with a slight reduction 
in flux between the 2nd and 4th hour, thereafter reaching a passive permeation and plateaux 
due to maximum CuNP translocation and end of the BZ reaction. Slight deviations occur in 
permeation rates where the flux does not follow the general trend. Formulation 2 has a burst 
CuNP release in the 1st hour only and steadily decreases in flux which can be accounted for 
by the use of the minimum concentrations of 5mg of oscillating polymer and 0.250 parts of 
reduction substrate. The initial burst permeation, however, can be accounted for by the low 
CMC concentration which does not hinder the oscillations and the duration of the BZ 
reaction.  Similarly, formulation 7 has a fairly linear permeation rate in the first 2 hours before 
reducing significantly in flux as compared to the other formulations. Also containing 5mg of 
oscillating polymer explaining the minimum permeation of CuNPs, this formulation has a 
higher reaction substrate concentration which would ideally potentiate the BZ reaction; 
however, the higher CMC gel part decreases the amplitude of the oscillations and 
subsequent flux of CuNPs. 
 
Formulations 3 and 13 show a higher initial CuNP flux by the 2nd hour of permeation studies 
as compared to other formulations explained by the high oscillation polymer concentration 
(30mg), intermediate reaction substrate concentration (1.625 parts) and CMC part (1.625) in 
formulation 3. The derived Tyson and Fife version of the Oregonator model (Yashin and 
Balazs, 2007) rationalises the higher ratio of oscillating polymer creating larger oscillation 
amplitudes, therefore having a higher flux during the period of the BZ reaction. Formulation 
13 has a lower oscillation polymer concentration of 17mg and a lower CMC concentration of 
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0.625 parts. Despite having a lower polymer concentration, the high permeation flux is 
maintained due to the lower CMC in the formulation. 
 
The force created by oscillations of the SOPN is relative to the formulation variables and 
sufficient to generate energy within the system to stimulate the movement of the geometric 
CuNPs as the model drug. According to classical physics, the wavefunction associated with 
the particle requirement movement must be continuous at the barrier. The wavefunction 
must also be continuous on the far side of the barrier to ensure finite probability of the 
nanoparticle tunnelling through the barrier. As the nanoparticle approaches the barrier, it is 
described by a free particle wavefunction. Upon reaching the barrier, it is required to satisfy 
the Schrodinger equation in the form:   
 
− ħ6
67
 86ᴪ#:%
8:6
= #E − U°%ᴪ#x%                 (Equation 5.4) 
 
which has the solution 
 
ᴪ = Ae?@: where a = B67 #C°?D%
EF
               (Equation 5.5) 
 
and has a dependence on the fundamental physical constant Planck’s constant h. 
 
Murase and associates (2008) discuss the Hertz Contact Theory which can also be adapted 
for nanoparticles embedded within a loose oscillating gel system. Their research study 
involved the transport of a cylindrical PAAm gel bead across the surface of an oscillating 
poly(NIPAAm-co-Ru(bpy)3-co-AMPS) gel sheet. As factors of mass transport, size, gravity, 
frictional force and contact force play key roles in the design of a transport system, very 
similar to the kinetics of this study with the exception of the materials for transport loaded 
within the SOPN. This research group investigated the adsorption of the cargo materials 
onto the gel surface by an attracting force such as hydrophobic interaction and performance 
of the peristaltic motion to mass transport materials. Likewise, in the current study, the 
CuNPs interact with the oscillating polymer and oscillate with the gel. This mechanism 
constantly disrupts the gel system and forces the movement of the CuNPs across the 
membrane providing a system useful for drug delivery.   
 
5.3.9. Cell toxicity and viability studies 
The oscillating phenomenon has previously not been applied for practical biological use 
possibly due to its toxicity profile. Elucidating the biocompatibility of the system was 
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necessary, especially for in vivo application. The toxicity profile of PNIPAM shows adequate 
cell viability, biocompatibility and does not elicit a cytotoxic response (Bluestein et al., 2017; 
Guo et al., 2017; Li et al., 2017), however, when used in combination with other possible 
cytotoxic polymers the toxicity of the complete system needs to be assessed. In a recent 
study by Chen and co-workers (2016), their toxicity studies showed the anti-proliferative and 
cytotoxic activity of ruthenium, in addition to its useful selectivity for cancer cells than normal 
cells which promotes its use in targeting psoriasis as function of hyperkeratosis. Montani and 
associates (2016) and Matsui’s research group (2016) also proved the reduction in cell 
viability based on dose dependent concentrations of Ru studied in accordance with anti-
cancer drugs. Research also shows the cytotoxic effects of sodium bromate and malonic 
acid inducing oxidative stress in in vitro cellular studies (Al-Sheddi et al., 2016; Lazarev et 
al., 2016; Saad et al., 2016). 
 
The cell toxicity profiles (Figure 5.10) give an indication of the toxic dose of this system 
considering all toxic profiles. Using Equation 5.6: 
 
% Cell viability =  JKL#L@7MNO%
JKL#KN@PQ%
x 100             (Equation 5.6) 
 
cell toxicity can be ascertained by the difference of 100% and the cell viability %. Differences 
are small but significant and affect the dosage for in vivo use. Using 100µL samples of the 
complete SOPN gel, toxicity results varied from 64.26 – 72.58%. The results indicate the 
increase in toxicity as the substrate concentration increased, as was hypothesized. In 
addition, reduction in the oscillating polymer concentration also resulted in higher cell toxicity 
due to the cytotoxic profile of ruthenium. However, at the appropriate concentration while still 
producing mechanical oscillations sufficient to stimulate energy in the system to translocate 
the geometric CuNPs, the SOPN shows to provide an ideal drug delivery system.  
 
As investigated in our previous research, the CuNPs also has its own toxicity profile which 
should be taken into consideration apart from the SOPN to prevent excess toxicity to the 
skin. The geometric CuNPs exerts a mechanism of DNA damage by ROS thereby inducing 
cell death. Cell toxicity by means of cell membrane damage, change in glutathione 
production and membrane lipid peroxidation were investigated and a dose dependent 
toxicity was analyzed. Pertaining to the cube-shaped CuNPs with the highest cellular 
internalization rates, 25µg/ml has a cell toxicity value of 46%. When 12.5g/ml of the CuNPs 
incorporated into the SOPN at 50µL were studied after incubated in 1x103 cells/well, toxicity 
varied from 52.8 – 66.53%. The reduced toxicity accounts for the 50% concentration 
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decrease of the CuNPs and SOPN which gives an accurate indication of the LD50 
concentration for in vivo application of the CuNP-loaded SOPN. 
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Figure 5.10: Cell viability analysis of the SOPN on NHEK cells. Data presented are mean ± 
SE of 3 experiments performed in duplicate. *p ≤0.05 versus control. 
 
5.3.10. In vivo analysis of the geometric copper nanoparticle-loaded self-oscillating 
polymeric network in the psoriasis model 
To investigate the effects of the treatments and control on a psoriasis model, 5% Aldara® 
was topically applied for 5 days to the shaved backs of BALB/c mice. Imiquimod application 
induces phenotypic skin changes resembling human psoriasis which includes epidermal 
hyper-proliferation and acanthosis. The treatment interventions aim to reduce the hyper-
proliferative plaque of the induced-psoriasis by cytotoxic mechanisms on the keratinocytes. 
Figures 5.11a and b, respectively, demonstrates the visual difference between healthy skin 
and imiquimod-induced psoriasis which presents with inflammation, scaling and thickening of 
the affected skin. Daily application of the imiquimod cream over a period of 5 days leads to 
an increased immune response resulting in erythema, swelling and scales (Figure 5.11b). 
The induction was visibly noticed on the third day of imiquimod application and reached the 
highest scoring according to the PASI system rendering the model ideal for the beginning of 
respective treatments. 
 
138 
 
5.3.10.1. Gross observation of the treated psoriatic lesions by photographic analysis 
and PASI scoring 
After adequate induction of the psoriasis, treatments were applied according to group 
specifications of CuNPs-loaded aqueous cream, unmedicated aqueous cream, CuNPs-
loaded SOPN, unmedicated SOPN and corticosteroid cream application. In the analysis of 
the effect of treatment, a combination of visual and PASI scoring was utilised as the primary 
characterization on the induced-psoriasis model. PASI was scored on a scale of 0 to 4 
where 0-none; 1-slight; 2-moderate; 3-marked and 4-very severe inflammation with 12 being 
the maximum possible total score considering the three scoring factors which comprises 
erythema, scaling and thickening. A hallmark of psoriasis is epidermal hyperplasia which 
was evident in the induced psoriasiform skin with representative images (Figure 5.11c), the 
feeling of skin thickness and roughness upon application of the treatments and the PASI 
scoring evaluation (Table 5.3). The macroscopic presentation of the treated skin after 3, 7 
and 14 days of treatment shows effectiveness of the different interventions (Figure 5.11c).  
 
By the end of Phase 1 (day 3) of the treatment interventions, slight differences in erythema, 
scaling and thickening were already noted according to the visual analysis and PASI scoring. 
Group 1, 4 and 5 which were the CuNPs-loaded aqueous cream, unmedicated SOPN and 
corticosteroid cream, respectively, indicated a higher PASI score. The lower PASI score of 
the CuNPs-loaded SOPN as compared to the CuNPs-loaded aqueous cream and SOPN can 
be accounted for by its higher cell toxicity profile. The images at the end of Phase 2 (day 7) 
of all treatment interventions show reduced erythema, scaling and thickening at varying 
scores. At this time point, according to PASI scoring, the CuNPs-loaded aqueous cream, 
CuNPs-loaded SOPN and the corticosteroid cream proved to be slightly more effective than 
the unmedicated aqueous cream and SOPN. There was also slight hair growth indicating 
effectiveness of the treatments with the most growth in the groups with the lowest PASI 
scoring. Over the course of the following 7 days (Phase 3), the PASI scoring approached 0, 
visual analysis indicated complete healing of the plaque and hair growth increased 
significantly. The time periods, however, varied with the unmedicated aqueous cream 
maintaining thickened skin. Histological evaluation gives better insight into plaque resolution 
at a cellular level amongst all treatment interventions. Essentially, these results show Group 
3 in which the intervention included the application of the CuNPs-loaded SOPN exhibiting 
the lowest average PASI score, effectively reducing epidermal thickening and inflammation; 
and superseding the plaque resolution of Group 5 which was the comparative group. 
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Figure 5.11: Macrological transition in the psoriasis model: a) healthy skin; b) imiquimod-
induced psoriasis; c) over the 3 phases during treatment interventions for Group1 (CuNPs), 
Group 2 (aqueous cream), Group 3 (CuNPs-loaded SOPN), Group 4 (SOPN) and Group 5 
(corticosteroid cream). 
 
Table 5.3: PASI scoring evaluation at 3 phase time points on day 3, 7 and 14 of treatment.  
 
Phase 1 (3 Days) Phase 2 (7 Days) Phase 3 (14 Days) 
Group 1 9 4 0 
Group 2 8 5 0 
Group 3 8 4 0 
Group 4 9 5 0 
Group 5 9 4 0 
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5.3.10.2. Histopathological investigation of the psoriasis interventions 
Histological analysis of healthy skin compares the changes in the induced-psoriasis model 
with the skin samples from each treatment intervention. In Figures 5.12a and b, respectively, 
samples of healthy, untreated skin complies with normal appearance while imiquimod-
induced psoriatic skin shows severe epidermal hyperplasia with shallow rete pegs and 
formation of psoriasiform-type hyperplasia. Figure 5.12b shows serocellular crusts in the 
keratin and acanthosis also extends similarly to the follicular infundibulae where increased 
mitosis is also visible in the basal layers. The skin shows severe orthokeratotic hyper-
keratosis and the dermis shows a diffuse interstitial inflammatory reaction consisting 
predominantly of neutrophils, lymphocytes, plasma cells and few mast cells and eosinophils. 
 
 The results (Figure 5.12c) show a change with each treatment over each time period, 
however, the extent of change varies. It should also be noted that the healing of the induced 
psoriasis is also time- and imiquimod-dependent. The cessation of the stimuli automatically 
results in cessation of the immune disorder. Therefore, effect of the treatment interventions 
were analyzed based on differences between samples and extent of healing; and not related 
to the chronic condition of psoriasis but rather the psoriasiform condition presented by the 
model.  
 
In the first phase of the treatment interventions where samples were taken at day 3 of 
application, an improvement is noted. At day 3, treatment Group 1 shows moderate 
epidermal hyperplasia with mild shallow rete pegs. Moderate acanthosis extending mildly 
into some of the follicular infundibulae and mild interstitial inflammation in the dermis with 
few neutrophils is evident. The aqueous cream Group 2 shows moderate epidermal 
hyperplasia and the presence of mitotic figures. Acanthosis is present in slight undulation in 
the basal layer and mild oedema was observed. Mild dermal inflammation is observed with 
mild hypergranulosis in the granular layer. The skin samples from Group 3 where the 
CuNPs-loaded SOPN was applied shows mild to moderate epidermal hyperplasia without 
rete peg presence or psoriasiform appearance. Small serocellular crusts are visible in the 
keratin. Mild acanthosis and inflammation is visible in very few areas of the samples and hair 
follicles appear normal. Skin samples from the unmedicated SOPN treatment Group 4 
shows moderate epidermal hyperplasia with features similar to Group 3 with the exception of 
the hair follicles showing mild infundibular acanthosis. The commercial product treatment 
Group 7 shows moderate hyperplasia with few mitotic figures present. There are few areas 
with mild dermal inflammation and moderate hypergranulosis is evident in the epidermis. 
Acanthosis extending to the follicular infundibulae are prominent with follicles showing 
perifollicular inflammation. The treatment group 1 and 3 were compared with 2, 4 and 5 and 
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obvious differences are noted where the changes in Group 5 are not as progressive as the 
other groups as was expected. Group 3 showed fair changes with the best outcome at this 
phase of treatment. 
 
In the second phase of the treatment interventions at day 7, the CuNP-loaded aqueous 
cream Group 1 shows a mild acanthotic dermis with moderate thickening. No dermal rete 
peg presence or psoriasiform changes are visible and mild to minimal inflammation is 
observed. In the unmedicated aqueous cream group, mild hyperplasia is noted with mild 
hypergranulosis and mild interstitial inflammation. Skin samples from Group 3 (CuNPs-
loaded SOPN) show mild epidermal hyperplasia without rete peg presence or psoriasiform 
appearance. The skin appears normal mild inflammation and active hair follicles. The 
samples from the unmedicated SOPN treatment Group 4 shows mild epidermal hyperplasia 
with fairly normal occurring epidermal layers, mild to minimal inflammation and active hair 
follicles. The application of the commercial product after 7 days results in mild epidermal 
hyperplasia, areas of acanthosis, mild hypergranulosis, single mitotic figures in the basal 
layer and mild interstitial inflammation with active hair follicles. Similar to phase 1, it is 
obvious that the copper nanoparticles have a positive effect on the psoriasis model, 
especially when in use with the SOPN for enhanced cellular delivery. It can be assumed that 
this drug delivery system potentiates its cytotoxic properties in the presence of inflammation 
and does reduce epidermal hyperplasia to a higher extent than it commercial counterpart. 
 
After 14 days (Phase 3) of applying the respective treatments, treatment Group 1 shows 
mildly increased thickness of the epidermis with normal three cell layer thick epidermis and 
few single lymphocytes in the interstitium. Group 2 shows mild acanthosis and mild flaking 
orthokeratotic hyperkeratosis. Further, few granular cells were present in addition to odd 
lymphocytes and mast cells interstitially. Group 3 showed normal appearance of the 
epidermis and active hair follicles except for few single lymphocytes in the interstitium. 
Similarly, Group 4 also showed healthy skin appearance but with few granular cells and 
lymphocytes. Group 5 showed a mild orthokeratotic keratosis and presence of few interstitial 
lymphocytes. It is deduced from these results that the novel systems have a significant role 
in psoriasiform conditions, more so than a moisturising aqueous cream and the current 
commercial gold standard. It is also noted that the CuNPs in combination with the SOPN is a 
system that reduced the typical features of the induced dermal condition. The CuNPs-loaded 
aqueous cream and unmedicated SOPN also elicited a positive effect and even though it 
was to a higher extent than the aqueous cream application (Group 2), it was minimal 
compared to the CuNPs-loaded SOPN. The dual toxicity and inflammation-selective 
properties of the optimized system CuNPs-loaded SOPN reflects an optimal drug delivery 
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system and surpassed the expectations of the commercial product. The commercial product 
maintained the inflammation longer than the experimental formulations, in contrast to its 
mechanism of action which includes inflammation reduction. It was noted that the 
unmedicated SOPN did elicit an anti-psoriasiform effect due to the presence of the cytotoxic 
ruthenium, however, not as significant to the CuNPs-loaded SOPN and slightly lagged 
behind the CuNPs-loaded aqueous cream. 
 
In essence, the both CuNPs systems had positive outcomes and proves its use as an agent 
for use in hyper-proliferative conditions. It should also be considered that the CuNPs has an 
optimum mechanism in the presence of the SOPN for its own toxic properties in addition to 
its ability to oscillate the system and stimulate the movement of active ingredient across the 
innate barrier. 
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Figure 5.12: Histology pictographs comparing mice skin samples from a) Group A (CuNPs-
loaded aqueous cream); b) Group B (Unmedicated aqueous cream); c) Group C (CuNPs-
loaded SOPN); d) Group D (Unmedicated SOPN); e) Group E (commercial product) at days 
3, 7 and 14. 
 
5.3.10.3. Quantification of copper retention in dermal skin and blood  
Copper has increased toxicity in the inflammatory environment due to the acidic components 
and converted ionic copper is manipulated in the reduction of the hyper-proliferative 
keratinocytes of the psoriasiform-plaque.  In healthy, physiological concentrations, copper is 
an essential trace element used in cellular oxidative phosphorylation in energy production 
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pathways (Ruiz et al., 2016). The geometric CuNPs at a LD50 dose exhibited cytotoxicity 
leading the cell death via oxidative stress. After dissolution of the CuNPs, high intracellular 
concentrations of redox active copper ions induces lactate dehydrogenase and lipid 
peroxidation activity and reduces glutathione. In addition to cell death by DNA damage, loss 
of membrane integrity resulted in the toxicity initiated by anion superoxide production. Anion 
superoxide formation leads to generation of radical hydroxyl ions responsible for interference 
in physiological cellular integrity.  
 
Used in the process of toxicity to reduce the psoriatic lesion, the excess copper is disposed 
into peripheral blood supply and excreted by the kidneys. As seen in Figure 13a and b, the 
measured copper in the blood and skin at days 3, 7 and 14 of topical application increases 
steadily within the first 3 days and thereafter stabilises, reaching a steady plateau after 7 
days as the body compensates for and excretes the influx of copper within the therapeutic 
range. The relative concentration of copper detected in the skin via ICP-OES is higher than 
that of the detection in the blood indicating excretion from the blood once in systemic 
circulation. At 3 days of application of the CuNPs-loaded aqueous cream, 3.031µg/g of 
copper was detected in the blood and 3.140µg/g of copper was detected in the skin, The 
lower amount of copper detection in the blood compared with the skin is constant until the 
14th day of sampling where 3.238 µg/g and 3.300µg/g was detected in the blood and 
3.360µg/g and 3.410µg/g was detected in the skin on the 7th and 14th days, respectively. By 
the 3rd day of application of the CuNPs-loaded SOPN, the copper concentration detected in 
the blood was minimally higher at 2.873µg/g as compared to the 2.870µg/g detected in the 
skin. However, this trend did not continue and similar to the CuNPs-loaded aqueous cream 
analyses; the application of the CuNPs-loaded SOPN resulted in reduced copper 
concentrations in the blood and skin until the 14th day. 3.006µg/g and 3.050µg/g copper 
detection in the blood and 3.040µg/g and 3.100µg/g copper detection in the skin on days 7 
and 14, respectively showed the healthy metabolism and excretion of the copper. 
 
Higher concentrations found in the skin also promote the copper nanosystem as an efficient 
material drug delivery system due to its retention, thus prolonging its effect in the target area. 
The increased copper detected in the blood and skin with the application of the CuNPs-
loaded aqueous cream is due to the higher concentration of copper loading. The LD50 
concentration of the CuNPs are reduced when incorporated into the SOPN as the SOPN 
exhibits its own level of toxicity. The nanosystem embedded in the corresponding vehicles 
show to be biocompatible entities at copper doses sufficient for its designated role in cell 
death while maintaining healthy concentrations in the well-being of the in vivo model. 
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Figure 5.13: Copper retention in a) blood; b) skin. Data presented are mean ± SE of 
3experiments. *p ≤0.05 versus control. 
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5.4. Concluding Remarks 
 
The successful synthesis of geometric CuNPs and a SOPN drug delivery vehicle has been 
applied in vivo in the imiquimod-induced BALB/c mouse model. It has been shown that the 
geometry of nanoparticles affects internalization rates and by designing geometric CuNPs 
and determining the nano-shape with the highest uptake in keratinocytes, we were able to 
determine optimum nano-shape for uptake in addition to its use as a cytotoxic agent in the 
treatment of psoriasis. Cellular internalization investigations proved cube-shaped CuNPs to 
have the highest rate of uptake and were therefore used in the study. The novel SOPN was 
also studied for its biological compatibility and was adapted for use as a vehicle and 
nanoparticle-stimulus to cross the stratum corneum of the skin. In vitro, the CuNPs-loaded 
SOPN was optimized to ensure optimal oscillations at the ideal duration for enhanced 
permeation of the CuNPs across a barrier. Utilizing the toxic profiles of the CuNPs and 
SOPN at ideal concentrations and the chemical-mechanical oscillations from the SOPN, the 
system showed promising results as a new topical drug device for psoriasiform and hyper-
keratotic conditions which includes warts caused by the human papilloma virus. The BZ 
reaction has been applied in vivo with excellent results and nitric acid being present in the 
psoriasiform model allows for the safe use of the SOPN. The multi-novel designed system 
exploits geometric CuNPs as a drug delivery system for cellular internalization and the 
SOPN for stimulated movement of the CuNPs defeating a strong biological barrier and 
treating a chronic condition at a faster rate than the commercial gold-standard. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
6.1. Conclusions 
 
The advancement in the field of drug delivery is a continuous avenue of growth in 
confronting treatment limitations. Merging various aspects of this field drastically aids the 
cause of improving drug delivery due to the different views and is therefore able to satisfy 
several aims within one system. Furthermore, as is with this study, the integration of a 
multitude of fields serves as the ideal outcome to solve the challenge of chronic diseases 
and patient compliance. Material science, polymer science and drug delivery is an apt 
combination and its innovation proves beneficial in progressing each field. 
 
Numerous breakthrough psoriasis treatment strategies have been designed to surpass 
current models, however, the common limitations continue to exist and no system is fully 
efficient. Hence, the design of the geometric CuNPs for enhanced cellular uptake and 
cytotoxic effects against hyper-proliferative cells of the plaque in addition to the self-
oscillating mechanism of the SOPN to stimulate the transport of the CuNPs across the 
stratum corneum which acts as a biological barrier and impediment to dermal drug delivery. 
 
90nm spherical, rod, pyramidal, cubic and 5nm spherical CuNPs were synthesized using two 
distinctive surfactants as shape-dictating parameters. The novelty of the concept, practice 
and experiment resulted in the geometric, controlled growth of copper nanocrystals. Post in 
vitro characterization, the nanocrystals were confirmed to exist as pure copper 
corresponding to the theoretical description of the metal. The key surfactants, CTAB and 
SDS, formed a catanionic complex which coated the CuNPs during synthesis. The coating 
was adsorbed dependent on surface energy of the growing nanoparticle and selectivity of 
the adsorption based on minimising the energy in the system. The surfactant adsorption 
assisted with preventing oxidation of the copper when exposed to air and maintained its 
crystallinity.  
 
In the determination of the cytotoxic range and LD50 of the CuNPs, ex vivo analyses included 
investigation against a human keratinocyte cell line and human cervical cell line. The 
difference in toxicity between the two cell lines allowed for distinguishing the activity of 
copper on normal and cancerous cells. Showing more toxicity against the cancer cell line, it 
was concluded that the copper will be suitable in the hypothesised model. In addition, the 
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effect of shape on the internalization kinetics of the nanoparticles showed higher uptake with 
the cubic CuNPs as opposed to the rods, pyramids and spheres (5 and 90nm). The uptake 
was independent of surface charge and relied on orientation to the cell membrane. Sharp 
aspects played a role in the attachment and endocytosis rates which were confirmed by 
imaging and ICP-OES analysis. 
 
Additional ex vivo studies included permeation kinetics of the geometric CuNPs across 
epidermal mice skin samples. The transport across the simulated barrier showed delayed 
results as the copper was retained in the skin and exited the barrier upon saturation. This 
system proved to be promising seeing as the copper is required to exert its effects within the 
epidermal skin layer. Delayed flux of the CuNPs at 2-4 hours after incubation exhibited burst 
release and reached plateaux after 12-16 hours. The ex vivo environments were insufficient 
to fully investigate the effects of a geometric copper nanosystem; hence in vivo analysis was 
pursued. 
 
The SOPN was synthesised to serve as a vehicle for the geometric CuNPs and to stimulate 
the movement of the nanoparticles across the stratum corneum of the skin. This barrier is 
the source of several limitations to dermal drug delivery and the SOPN aimed to overcome 
the limitation of the barrier being a rate limiting factor hindering the permeation of 
nanoparticles. Using the inflammatory environment of the psoriasis and acidic mediators, the 
reaction stimulating the oscillations are initiated by exploiting the existing condition. On-off 
changes in the oxidative state of the catalyst ion promote hydrophilic changes in the 
responsive polymer it is cross-linked to which results in the oscillating mechanism of the 
network. In vitro investigations of the synthesized polymer determined the amplitude and 
duration of the oscillations which when applied to ex vivo permeation studies corresponded 
to the enhanced permeation rates of the CuNPs which were embedded in the SOPN. 
Inclusive ex vivo analyses probed the toxicity of the SOPN and further changes to the 
CuNPs-SOPN system were made to ensure biocompatibility and maintenance of skin 
integrity with minimal irritation. 
 
Psoriasis was induced in the BALB/c mouse by applying imiquimod on the shaved dorsal 
aspect of each mouse for 5 consecutive days. An immune reaction cascade resulted in the 
psoriasis-like plaque at the site of application which acted as the disease model for the in 
vivo investigation of the CuNPs-SOPN drug delivery system. CuNPs embedded in an 
aqueous cream base, aqueous cream, CuNPs-loaded SOPN, unmedicated SOPN and a 
commercial corticosteroid were the treatment groups used for investigation of the 
synthesised systems and comparison. The CuNPs-aqueous cream, CuNPs-loaded SOPN 
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and commercial product showed higher plaque healing than their counterpart groups with 
the CuNPs-loaded SOPN showing highest resolve. Essentially, the optimized SOPN proved 
to be a successful therapeutic option and should be considered for further trials in the control 
of psoriasis. 
 
In summary, this thesis focused on the formulation of geometric CuNPs ensuring increased 
cellular internalization as a function of shape and cytotoxicity based on the copper in vivo 
reaction. Cube-shaped nanoparticles showed the best results with regards to the discussed 
and an SOPN gel vehicle for enhanced dermal drug delivery fulfilled the role as a mediator 
for the aim. The SOPN also exhibited its own toxicity allowing for a reduction in the active 
CuNPs concentration. In essence, the limitations and barriers to improved psoriasis 
treatment was addressed by improving target cell uptake, increasing the rate of cell uptake 
of nanoparticles, dose reduction due to targeted intracellular delivery, elimination of drug-
associated side-effects and enhanced permeation through the stratum corneum as a 
biological barrier to dermal drug delivery. Thus, this invention is a novel and innovative 
addition to the treatment strategies of psoriasis and supersedes benefits to the patient.   
 
6.2. Recommendations 
 
The formulation of the CuNPs-loaded SOPN resulted in a system that satisfied the aims and 
objectives of the study. In vitro, ex vivo and in vivo analysis showed the fabrication of a 
system that is significant enough, however, additions to the study may have enhanced the 
data output.  
 
An addition to Chapter 2 in ex vivo characterization of the CuNP internalization using human 
keratinocyte cells should include TEM image investigation to elucidate the movement of 
CuNPs within the cell. Observation of the trafficking the internal location of CuNPs may give 
more insight into the site of activity induced by the copper and the preferential location of 
stability for the CuNPs. In addition, live-time imaging of the internalization process will further 
add to the interest upon viewing the endocytosis of the CuNPs and dissect the orientation 
dependence on the internalization. 
  
Furthermore, in the permeation analysis of the SOPN in Chapter 5, a cellulose membrane 
was used as the simulated barrier of the stratum corneum. Complementing the study on 
permeation kinetics of the SOPN based on the oscillations, epidermal mice skin could be 
used to determine if the flux of the CuNPs through the epidermis CuNPs was maintained or 
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if the increased trans-stratum corneum transport stimulated the permeation through the 
entire skin layer. These results would compare to that of the geometric CuNPs in Chapter 3. 
 
Although the in vivo animal study model proved to be efficient, additional analyses of 
samples could have been included. Results obtained include imaging of the psoriatic plaque 
throughout the 14 day treatment period, PASI score recording of the degrees of 
inflammation, histology analysis of the treated skin samples for a thorough investigation into 
the effects of the treatments applied, blood and skin sampling at 3, 7 and 14 day intervals to 
determine the in vivo fate of the CuNPs and confirm biocompatibility of the systems at 
systemically non-toxic doses. To enhance the current study, mouse urine should be 
collected daily or at the end of each phase (days 3, 7 and 14) for further elucidation using 
ICP-OES to detect and quantify copper excretion and tracking of the rate of copper 
metabolism. 
 
6.3. Future Outlook 
 
The crucial goal of this research was to develop a geometric CuNPs system for enhanced 
intracellular drug delivery with toxic properties embedded in a self-oscillating gel for 
promoted delivery across the skin barrier with the focal-point honing in on the improvement 
of patient compliance and reduction of the thickness of the psoriatic plaque. Ultimately, the 
optimum benefit of the CuNPs-loaded SOPN will be experienced if the system is employed 
in its entirety; however, in the application of other disease conditions, each system may be 
employed individually. Therefore, owing to the immense promise of the geometric CuNPs 
and the SOPN, disease applications may include but not limited to the following conditions: 
 
• Cancer therapy: the concept of the nanoparticles can be applied to other hyper-
proliferative cells, especially in a systemic in vivo model. The geometric property of 
the CuNPs promotes the ideology of enhanced cell uptake when compared to 
standard CuNPs intended for cancer drug delivery. This research shows the toxic 
activity of the copper while maintaining healthy copper blood levels, showing a 
biocompatible system. The nanoparticles can be tailored by surface-coating adjuvant 
chemo drugs in addition to the surfactants and targeting moieties for cancer cells. 
The dose administered will therefore differ depending on the toxicity of the chemo 
drug. 
 
• Skin cancer: as is with the geometric CuNPs in the systemic application of 
chemotherapy, it can be applied topically in the treatment of skin cancer. This would 
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call for the dual use of the SOPN to penetrate the stratum corneum barrier and target 
the epidermal hyperplasia. Topical therapy of the CuNPs coated with chemo drugs 
facilitates reduced side effects due to a lower concentration of chemo drug and a 
possible reduced therapeutic time due to intracellular delivery of the copper and drug. 
Similar to psoriasis, the geometric CuNPs would exert the same effects.  
 
• Warts: employing the CuNPs-loaded SOPN in the treatment of warts could be 
significantly effective in the prognosis of the condition. Current wart therapy has 
deleterious side effects and affects patient compliance due to the irritation of healthy 
skin exposed to the treatment or specific instructions for application. Imiquimod is 
used in wart therapy and prolonged use initiates an immune response which may 
lead to lifelong effects. In this research study, imiquimod was used as the inducing 
agent for psoriasis indicating the toxicity of the drug. Application of the CuNPs 
prevents the onset of these side effects and the cytotoxic effects are exerted on the 
hyper-keratinized lesion. The SOPN assists with potentiating the transport of the 
CuNPs lesion and exposure to healthy skin will not be detrimental to the patient.  
 
• Keratin disorders: epidermal thickening, keratinocyte proliferation, ichthyosiform 
dermatoses and acanthosis are dermal conditions which suit the application of the 
CuNPs-loaded SOPN. Current therapy focuses on reducing inflammation and 
challenges to the therapy exist as these are chronic therapies. Similar to psoriasis, 
these conditions have proliferation presentation and the cytotoxic mechanism of 
plaque resolve applies. 
 
• Calluses and corns: hypertrophy of the stratum corneum and accelerated 
proliferation of dermal cells result in callus formation commonly found on the feet. 
Also occurring on the feet, corn formation is a condition of hyperkeratosis. 
Conservative treatments for calluses and corns include corticosteroids leading to 
surgical removal. The ease of employing the CuNPs-loaded SOPN to treat these 
conditions could promote reduction of the proliferating lesion. 
 
• Dermal bacterial conditions: the neo-geometric CuNPs can be investigated for its 
activity against bacterial strains in its future use as a topical anti-bacterial agent in the 
aim of preventing antibiotic resistance by using an alternate active agent. The varied 
nano-shapes may have differed toxic effects and can be applied for its anti-bacterial 
properties in the treatment of dermal bacterial conditions. In addition, the CuNPs 
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embedded in an aqueous cream base may be a suitable vehicle for the delivery of 
the nanosystem. 
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7.2. Research Presentations 
 
7.2.1. Poster presentation – 2015 
School of Therapeutic Sciences Research Day, University of the Witwatersrand, 
Johannesburg, South Africa, September 08, 2015 
Synthesis of superstable neo-geometric cytotoxic copper nanocrystals by 
competitive, dual surfactant-mediated facet adsorption 
Karmani Murugan, Yahya Choonara, Pradeep Kumar, Lisa du Toit, Viness PillayWits 
Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, 
School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, 7 York Road, Parktown, 2193, South Africa 
Purpose: 
   The versatility of copper nanoparticles (CuNPs) facilitates its biomedical applications as a cytotoxic 
agent via oxidative stress, an antibacterial agent, an in vivo agent for imaging as well as for advanced 
drug delivery applications. By further controlling the shape of CuNPs, intracellular internalization can 
be dictated thereby enhancing copper delivery to target cells. The aim of the study was to synthesize 
homogenous, shape-specific CuNPs to promote cellular uptake of the cytotoxic nanocrystal.  
Methods: 
   Preparation of CuNPs: The synthesis of stable CuNPs of various monodisperse structural 
geometries was achieved using a bottom-up thermo-chemical reduction method. Standard 
CuSO4.5H2O solution was added to varied molar concentrations of two aliquot surfactant solutions 
heated at 50°C and thereafter reduced by ascorbic acid at 80°C. 
   Confirmation of synthesis of neo-geometric nanocrystals: TEM and High-Resolution TEM were 
conducted to confirm the synthesis of self-assembled neo-geometric NPs.   
   Confirmation of crystalline copper formation: Samples were subjected to TEM-EDS and SAED for 
high-speed elemental analysis and powder XRD was used to monitor diffraction patterns of the CuNP 
samples to validate the synthesis of crystalline copper.  
 Synthesis of stable CuNPs: The zeta potential was used to measure the surface charge of the 
CuNPs, thus indicating the stability and aggregation potential of the NPs.  
Validation of surface adsorption and coating: FTIR analysis of ascorbic acid, both surfactants and 
synthesized polymer-coated CuNPs was undertaken to evaluate, ascertain and compare vibrational 
characteristics of the chemical functional groups in response to infrared light interactions. TGA was 
conducted to evaluate the polymer-coating of the CuNP samples. 
Results: 
   The approach to the shape design involved the control of dual surfactants to direct the shape 
organization of the nanoparticles while an interesting aspect of the study showed the competitive 
adsorption of the surfactants onto the nanocrystal facets to direct facet growth. By surfactant 
competition for facet adsorption, various nano-geometries including spheres (90nm), rods, cubes, 
pyramids and spheres (5nm) were orientated while maintaining homogeneity. Additionally, it was 
discovered that the highest geometrical control occurred at a surfactant1 concentration of 0.02M and 
0.04M achieving high shape uniformity throughout the solution. XRD, SAED and EDS confirmed 
100% pure crystalline nano-structures. FTIR and TGA established the coating of the CuNPs produced 
with surfactant serving as a geometry control factor and a coat to prevent oxidation and aggregation 
of the CuNPs. 
Conclusion: 
 This approach in the synthesis of neo-geometric copper nanocrystals offers the controlled shape 
formation of copper nanocrystals and reproducibility of heterogeneous and homogenous shape-
formation based on the surfactant concentration. The CuNPs will be further used as a cytotoxic agent 
in drug delivery due to its shape-specificity and enhanced internalization properties. 
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7.2.2. Podium presentation – 2015 
36th Annual Conference of the Academy of Pharmaceutical Sciences of South Africa 
(APSSA) and the South African Association of Pharmacists in Industry (SAAPI), 
Ingelheim Boehringer Young Scientist Competition, CedarWood Conference Centre, 
Sandton, South Africa, September 18, 2015 
Surfactant directed synthesis and self-assembly of geometric cytotoxic copper 
nanocrystals  
Karmani Murugan, Yahya Choonara, Pradeep Kumar, Lisa du Toit, Viness PillayWits 
Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, Johannesburg, South 
Africa 
 Purpose: The versatility of copper nanoparticles (CuNPs) facilitates its biomedical 
applications for advanced drug delivery applications. By further controlling the shape of 
CuNPs, intracellular internalization can be dictated thereby enhancing copper delivery to 
target cells. The aim of the study was to synthesize homogenous, shape-specific CuNPs to 
promote cellular uptake of the cytotoxic nanocrystal. 
 
Methods: Preparation of CuNPs: The synthesis of stable CuNPs of various monodisperse 
structural geometries was achieved using a bottom-up thermo-chemical reduction method 
utilizing dual surfactants as shape-directing parameters.  
TEM and High-Resolution TEM were conducted to confirm the synthesis of self-assembled 
neo-geometric NPs. Samples were subjected to TEM-EDS and SAED for high-speed 
elemental analysis and powder XRD was used to monitor diffraction patterns of the CuNP 
samples to validate the synthesis of crystalline copper. Zeta potential was used to measure 
the surface charge of the CuNPs, thus indicating the stability and aggregation potential of 
the NPs. FTIR analysis of ascorbic acid, both surfactants and synthesized polymer-coated 
CuNPs was undertaken to evaluate, ascertain and compare vibrational characteristics of the 
chemical functional groups in response to infrared light interactions. TGA was conducted to 
evaluate the polymer-coating of the CuNP samples. 
 
Results: The approach to the shape design involved the control of dual surfactants to direct 
the shape organization of the nanoparticles while an interesting aspect of the study showed 
the competitive adsorption of the surfactants onto the nanocrystal facets to direct facet 
growth. By surfactant competition for facet adsorption, various nano-geometries including 
spheres (90nm), rods (decahedrons), cubes (cuboctahedrons), pyramids (tetrahedrals) and 
spheres (polyhedrons) (5nm) were orientated while maintaining homogeneity. Additionally, it 
was discovered that the highest geometrical control occurred at a surfactant1 concentration 
of 0.02M and 0.04M achieving high shape uniformity throughout the solution. XRD, SAED 
and EDS confirmed 100% pure crystalline nano-structures. FTIR and TGA established the 
coating of the CuNPs produced with surfactant serving as a geometry control factor and a 
coat to prevent oxidation and aggregation of the CuNPs. 
 
Conclusion: This approach in the synthesis of neo-geometric copper nanocrystals offers 
the controlled shape formation of copper nanocrystals and reproducibility of heterogeneous 
and homogenous shape-formation based on the surfactant concentration. The CuNPs will be 
further used in drug delivery due to its shape-specificity, thereby enhancing cellular 
internalization and resulting in elevated drug concentrations to the target area.  
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7.2.3. Poster presentation – 2015 
2015 American Association of Pharmaceutical Scientists – Annual Meeting and 
Exposition, Orange County Convention Centre, Orlando, Florida, United States of 
America, October 25, 2015 
Synthesis of superstable neo-geometric cytotoxic copper nanocrystals by 
competitive, dual surfactant-mediated facet adsorption 
Karmani Murugan, Yahya Choonara, Pradeep Kumar, Lisa du Toit, Viness Pillay 
Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa 
Purpose: 
   The versatility of copper nanoparticles (CuNPs) facilitates its biomedical applications as a cytotoxic 
agent via oxidative stress, an antibacterial agent, an in vivo agent for imaging as well as for advanced 
drug delivery applications. By further controlling the shape of CuNPs, intracellular internalization can 
be dictated thereby enhancing copper delivery to target cells. The aim of the study was to synthesize 
homogenous, shape-specific CuNPs to promote cellular uptake of the cytotoxic nanocrystal. 
Methods: 
   Preparation of CuNPs: The synthesis of stable CuNPs of various monodisperse structural 
geometries was achieved using a bottom-up thermo-chemical reduction method. Standard 
CuSO4.5H2O solution was added to varied molar concentrations of two aliquot surfactant solutions 
heated at 50°C and thereafter reduced by ascorbic acid at 80°C. 
   Confirmation of synthesis of neo-geometric nanocrystals: TEM and High-Resolution TEM were 
conducted to confirm the synthesis of self-assembled neo-geometric NPs.   
   Confirmation of crystalline copper formation: Samples were subjected to TEM-EDS and SAED for 
high-speed elemental analysis and powder XRD was used to monitor diffraction patterns of the CuNP 
samples to validate the synthesis of crystalline copper.  
 Synthesis of stable CuNPs: The zeta potential was used to measure the surface charge of the 
CuNPs, thus indicating the stability and aggregation potential of the NPs.  
Validation of surface adsorption and coating: FTIR analysis of ascorbic acid, both surfactants and 
synthesized polymer-coated CuNPs was undertaken to evaluate, ascertain and compare vibrational 
characteristics of the chemical functional groups in response to infrared light interactions. TGA was 
conducted to evaluate the polymer-coating of the CuNP samples. 
Results: 
   The approach to the shape design involved the control of dual surfactants to direct the shape 
organization of the nanoparticles while an interesting aspect of the study showed the competitive 
adsorption of the surfactants onto the nanocrystal facets to direct facet growth. By surfactant 
competition for facet adsorption, various nano-geometries including spheres (90nm), rods, cubes, 
pyramids and spheres (5nm) were orientated while maintaining homogeneity. Additionally, it was 
discovered that the highest geometrical control occurred at a surfactant1 concentration of 0.02M and 
0.04M achieving high shape uniformity throughout the solution. XRD, SAED and EDS confirmed 
100% pure crystalline nano-structures. FTIR and TGA established the coating of the CuNPs produced 
with surfactant serving as a geometry control factor and a coat to prevent oxidation and aggregation 
of the CuNPs. 
Conclusion: 
 This approach in the synthesis of neo-geometric copper nanocrystals offers the controlled shape 
formation of copper nanocrystals and reproducibility of heterogeneous and homogenous shape-
formation based on the surfactant concentration. The CuNPs will be further used as a cytotoxic agent 
in drug delivery due to its shape-specificity and enhanced internalization properties. 
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7.2.4. Poster presentation – 2015 
Molecular Biosciences Research Thrust Postgraduate Research Day 2015, University 
of the Witwatersrand, Johannesburg, South Africa, December 03, 2015 
 
Ordered Synthesis of Geometric Copper Nanocrystals for Enhanced Drug Delivery 
 
Murugan, K.1, Choonara, YE.1, Pradeep, K1. and Pillay, V1. 
1
 Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of 
Health Sciences, University of the Witwatersrand.  
 
 
Neo-geometric copper nanoparticles (CuNPs) have various applications yet its synthesis still 
proves to be challenging with regards to self-assembly and uniformity control. The synthesis 
of stable CuNPs of various monodisperse structural geometries was achieved using a bottom-
up thermo-chemical reduction method. The approach to the shape design involved the control 
of dual surfactants to direct the shape organization of the nanoparticles while an interesting 
aspect of the study showed the competitive adsorption of the surfactants onto the nanocrystal 
facets to direct facet growth. By surfactant competition for facet adsorption, various nano-
geometries including spheres (polyhedrons, 90nm), rods (decahedrons), cubes 
(cuboctahedrons), pyramids (tetrahedrals) and spheres (polyhedrons, 5nm) were orientated 
while maintaining homogeneity. Additionally, it was discovered that the highest geometrical 
control occurred at a surfactant1 concentration of 0.02M and 0.04M achieving high shape 
uniformity throughout the suspension. X-Ray Diffraction, Selected Area Electron Diffraction 
and Energy Dispersion Spectroscopy confirmed 100% pure crystalline nanocrystals. Fourier-
Transform Infrared and Thermogravimetric Analysis established the coating of the CuNPs 
produced with surfactant serving as a geometry control factor and a coat to prevent oxidation 
and aggregation of the CuNPs. This approach in the synthesis of neo-geometric copper 
nanocrystals offers the controlled shape formation of copper nanocrystals and reproducibility 
of heterogeneous and homogenous shape-formation based on the surfactant concentration. 
The CuNPs will be further used in drug delivery due to its shape-specificity, thereby 
enhancing cellular internalization and resulting in elevated drug concentrations to the target 
area. 
 
Word count: 236 words  
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South Africa, March 01, 2016 
 
MURUGAN, KARMANI  
Choonara Yahya, Kumar Pradeep, du Toit Lisa, Pillay Viness 
School of Therapeutic Sciences 
 
Dual surfactant-mediated synthesis of self-assembled geometric cytotoxic copper 
nanocrystals  
 
Neo-geometric copper nanoparticles (CuNPs) have various applications yet its synthesis still proves 
to be challenging with regards to self-assembly and uniformity control. The synthesis of stable CuNPs 
of various monodisperse structural geometries was achieved using a bottom-up thermo-chemical 
reduction method. The approach to the shape design involved the dual control of two surfactants to 
direct the shape organization of the nanoparticles while an interesting aspect of the study showed the 
competitive adsorption of the surfactants onto the nanocrystal facets to direct facet growth. 
Formulations at various concentration combinations resulted in heterogeneous or homogenous 
samples of geometries. By surfactant competition for facet adsorption, various nano-geometries 
including spheres (90nm), rods (decahedrons), cubes (cuboctahedrons), pyramids (tetrahedrals) and 
spheres (polyhedrons) (5nm) were orientated while maintaining homogeneity. Additionally, it was 
discovered that the highest geometrical control occurred at a surfactant1 concentration of 0.02M and 
0.04M achieving high shape uniformity throughout the solution. XRD, SAED and EDS confirmed 
100% pure crystalline nano-structures. FTIR and TGA established the coating of the CuNPs produced 
with surfactant serving as a geometry control factor and a coat to prevent oxidation and aggregation 
of the CuNPs. This approach in the synthesis of neo-geometric copper nanocrystals offers the 
controlled shape formation of copper nanocrystals and reproducibility of heterogeneous and 
homogenous shape-formation based on the surfactant concentration. The CuNPs will be further used 
in drug delivery due to its shape-specificity, thereby enhancing cellular internalization and resulting in 
elevated drug concentrations to the target area. 
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Surfactant directed synthesis and self-assembly of novel neo-geometric cytotoxic 
copper nanocrystals for enhanced cellular internalization 
K. Murugan1, Y.E Choonara1, P. Kumar1, L.C du Toit1, V. Pillay1 
1Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and 
Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, Johannesburg, South 
Africa 
Aim: The versatility of copper nanoparticles (CuNPs) facilitates its biomedical applications for 
advanced drug delivery applications. By further controlling the shape of CuNPs, intracellular 
internalization can be dictated thereby enhancing copper delivery to target cells. The aim of the study 
was to synthesize homogenous, shape-specific CuNPs to promote cellular uptake of the cytotoxic 
nanocrystal and investigate the internalization and toxicity profiles of the CuNPs based on its 
geometric structures. Methods & Results: The approach to the shape design involved the control of 
dual surfactants to direct the shape organization of the nanoparticles while an interesting aspect of 
the study showed the competitive adsorption of the surfactants onto the nanocrystal facets directed 
CuNP growth. TEM confirmed various monodisperse nano-geometries including spheres (90nm), 
rods (decahedrons), cubes (cuboctahedrons), pyramids (tetrahedrals) and spheres (5nm) (Figure 1). 
Additionally, it was discovered that the highest geometrical control occurred at a surfactant1 
concentration of 0.02M and 0.04M achieving high shape uniformity throughout the solution. XRD, 
SAED and EDS confirmed 100% pure copper crystalline nano-structures. FTIR and TGA established 
a 3-5% coating on the CuNPs produced with surfactant serving as a geometry control factor and 
preventing oxidation and aggregation of the CuNPs. Following the cell studies, it was conclusive that 
nano-shape significantly affects the rate at which nanostructures internalize human keratinocyte cell 
line over 24 hours, as well as the effect that shape has on cytotoxicity profiles especially differing 
between the human keratinocyte and HeLa cell lines. Conclusion: This approach in the synthesis of 
neo-geometric copper nanocrystals offers the controlled shape formation of copper nanocrystals and 
reproducibility of heterogeneous and homogenous shape-formation based on the surfactant 
concentration. The CuNPs will be further used in drug delivery due to its shape-specificity, thereby 
enhancing cellular internalization and resulting in elevated drug concentrations to the target area. 
Conclusion: This approach in the synthesis of neogeometric copper nanocrystals offers the 
controlled shape formation of copper nanocrystals and reproducibility of heterogeneous and 
homogenous shape-formation based on the surfactant concentration. The CuNPs will be further used 
in drug delivery due to its shape-specificity, thereby enhancing cellular internalization and resulting in 
elevated drug concentrations to the target area.  
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